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Transmissible spongiform encephalopathies (TSEs) or prion diseases, are 
subacute neurodegenerative diseases that infect humans and animals. Many 
of these diseases are acquired by peripheral exposure (e.g. orally). After oral 
exposure prion replication within the Peyer’s patches (PP) in the small 
intestine is necessary for the efficient spread of the disease to the brain. Within 
the intestine, bacteria and pathogenic microorganisms can affect the status of 
the gut associated lymphoid tissue (GALT). GALT consists of PP and isolated 
lymphoid follicles (ILF) that maintain homeostasis and protect from infections. 
Therefore, factors which modify GALT status, might dramatically affect oral 
prion disease pathogenesis by influencing the uptake of prions from the gut 
lumen or expanding their distribution within the host. Chronic intestinal 
helminth infections are common in animals and in man, and can cause 
significant pathology within the intestine. Little is known of the effects that 
intestinal helminth infections may have on oral prion diseases susceptibility. 
Therefore, in this study the influence that co-infection with Heligmosomoides 
polygyrus (a natural pathogen of the mouse small intestine) may have on oral 
prion disease pathogenesis and susceptibility was determined. 
The studies consisted of groups of 4 (for H. polygyrus characterization and for 
early prion detection) and 8 (for H. polygyrus-prion co-infection to terminal 
stage) mice infected with H. polygyrus (orally) alone or subsequently infected 
with ME7 scrapie prions (orally) at different time-points after parasitic 
infection. The effects of the H. polygyrus infection alone, and on oral prion 
disease pathogenesis and susceptibility were then determined. Initially the 




this parasite caused significant pathology in the small intestine and affected 
the GALT microarchitecture. In the PP follicles, H. polygyrus infection 
increased the area of follicular dendritic cell expression, altered the positioning 
of mononuclear phagocytes and increased M cell density. H. polygyrus 
infection also reduced the number of ILF in both the small and large intestines. 
Additional studies in mice co-infected with a low dose of prions, revealed that 
these pathological changes affected the survival time and disease 
susceptibility. Data also show that the extent of the effects on prion disease 
pathogenesis and susceptibility were dependent on the stage of the helminth 
infection at which the mice were orally-exposed to prions. 
Data demonstrate that co-infection with the gastrointestinal helminth H. 
polygyrus can influence oral prion disease pathogenesis and susceptibility. 
Helminth infections can significantly modify the microarchitecture of the gut 
and the GALT. Data presented suggest the pathological changes that 
pathogens such as small intestinal helminths cause, may also influence the 








Transmissible spongiform encephalopathies, are neurodegenerative diseases 
that affect the nervous system of humans and animals. Many prion diseases 
are acquired orally through consumption of contaminated food. After 
consumption, the prions (responsible for the disease) first infect the 
immunological structures in the small intestine called Peyer’s patches. In these 
structures the prions proliferate before they subsequently spread to the brain. 
Within the intestine, bacteria and other pathogenic microorganisms can 
adversely affect function of the Peyer’s patches and the cells within them. 
Therefore, co-infection with these pathogenic microorganisms might 
dramatically affect the amount of prions acquired after oral ingestion which 
may also affect disease pathogenesis and susceptibility. Worm infections are 
common in animals and in man, and can adversely affect the intestine 
structure and function. Little is known of the effects that intestinal worm 
infections may have on oral prion disease pathogenesis and susceptibility. 
Therefore, in this study, the influence that a co-infection with an intestinal 
worm called Heligmosomoides polygyrus (specific of mouse small intestine) may 
have on oral prion disease was determined. 
Initially the characterization of the effects of H. polygyrus infection on the 
intestine revealed that this parasite caused significant damage specifically in 
the small intestine breaking the epithelial barrier when the worms eat the 
intestinal villi. The infection also affected immune cell distribution within 
Peyer’s patches. Experiments were then designed to determine whether the 
worm-induced changes to the gut microarchitecture might modify oral prion 
pathogenesis. Groups of mice were orally infected with H. polygyrus and 




worm infection. The effects of the H. polygyrus infection on oral prion disease 
pathogenesis and susceptibility were then determined. Data from these 
experiments showed that prion detection rate was significantly reduced 15 
weeks post scrapie infection in Peyer’s patches and mesenteric lymph nodes. 
And, although H. polygyrus infection did not affect the incubation period, the 
survival rate or the survival time of prion disease, it does increase the duration 
of the clinical signs. However, the changes in prion disease were dependent 
on the stage of the helminth infection at which the mice were orally-exposed 
to prions. 
Data in this thesis suggests that the small intestine restricted helminth (H. 
polygyrus) causes significant changes to the gut. After oral exposure to prions, 
the initial accumulation of prions in Peyer’s patches in the small intestine is 
essential for the efficient establishment of infection. However, the pathological 
disturbances to the small intestine and Peyer’s patches caused by H. polygyrus 
infection had little influence on the early accumulation of prions in their 
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1.1 Prion diseases 
Prion diseases, are a group of progressive degenerative pathologies of the 
nervous system that can affect humans and animals [1]. The earliest recorded 
accounts of prion disease in animals date from the 18th century, when Spanish 
shepherds noticed an itchy/scraping behaviour in their sheep [2]. Later, this 
was described as a clinical sign of a prion disease pathology in the central 
nervous system (CNS) known today as scrapie. Prion diseases were first 
considered to be caused by infection with a slow-virus due to the very long 
disease incubation period [3]. With this theory in mind, many scientists tried 
unsuccessfully to inactivate the pathological scrapie agent in affected tissues 
either by using ionizing or UV irradiation, extreme temperatures and 
pressures, and other substances known to inactivate bacteria and virus [4-7].  
This indicated that the infectious prion agent was extremely resistant, and 
resistance to ionizing and UV radiation hinted that the pathogenic agent may 
be able to replicate without the need of nucleic acid [8]. This raised the 
possibility that the infectious prion agent may be mostly, or entirely, 
comprised of protein [9-12]. But it was not until the 1980’s that the term 
“prion” was used by Prusiner to describe the proteinaceous infectious particle 
which was responsible for the transmission of prion diseases [6]. Later on in 
that decade (1985), it was shown that the same protein was present in both 
infected and uninfected tissue, and that the uninfected material was linked to 
PRNP gene which  encodes the cellular prion protein (PrPC) [13, 14]. PrPC was 
later also linked with prion disease development; as mice that lack PrPC fail to 
develop prion diseases after infection [15].  
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Sporadic CJD Human 
Spontaneous conversion of PrPC 
to PrPSc [18, 19] 
Familial/Genetic CJD Human PRNP gene mutation [20] 
Iatrogenic CJD Human 
Accidental infection with prions of 
human origin via medical 
procedures [21] 
variant of Creutzfeldt-
Jakob disease (vCJD) 
Human Infection with BSE prions [22, 23] 
Gerstmann-Sträussler 
syndrome (GSS) 
Human PRNP gene mutation [24] 
Kuru Human Ritualistic cannibalism [25] 
Fatal familial insomnia Human 
PRNP gene mutation (codon 
178N and 129M) [26-28] 










mink Infectious [18] 
Chronic wasting 
disease 











domestic cats Infectious [30] 
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Infectious, sporadic and genetic forms of prion diseases have been described 
in humans and animals (Table 1.1). The acquired prion diseases include 
variant Creutzfeldt-Jakob disease (vCJD) and kuru in humans, and bovine 
spongiform encephalopathy (BSE), natural sheep scrapie, and chronic wasting 
disease (CWD) in cervids [1, 29, 31]. Past experience has shown that prion 
diseases can have a devastating impact on animal and public health.  
Rates of prion diseases in humans are low and most are sporadic. 
Approximately only 1 person per million is affected annually with 
Creutzfeldt-Jakob disease (CJD) [32]. From those about 10% are genetic 
(familial) CJD, 2-5% are infectious and iatrogenic prion diseases [33], and the 
rest correspond to sporadic prion diseases. 
However, the risk of human to human transmission remains due to the 
potential number of asymptomatic carriers [34, 35]. Data from the 
retrospective analysis of abnormal prion protein in human appendixes has 
estimated an overall prevalence of 493 per million people born between 1961 
and 1985 in the UK [34]. In cattle, BSE was shown to have zoonotic potential, 
resulting in the occurrence of vCJD in the UK human population through 
consumption of BSE-contaminated food [36, 37]. The appearance of certain 
prion diseases such as BSE in domestic animals, can result in huge economic 
losses. For example, in the United States the identification of a single case of 
classical BSE in 2003 was estimated to have caused a $4.5 billion loss due to 
the barriers to beef exports and reduced domestic consumption [38]. In the 
United Kingdom, during the BSE epidemic 3 million cattle were estimated to 
be affected with the disease, with >180,000 diagnosed. This epidemic is 
estimated to have had public cost of more than £5 billion. Meanwhile, in the 
United States, natural sheep scrapie has an annual costs from $10-20 million 
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USD associated with the production and export losses, and the disposal of 
carcases [38]. 
 
1.2 Prion disease pathology 
Prion disease pathologies within the CNS are characterized by neuronal cell 
loss, spongiform degeneration (vacuolation), gliosis, and in some cases 
amyloid plaque formation. Unfortunately, given that the brain is often the 
most affected organ, definitive diagnosis in humans can often only be 
determined by post-mortem histopathology. However, prion disease 
pathology can be clinically manifested in humans as dementia, muscle 
incoordination (gait abnormalities), tremors, visual and speech problems, 
dysphagia, and psychiatric disorders, among others [18, 39]. Since these 
manifestations are not pathognomonic of prion disease they can be easily 
misdiagnosed, especially during the early clinical stages. This may especially 
be the case for some patients with a genetic prion disease which do not have a 
known clinical history of prion disease.  However, in these instances they may 
have a history of other neurological and psychiatric disorders [40].  
The incubation period for prion disease vary: for scrapie in caprine it is 1 year 
while in ovine it is ~2 years; for BSE it is ~5 years; for kuru it is 15 years; and 
for iatrogenic CJD between 12-15 years [41]. A clinical diagnosis of probable 
prion disease can be made using complementary tests which include 
electroencephalograms, protein detection in cerebrospinal fluid and magnetic 
resonance imaging for sCJD; in the case of vCJD, neuropathological lesion 
profiles, genotype (codon 129 of the PRNP gene) and the confirmation of 
proteinase K-resistant prion protein are needed [42]. The detection of disease-
specific prion protein in biopsy samples of lymphoid tissues such as tonsil or 
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appendix is also possible; but there are currently no treatments for these 
devastating diseases [34, 43]. 
 
1.3 Cellular prion protein (PrPC)  
The cellular prion protein, PrPC, is expressed in many mammalian cells and 
tissues from the early embryogenesis stages [44]. Murine PrPC  is composed of  
208 amino acids [45], and is a glycosylphosphatidylinositol-anchored 
glycoprotein that is normally attached to the lipid bilayer of the cell surface by 
its carboxyl-terminal domain (anchor) [46]. This domain consists of a long 
flexible amino-terminal tail, three α-helices and two-stranded anti-parallel β-
sheets [47, 48]. One β-sheet is positioned towards the first α-helix while the 
second β-sheet links to the third α-helix [31, 49] (Figure 1.1). It has been 
suggested that there are some morphological differences in this protein 
domain between species. The link between the β-sheet and the third α-helix is 
considered to be rigid in cervids (elk and deer), but flexible in other species 
such as bovine and human [50].  
The flexible N-terminal domain of PrPC contains an octapeptide repeated 
region.  This  consists of a sequence of octameric amino-acid repeated five 
times [47], and is considered to have copper binding activity [51]. However, 
the precise function of each portion domain of the PrPC protein are mostly 
uncertain.  
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Figure 1.1 Cellular prion protein structure representation (taken from: 
Aguzzi A. and Heikenwalder M., Pathogenesis of prion diseases: current 
status and future outlook. Nature Reviews Microbiology, 2006.4:765-775).  (A) 
Linear representation of the PrPC (glycosyl phosphatidyl inositol (GPI)-linked 
glycoprotein) structure which shows the anchor domain to the membrane 
anchor region (MA) on the right and the N-Terminal domain on the left. It also 
highlights characteristics such as the hydrophobic core (HC in red) and 
proteinase K resistant fragment in the globular part of the structure. In the 
disordered structure, the charged cluster (CC), the octarepeat region (OR) that 
consist in a segment of five repeats of an octameric amino-acid sequence; and 
the secretory signal peptide at the extreme. High affinity epitopes recognised 
by POM2 (in blue), POM3 (in red) and POM5 (in green) monoclonal antibodies 
are also shown. (B) Bidimensional representation of the protein which in the 
base shows the glycosylphosphatidylinositol-anchored glycoprotein attached 
to the lipid bilayer of the cell (anchor), the three α-helices (yellow and red), and 
the N-terminal tail (in grey). (C) Suggested flexible (mouse, top) and rigid (elk 
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1.4 Expression and function of PrPC 
PrPC has been reported to be expressed in mammals, turtles and amphibians 
[52, 53], suggesting that this protein is highly conserved in evolution. PrPC is 
also expressed in a wide number of tissues implying that it may also have a 
variety of cellular functions. However, the evidence in this regard is not solid.  
In the brain, it has been suggested that PrPC is involved in synaptic 
transmission and plasticity [54, 55], memory formation [56, 57], calcium 
regulation [58, 59], circadian rhythm [60], neuroprotection [61, 62], and myelin 
maintenance [63] among others. Outside the brain, PrPC is also expressed in 
the skin: in pilo-sebaceus units, keratinocytes, the non-keratinocyte epithelium 
of hair follicles, dermal axons and dermal lymphocytes [64]. In lymphoid 
tissues PrPC is expressed on follicular dendritic cells (FDC) in the B cell 
follicles, and on most other immune cell types including lymphocytes, 
mononuclear phagocytes and mast cells [64-66]. PrPC had also been identified 
in different cellular subsets in the post-gastric tract (gut wall), including 
enteroendocrine cells, villus myofibroblasts, and lamina propria lymphocytes 
[64].  It is also highly expressed in cells of the enteric nervous system, including 
enteric neurones, parasympathetic neurons of the oesophagus wall, myenteric 
neurons, the submucosal plexus and smooth muscle myofibrils [64]. Although 
a similar cellular distribution of PrPC in the gastrointestinal tract has been 
suggested in different species, some differences exist.  For example, PrPC+ cells 
in the epithelium of fundic and pyloric glands are mainly in the basal 
epithelium in the rat, while in the monkey and cow they are located in the 
middle area, but the three species consistently have lower PrPC+ cells in the 
colon than in other intestinal areas [67]. In the gut-associated lymphoid tissues 
(GALT), in lambs, the expression of PrPC in lymphoid Peyer’s patches was 
lower than the submucosa and muscularis [68]. In the intestine, it has been 
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suggested that the expression of PrPC on enterocytes may be implicated in 
maintaining the integrity of cell-cell junctions (barrier property) [69-71]. While 
other studies suggest that PrPC may also be implicated in the differentiation of 
on T and B cells, natural killer cells, platelets and monocytes where it is also 
expressed [66, 72-75].  
 
1.5 Infectious prion protein (PrPSc)  
Infectious prion protein (PrPSc) is thought to be the main, if not only, molecule 
involved in the infectious pathogenesis of prion disorders. It has been 
suggested that PrPC is essential substrate for the prion disease associated agent 
(PrPSc)[15]. It is thought that the misfolding of PrPC through a posttranslational 
process from α–helical to a high β–sheet, results in the generation of PrPSc [31]. 
Besides the infective characteristics of PrPSc, it is also differentiated from PrPC 
by being insoluble in non-ionic detergents, showing only limited digestion by 
proteinase K (proteinase K resistant) and having the capacity to form 
aggregates [1, 31, 76-78]. 
 
1.6 Prion strains and host susceptibility. 
Many different strains have been identified in humans and animals. Prion 
strains may differ in the biochemical properties of PrPSc which may impact in 
the disease pathology [79, 80]. This was first demonstrated with the infection 
of C57BL and VM mice with different prion strains; mice developed prion 
disease, but with differences in the incubation period, and the severity and 
distribution of the spongiform pathology within the CNS. Furthermore, these 
characteristics were retained and remained consistent in several subsequent 
passages in the mice [81, 82]. Later, the molecular diversity of the prion agent 
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was identified in scrapie-associated fibrils resulting in the isolation of the 
strains ME7 and 139A in mice, and 263K in hamster. ME7 and 139A differ from 
263K in morphology, sedimentation rate, protein composition like 
posttranslational amino acid modification [83], and sensitivity to proteinase K 
[84]. Other strains and sub-strains, such as transmissible mink 
encephalopathy, were adapted in hamsters to the sub-strains hyper and 
drowsy. The hyper strain is characterized by the clinical signs of 
hyperexcitability and ataxia while drowsy strain produces lethargy [85]. Prion 
strain differences have also been identified in sheep [86, 87].  
The prion protein is encoded by the gene PRNP [88, 89]. In humans, the PRNP 
gene locus is situated at chromosome position 20p 12-ter [89]. This single-copy 
gene spans 16 kb, comprises two exons and encodes a 253-amino acid protein 
by its larger exon (prion protein described in Section 1.3) [90-92].  The PRNP 
gene may have polymorphisms resulting in different alleles; mainly at codons 
136, 154 and 171 [93]. The PRNP genotype may also influence host 
susceptibility to prion disease and the pathogenesis of the disease within the 
host. This means that prion strain characteristics may vary according the host 
PRNP genotype, even when the hosts are infected with the same prion strain 
[94]. Scrapie in sheep is an example of how these individual genetic 
characteristics determine host susceptibility: homozygous animals with 
ARR/ARR (representing the amino acid in codons 136, 154 and 171) are less 
susceptible to natural sheep scrapie, while animals with the VRQ/VRQ 
genotype are more susceptible in comparison with ARQ/ARQ wild type 
homozygous animals. Whereas heterozygous animals (ARR/VRQ) have 
longer incubation periods of scrapie disease [95].    
Some prion diseases in humans are associated with genetic mutations in the 
PRNP gene.  CJD and fatal familial insomnia (FFI) had been associated with 
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same genetic mutation (D178N) in the PRNP gene. However, they differ at 
another codon with a different amino acid located in the same position (codon 
129): valine (CJD) or methionine (FFI) [96].  
Although approximately 80 classical scrapie isolates (primary source of 
naturally acquired prion disease) have been described in Europe, the exact 
number of prion strains associated with distinct biological and biochemical 
phenotypes of prions is unknown [97, 98]. Strains characterization is based on 
characteristics such as: the time of clinical onset of the disease (incubation 
period), and the severity of the pathology [98-100]. Usually strains are 
characterized using transgenic mice with adapted mutation in the PRNP gene, 
as a mechanism to adapt the host to the prion strain in order to produce the 
disease. This process has limitations such as the cost to produce and maintain 
the mice line. However, three sheep strains (ME7, 87A, and 87V) had been well 
characterized in inbred mice [101, 102]. Similar studies in mice have also 
pointed to the possibility of a different strain of BSE responsible for human 
infection (zoonotic strain) [103, 104]. However, the exact strain responsible for 
the human disease zoonosis remains unknown. 
 
1.7 Routes of prion transmission 
Data suggest that acquired prion isolates may be horizontally transmitted 
between host species by a range of different exposure routes.  For example, it 
has been suggested that some prion isolates can be excreted through urine 
(experimentally in mouse [105], deer (CWD) [106], and naturally in vCJD in 
humans [107]), saliva (sheep and deer [108]), colostrum (sheep), milk (sheep), 
placenta and faeces (sheep and cervids) [109-117]. Therefore, these secretions 
either by contaminating the environment (bedding/pasture) or feed may 
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provide means of oral prion transmission. Studies also indicate that certain 
prions, such as BSE may also be vertically transmitted from an infected mother 
to developing foetus of mice expressing bovine PrP (boTg) when mated close 
to the onset of the clinical disease [118]. In humans, vCJD is considered to have 
been acquired through the oral consumption of BSE contaminated food. This 
disease (vCJD) could have also been accidentally spread to other humans 
through transfusion of blood or blood products from a vCJD infected donors 
[119]. Studies that used protein misfolding amplification (PMCA) technique 
had successfully detected PrPSc in whole-blood and in its individual fractions 
(plasma and white cells) from patients affected with vCJD [120, 121]. Other 
examples of accidental iatrogenic transmission of prion disease (CJD) in 
humans have been associated with patients that received corneal transplant 
(cases were either associated with sCJD or unspecified CJD due patient death) 
[122], and with the use of contaminated surgical instruments (this was not 
proven) [123]. 
 
1.8 Cells involved in the spread of prions from the gut lumen to the 
CNS 
Many acquired prion diseases are mainly considered to be orally acquired, 
most-likely through the consumption of prion contaminated food or pasture. 
Many studies, mostly in experimental animals (especially mice and hamsters) 
have been undertaken to determine the interactions of prions with the host 
after oral exposure, and to determine how prions establish infection in the 
brain after infecting the intestine. By understanding this process, it may be 
possible to create novel mechanisms to block the spread of prions from the gut 
to the brain, and by doing so, block oral prion disease transmission. The 
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sections below describe our current understanding of how orally-acquired 
prions establish host infection. 
 
1.8.1 M cells  
After oral ingestion, prions first transit through the epithelium which overlies 
gut associated lymphoid tissues (GALT) in the small intestine. Although 
GALT are distributed along the entire intestine, evidence suggest that the 
small intestine GALT are the essential sites for prion acquisition from the 
intestinal lumen [124], as in the specific absence of Peyer’s patches (PP), 
gastrointestinal infection with prions was blocked [125]. GALT refers to the 
lymphoid organs such as PP and isolated lymphoid follicles (ILF) which are 
distributed throughout the small and large intestines [126, 127]. GALT 
contains B cell follicles with a germinal centre and are covered by a specialised 
follicle associated epithelium (FAE) [128]. The FAE predominantly contains M 
cells, goblet cells and enterocytes. M cells are a unique subset of epithelial cells 
which function to constitutively sample the intestinal luminal contents to 
enable the mucosal immune system to mount an effective immune response 
to gut pathogens or their toxins [129]. M cell differentiation is regulated by 
stimulation from the cytokine RANKL which is produced by stromal cells in 
the sub-epithelial dome region of the GALT beneath the FAE [130, 131].  Many 
pathogens including reovirus, polio virus, and Mycobacterium avium subsp. 
paratuberculosis can use M cells to enter mucosal tissues and establish host 
infection [129, 132-134]. Furthermore, it has been suggested that for some 
pathogens such as Yersinia enterocolitica, M cells are essential intestinal 
entrance sites [135, 136]. In the absence of M cells, prion disease pathology is 
blocked [135]. Conversely, when M cells are increased, so is the susceptibility 
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of mice to oral prion infection [137]. However, other potential routes of prion 
entrance into the GALT cannot be excluded. Enterocytes are found along the 
intestine and are involved in the uptake of nutrients and macromolecules from 
the gut lumen via endocytosis [138]. A potential role for enterocytes in the 
uptake of prions from the gut lumen has been suggested [139, 140]. However, 
if this was a major route for prions to establish infection after oral exposure, 
one would not expect the prion disease pathogenesis to be blocked in the 
specific absence of M cells. 
 
1.8.2 Mononuclear phagocytes   
Mononuclear phagocytes are originated in the bone marrow [141, 142]; these 
cells evolve from pluripotent stem cells that undergo different progenitor 
stages: from granulocyte/macrophage colony-forming unit (CFU) to 
macrophage-CFU to monoblast to pro-monocyte [143]. At these stage, a 
specific differentiation begins to osteoclast progenitors (in the bone) or 
monocytes [143]. This differentiation is in response to the colony-stimulation 
factor 1(CSF1) [143]. Monocytes are released in the circulatory system to 
different body tissues.  
Monocytes differentiate into varied cell types. Over many years, it was 
considered that bone marrow monocytes differentiate into bone marrow 
macrophages in response of CSF1 [142, 143]; depending on grow factors, 
cytokines and inflammation into dendritic cells (DC); tissue resident 
macrophages (e.g. microglial cells or Langerhans cells) [144]; alternatively 
activated macrophages (M2) in response to allergic conditions, parasitic 
infections and tissue repairing process; and inflammatory macrophages (M1) 
at infection and injury sites [143]. However, nowadays there is evidence that 
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adult tissue macrophages can have an embryonic origin [145-147]; but 
whether the functionality of different-origin macrophages is 
interchangeable or specific remains unclear [145]. 
The relationship between macrophages and DC has been matter of debate. 
However, the importance of DC relies on their property to be antigen-
presenting myeloid dendritic cells and the ability to activate naïve T cells [142]. 
While the importance of macrophages is their phagocytic function to clear 
apoptotic or dying cells, as well as their ability to regulate functions and 
differentiation of neighbour cells [142]. The possible origin of the controversy 
between macrophages and DC may be natural ageing process. For example, 
yolk-sac-derived macrophages have a characteristic 
CX3CR1hiF4/80hiCD11blo expression pattern during embryogenesis [147-149]; 
but at adult stage, as many resident tissue macrophages originated during 
embryogenesis alter these cell-surface markers expression [145, 148]. These 
reduces the ability to precisely track macrophage populations. 
In the intestine the interaction of mononuclear phagocytes (DC and 
macrophage) with M cells is necessary for antigen presentation to immune 
effector cells [150]. Antigen presentation by the mononuclear phagocytes, is 
key to induce a mucosal immune response [151]. However, the role of each 
phagocyte subpopulation in infection has remained unknown due the lack of 
definitive phenotype markers for each subset. Up to date, there is an overlap 
in several surface markers between macrophages and DC (e.g., CD11c, CD11b, 
SIRPα, and the major histocompatibility complex class II (MHCII)) [150, 152].  
In PP, conventional DC (cDC) precursors derive in two subsets: cDC1 and 
cDC2. These were first identified through the expression of either CD8α 
(cDC1) or CD11b (cDC2) in addition to CD11c and MHCII [153, 154]. 
Nowadays, there are more specific markers for these subsets. For cDC1, XCR1 
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and Clec9a [155-160] and for cDC2, SIRPα. This cDC2 marker is more widely 
distributed than CD11b, but is also shared with macrophages [161]. A third 
DC subset has also been suggested. The double negative cDC (DN cDC) 
neither expresses CD11b nor CD8α [162, 163]. However, it had also been 
suggested that this subset (DN cDC) is a different stages of the cDC2 subset 
[164].  All these types of DC are present in PP domes [162, 165]. 
The identification of the macrophages in the PP has not been conclusive due 
to the lack of expression of classic macrophage markers (F4/80 (EMR1), 
sialoadhesin (Siglec1/CD169), Mannose Macrophage Receptor (MMR/CD206), 
or Fc Gamma Receptor I (FcGRI/CD64)) [166], and the overlap of CD11c, 
CD11b, MHCII, and SIRPα (surface markers), between macrophages and DC 
[152]. This led to confusion about location and functions of both dome 
phagocyte populations. 
Nevertheless, it is possible to distinguish dome cDC from monocyte-derived 
cells (dome macrophages (LysoMac) and the monocyte-derived DC (LysoDC)) 
[164, 166, 167]. Dome monocyte-derived cells express CD11c, CD11b, SIRPα, 
BST2, CX3CR1, MerTK, and lysozyme [166, 168]. Specifically, CD11c+ LysoMac 
are large long-lived cells, dependant on the growth factor M-CSF for their 
development [166], express CD4, and low levels of MHCII. Furthermore, 
according on the expression of the phosphatidylserine receptor TIM-4, there 
had been described two main subsets of LysoMac [166]. All these contrast with 
LysoDC, which are short-lived DC, express high levels of MHCII, no CD4, and 
are strongly dependent on CCR2 (chemokine receptor that allows monocyte 
egress from the bone marrow) [166]. Upon stimulation with the TLR7 agonist 
R848, LysoDC secrete IL-6 and TNF but no IL-10 [166].  
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Other type of DC in the PP are the plasmacytoid DC (pDC). These are a 
specialized subset of DC which sense viral and bacterial pathogens and release 
high levels of type I interferon (IFN-I) in response to infection [169]. pDC are 
also implicated in the pro-inflammatory activation of effector T cells, cytotoxic 
T cells, and conventional DC [169]. Like monocyte-derived cells express higher 
levels of BST2 and lower levels of CD11c and SIRPα than LysoDC and 
LysoMac [164, 166]. PP pDC are also distinguished from monocyte-derived 
cells, thanks to their B220 expression. PP pDC differentiate from the pDC in 
other tissues by their inability to secrete abundant type I IFN in response to 
the TLR9 agonist CpG [170], their reduced expression of the mucosal 
migratory receptor CCR9, and the reduction of the specific transcriptional 
regulator of the pDC lineage E2-2 [171]. Like other pDC, PP pDC are derived 
from the same precursor and induced by Flt3L [171]. The recruitment of PP 
pDC requires type I IFN/STAT1 signalling. This conditional signalling could 
be the factor that favour the production of inflammatory cytokines IL-6, IL-23, 
and tumor necrosis factor (TNF) instead of type I IFN [171]. 
In the lower part of the PP dome, phagocytes are mainly composed of 
CD11c+CD11b+ cells [162, 164, 168]. Although they were thought to be cDC2, 
these CD11c+CD11b+ cells also express CX3CR1 and lysozyme and belong to 
the monocyte-derived family of phagocytes (LysoDC and LysoMac) [164]. 
They represent two-third of subepithelial phagocytes. This contrast with the 
subepithelial dome cell population, which contains few cDC, mainly DN cDC2 
(JAM-A−CCR7−CD11b−SIRPα+ cDC) [164]. However, both subepithelial 
LysoDC and DN cDC2 can penetrate the FAE and interact with M cells, 
meanwhile LysoMac remain mainly located in the lower part of the PP [164]. 
Their different anatomical localization within PP suggests a regional 
specialization of macrophage functions [166]. 
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1.8.2.1 Mononuclear phagocytes role in prion disease 
Antigens that cross the FAE through M cells are subsequently deposited in the 
basolateral pocket of the M cell which contains mononuclear phagocytes [172, 
173]. After prions cross the epithelial barrier, they are similarly released into 
the basolateral pockets of M cells, in the sub-epithelial dome of the PP. There, 
the prions are taken up by mononuclear phagocytes where they may be either 
phagocytosed and destroyed by macrophages or conveyed to the follicular 
dendritic cells (FDC) within the B cell follicles by DC.   
Bone-marrow-derived DC have the capacity to acquire antigens directly from 
the gut lumen through dendrites that can penetrate the epithelium [174], or 
indirectly acquire them after their transcytosis across the gut epithelium by 
goblet cells [175] or M cells [176]. The antigens acquired by DC are commonly 
processed into short peptides for display on the cell surface in association with 
MHCII. These peptides are then presented to T lymphocytes to initiate a 
specific immune response to the antigen [177]. Consistent with this role, in 
vitro studies suggest that some DC can also degrade prions[178]. However, 
some DC are able to retain antigens in their native states and deliver them to 
B cells [179]. In the absence of CD11c+ DC prion neuroinvasion is impaired or 
delayed [180]. These absence of CD11c+ cells was tested in using CD11c-
diptheria toxin receptor transgenic mice where CD11c+ cells were specifically 
depleted in the GALT, and after prion infection with ME7 and 139A scrapie, 
early prion accumulation was block in GALT, and the susceptibility to prion 
disease was reduced [180]. However, this study make reference to migratory 
CD11c+ DC and as previously mentioned, this is not a specific marker of DC. 
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Outside the PP, in the intestine, macrophages tend to be positioned closer to 
the lamina propria epithelium than DC [181], possibly to enable them to 
uptake intestinal luminal antigens. These cells can also extend processes 
through the epithelial layer to trap antigens [182]. Besides the lamina propria, 
they are also situated in the serosa and muscularis layers of the intestine where 
they interact with the enteric nervous system [183, 184]. In the PP, prion 
accumulation has also been identified within macrophages of hamsters after 
oral prion infection [185]. Prion degradation by macrophages had been proved 
to reduce prion disease susceptibility after intraperitoneal inoculation of 
C57BL mice with a bovine cell line Bo120 of macrophages infected with scrapie 
brain homogenate [186]. Prion degradation had also been tested in CD11c+ 
myeloid dendritic cells in vitro [178]. This suggests that mononuclear 
phagocytes can clear the prions from the host by phagocytosing and 
destroying them.    
 
1.8.3 FDC in prion disease  
Follicular dendritic cells (FDC) are a subset of heterogeneous and non-
migratory stromal cells which reside within the B cell follicles and germinal 
centres of secondary lymphoid organs (e.g. lymph nodes, spleen, PP, ILF, 
tonsils and appendix) [187-191]. FDC characteristically trap and retain 
antigens as complement-opsonized complexes on their surface for long 
periods [191, 192]. After prions are acquired by mononuclear phagocytes, they 
are delivered to FDC where they replicate upon their surfaces before 
neuroinvasion [125, 193]. Prions are similarly acquired by FDC as 
complement-opsonized complexes [191, 194-197]. In the absence of 
complement C3 component or C1q, scrapie infection is delayed [197].  
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Prion replication on FDC within lymphoid organs had been suggested 
necessary for prion neuroinvasion [125]. However, data suggest that FDC are 
as important as their location. The small intestine PP are the essential sites for 
prion entrance and replication [139][198]. After prions accumulate in the PP, 
they then disseminate to and accumulate within FDC in the mesenteric lymph 
nodes (MLN) that drains the gut. Stimulation via tumor necrosis factor 
receptor 1 (TNFR1) through TNF and lymphotoxin (LT) α; and stimulation via 
LTβ receptor by LTα/β heterotrimers is necessary for the development of 
secondary lymphoid organs [199-203]. Activation of LTβ receptor is also 
necessary for maturation and maintenance of FDC [204]. Therefore, for prions 
to accumulate in MLN, TNF and LT are required to have optimal developed 
FDC. In the absence of lymphotoxin, prion accumulation is ablated in spleen 
and MLN, but in the absence of TNFR, prion infection was still detected in 
MLN but not in spleen [204]. Nonetheless, prion accumulation in the spleen 
does not impact prion disease development after oral exposure. In 
splenectomised mice, the percentage of survival and the incidence to prion 
disease remain the same as in control groups [205]. 
 
1.9 Prion neuroinvasion occurs via the peripheral nervous system 
Prion neuroinvasion is considered to occur via infection of the peripheral 
nerves within the lymphoid tissues [139, 206].  The prions then spread along 
these nerves to the CNS where they ultimately cause neurodegeneration and 
death of the host [207]. This is based on the detection of prion disease-specific 
PrP upon the plasma membranes of enteric neurones in the myenteric plexus 
on day 21 post oral prion infection in mice [208]. Also in hamsters PrPSc has 
been detected half-way through the incubation period within enteric ganglia 
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and the vagus nerve in accordance with a similar temporal sequence of prion 
spread to the CNS [206]. Furthermore, in mice with hyper innervated 
lymphoid organs the disease incubation period after peripheral prion infection 
was significantly reduced [207]. In contrast, the incubation period is 
significantly extended in mice that underwent sympathectomy (extraction or 
destruction of the sympathetic nerves) prior to prion infection [207]. How the 
prions initially establish infection within peripheral nerves after replication 
upon FDC is not known, but the distance between FDC and peripheral nerves 
has been shown to influence the rate of prion neuroinvasion [209]. Here DC 
have been proposed to play a role as it has been suggested that DC are able to 
transmit prion infection directly to the nervous system [210]. However, studies 
in this regard are not conclusive as mononuclear phagocytes and B cells were 
unable to transmit the disease to peripheral nervous system in the absence of 
FDC in a different study [211]. 
 
1.10 Factors which may influence prion disease pathogenesis and 
susceptibility. 
Along the life of humans and animals, individuals experience many different 
health conditions. The origin of these could be infectious, genetic, accidental, 
autoimmune, idiopathic as well as the natural process of ageing. As described 
below, the effects of these processes on the key cells and tissues mentioned 
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1.10.1 Ageing 
Over the time, physical, psychological, and even social alterations are 
accumulated. This process is known as ageing [212-214]. During ageing, M cell 
maturation and density in the FAE of PP is reduced and therefore the ability 
to transcytose particulate antigens into PP is similarly reduced [215]. In sheep, 
cattle and humans, it has been reported that age affects PP development, as 
the weight of PP in cattle and the number of PP in humans decreases over time 
[216].  
In the MLN of mice, FDC activity significantly decreases with age, as well as 
their ability to retain immune complexes [217, 218]. However, the ability of 
macrophages in the lymph nodes to uptake immune complex is not impeded 
with age [218]. In the spleen, the FDC are also affected in aged mice. Aged 
murine FDC have been reported to be atrophic, and like those in aged MLNs, 
lose their ability to efficiently trap and retain immune complex [218].  
In the spleen, there are also changes on the marginal zone, where the 
distribution of macrophages and B cells is adversely affected. The 
disorganized marginal zone may affect its ability to clear antigens from the 
blood stream and deliver immune complexes to FDC in the B cell follicles [219-
221].  
Each of these ageing-related structural and morphological changes may 
significantly influence susceptibility to peripherally acquired prion diseases. 
For example, in aged mice, prion deposition in lymphoid tissue was reduced 
[222].  Effects on M cells and PP size similarly may reduce the uptake of prions 
from the gut lumen, and help explain the reduced susceptibility of aged 
animals, humans and mice to oral prion infections. 
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1.10.2 Differences between vCJD and sCJD 
Although the ageing process may negatively affect prion disease due the 
cellular changes described above, other factors such as the type of disease may 
influence prion disease pathogenesis and susceptibility. In humans, two prion 
diseases: variant and sporadic CJD behave different. Positive cases of vCJD 
have almost exclusively been observed in people with a mean age of 29 years 
old. In these individuals the mean duration of disease was 13 months and, 
although rapid progressive dementia is rare in this disease, psychiatric 
symptoms at the onset of the disease as well as sensory symptoms (pain, 
paraesthesia (tingling sensation) and dysesthesia (unpleasant sensation felt 
when touched) are common [223]. Contrary, sCJD cases predominantly occur 
in older people (median 67 years old) with the mean duration of the illness 
around 4 months. While the rapid progressive dementia is common in sCJD, 
the psychiatry and sensory disorders are rare [223]. vCJD is also differentiated 
from other human prion diseases by the formation of amyloid plaques [224].  
 
1.10.3 Inflammation 
In the intestine, inflammation can occur following infection, with treatments 
such as non-steroidal anti-inflammatory drugs (NSAID) [225], infection with 
pathogens or parasites (e.g. Ascaris lumbricoides) [226] and certain autoimmune 
diseases (e.g. intestinal bowel diseases) [227]. Although NSAID (e.g. aspirin, 
diclofenac or ibuprofen) are commonly used, they are associated with 
gastrointestinal mucosal injury. NSAID inhibit the synthesis of prostanoids 
which derivate from the arachidonic acid by cyclo-oxigenase (COX) 
isoenzymes [228, 229]. There are two isoforms of COX; NSAID aim to inhibit 
COX2 which induces inflammation. Unfortunately, NSAID do not have 
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specific target and also affect COX1, which is present in endothelial cells, 
gastrointestinal epithelium and platelets [229]. Inhibition of COX1 reduces 
prostaglandin secretion which have a cytoprotective effect of the gastric 
mucosa [230]. The gastroenteritis associated with NSAID, led to erosions and 
ulcers of the gastrointestinal tract [231]. As with NSAID, intestinal 
inflammation may affect the integrity of the cellular epithelial junctions in the 
lining of intestine, resulting in increased gut permeability that may 
compromise intestinal epithelial barrier function [232, 233]. Damage to this 
barrier may potentially enhance the entrance of intestinal luminal pathogens 
into the host, including prions. The immune response to chronic inflammation 
may induce the formation of granulomas. As granulomas can express PrPC, 
experiments show that the they can also act as additional sites of prion 
replication in prion infected animals [234]. Also, the formation of FDC-
containing ectopic lymphoid tissues in chronically-inflamed kidneys, pancreas 
and livers, have also been shown to be potential sites of  prion accumulation 
in affected hosts [235]. In a similar response, it had been shown the neo-
formation of ILF under inflammatory conditions [236, 237]. 
The occurrence of autoimmune diseases may also have an impact on the 
pathogenesis of some prion diseases. In a study of C57BL/6J mice infected with 
1% scrapie brain homogenate and experimental autoimmune 
encephalomyelitis (EAE; characterized by the inflammation of the CNS), prion 
disease survival time was reduced. The presence of EAE did not influence the 
abundance of PrPSc in the spleen or brain. Instead, this reduction was 
considered to be due to enhanced demyelination, immune cell infiltrates, 
gliosis, and PrPSc deposition in the spinal cord [238].  
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1.10.4 Pathogen co-infection 
The inflammation and pathology that other pathogens may also cause to host 
cells and tissues may also modify prion disease pathogenesis and 
susceptibility. For example, clinical prion disease is exacerbated in mice co-
infected with adenovirus and prions [239]. However, whereas co-infection of 
NIH3T3-22L fibroblast with murine friend leukemia virus (retrovirus) can 
enhance accumulation of scrapie strain 22L prions in vitro, viral co-infection 
had no effect on prion disease pathogenesis in vivo [240].  Analysis of a natural 
co-infection model in sheep, showed that although Visna-maedi virus did not 
affect the risk of natural sheep scrapie transmission, the inflammation it 
caused in the host did favour the accumulation of prions in organs such as 
lung or inflamed mammary gland [241]. Studies in mice have also suggested 
that the inflammation caused in the cecum and colon by infection with the 
pathogenic bacterium Salmonella typhimurium (M556) increased the risk of 
prion disease in mouse model [242]. However, co-infection of mice with a 
natural helminth pathogen parasite that specifically infects the caecum of the 
large intestine (Trichuris muris), did not influence prion disease pathogenesis 
or susceptibility [198].  
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1.11 Heligmosomoides polygyrus: a model helminth pathogen with 
infection restricted to the murine small intestine 
1.11.1 Heligmosomoides polygyrus  
H. polygyrus is a nematode (round worm) of the Strongylida order and 
Trichostrongylina suborder [243]. It is a natural small intestinal helminth 
parasite of mice. However, the intensity and length of the infection depends 
on the mouse strain affected. Susceptible mouse strains such as CBA, C3H, SL, 
A/J, C57BL/6, and C57BL/10 can host chronic H. polygyrus infections which 
may last 20 weeks or more [244, 245]. Other parasites such as Haemonchus 
contortus and Teladorsagia circumcincta (ruminant parasites) or Ancylostoma 
duodenale and Necator americanus (human hookworm parasites) have close 
genetic similarities with H. polygyrus.  These similarities make H. polygyrus an 
excellent comparative model to study the mechanisms used by these parasites 
to cause chronic infections [243, 246, 247]. 
 
1.11.2 H. polygyrus life cycle 
H. polygyrus has a direct life cycle with the mouse as definitive host [245, 246]. 
The larval stage 3 (L3) is the infective form when orally acquired. Within 24 
hours of oral exposure, the larvae reach the small intestine submucosa. There, 
they undergo two moult developmental stages before emerging into the small 
intestine lumen as adult worms on or around day 8. The adult worms then 
establish infection in the lumen. There, they coil around the villi to avoid being 
expelled and feed on epithelial cells. H. polygyrus adult worms reside in the 
duodenum and jejunum where the height of the villi is longer when compared 
to other intestinal regions, allowing the parasite to wrap their highly coiled 
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bodies around them [243, 248, 249] (Figure 1.2). While in lumen, the worms 
also mate and begin to produce eggs from around day 10 of infection. The eggs 
are then excreted from the host in the faeces. Outside the mouse, the eggs hatch 
the first larval stage (L1) which undergoes two moults to become a larval stage 
L3. The life cycle starts again [248, 250].  
During its life cycle within the host H. polygyrus causes significant damage to 
the epithelium of the small intestine: both while the parasite transits in and out 
of the submucosa; and also as it feeds on it. Therefore, the disruption of the 
epithelium at those moments (days 1 and from day 8) may potentially increase 
the susceptibility of the host to another orally-acquired pathogen infection 





Figure 1.2 Location of H. polygyrus from larval to adult stages during infection in the mouse small intestine. L3 is the 
infective stage which is acquired orally by the mice. Within the first 24 hours (day 1), the larvae reach the small intestine 
submucosa. There, it undergoes two moult development-stages in 7 days and the adult worms emerge into the lumen around 
day 8. In the lumen, adult worms coil around the villi where they feed on epithelial cells, mate and produce eggs (about day 10). 
These are excreted in faeces and follow an external development until L3 to complete the cycle. 
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1.11.3 Pathological changes to the intestine caused by H. polygyrus 
H. polygyrus infection causes direct damage to the small intestinal tissue by the 
attachment of the parasite to the villi, the feeding process and the migration of 
the larvae in and out of the subepithelial layers. During infection, there are 
also multiple cellular changes as a consequence of the host immune response 
to the infection [245, 251-253].   
The enteropathological changes caused by H. polygyrus infection induce the 
modification of the villi:cript ratio, cellular reactions in mononuclear 
phagocytes, Paneth cells, goblet cells, enteritis and granuloma formation [245, 
254-256]. As a consequence of the infection other organs such as spleen or 
mesenteric lymph nodes can be also affected. A particular response of the host 
immune system is the formation of granulomas. These are developed as a 
consequence of H. polygyrus infection in the sites of larval tissue encystment. 
They are considered to be an immune response to immobilize and trap 
external bodies, parasites and bacteria and as a response to chronic 
inflammation [256-259]. These nodules consist of specialized macrophages 
surrounded by fibroblasts and lymphocytes.   
 
1.11.4 Effect of H. polygyrus infection on goblet cells 
As part of the host innate responses to H. polygyrus infection, there is an 
increased mucus secretion into the intestinal lumen. To increase mucus 
production goblet cells proliferate (hyperplasia) [260].  A main component of 
the mucus is mucin 2 (MUC2) [261]. This mucin had been correlated with the 
expulsion of other pathogenic worms such as T. muris and Nippostrongylus 
brasiliensis [262, 263].  Although there is currently no evidence of MUC2 role 
in the expulsion of H. polygyrus, these studies suggest that it is plausible MUC2 
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may a similar role in the expulsion of many gastrointestinal parasites. Goblet 
cells also secrete the antimicrobial peptide RELMβ into the gut lumen [264]. 
This protein can inhibit the ability of the H. polygyrus to feed and therefore 
reduce the worm burden and their fecundity [265]. 
 
1.11.5 Effect of H. polygyrus infection on intestinal peristalsis 
Peristalsis is the movement of muscle by contractions. In the intestine, this acts 
to facilitate the movement of the intestinal contents through the 
gastrointestinal tract.  This mechanism can be modified by the host in response 
to intestinal infections to enhance the excretion of the intestinal contents. It has 
been reported that in mice, guinea pigs, and rats, activation of the protease 
receptors (PAR2) stimulates the enteric nerves to trigger intestinal contractions 
[266-268]. In H. polygyrus infection IL-4 has been shown to stimulate hyper-
contractibility of the intestinal smooth muscle [269]. Although the activation 
of PAR2 in H. polygyrus infection is dependent on IL-4, in Trichinella spiralis 
infection, the activation of PAR1, which can also induce smooth muscle 
hypercontraction, was dependant on IL-13 but not IL-4 [269, 270]. These data 
demonstrate that although this response is considered to be an innate host 
response to pathogen infection, it can also be activated by the adaptive 
immune response through secretion of Th2 cytokines.  
 
1.11.6 Predominant Th2 response to H. polygyrus infection 
The immune protection against H. polygyrus is mainly Th2 dependent [271, 
272]. This refers to the adaptive immune response by CD4+T cells which 
differentiate into T helper cells (Th1, Th2, Th17 and regulatory T cells (Tregs)) 
[273]. Th2 cells have been closely related with the host immune response to 
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external parasites. It is considered that dendritic cells can prime Th2 response 
[274].  Th2 activation results in the production of Th2 cytokines (IL-4, IL-5, IL-
13 and IL-25) [273]. However, Th2 cells can also regulate IgE production by B 
cells [275]. Immune complexes with IgE can also activate innate immune 
response, such as basophils and mast cells. The innate immune response is also 
activated during H. polygyrus infection. Th2 cytokines are responsible for the 
alternative activation of macrophages [276-278]. Macrophages can be activated 
through pattern-recognition-receptor of microbial stimuli, by complement 
receptors (immune response), by IFN-γ stimuli (classical activation), and by 
IL-4 and 13 (alternative activation) [279]. Macrophages may be mediators of 
smooth muscle hypercontraction in helminth infections [280] and are involved 
in tissue remodelling and debris clearance [272, 281].  
 
1.11.7 Effect of H. polygyrus infection on mast cells 
Intestinal mast cell activation by Th2 cells results in their degranulation and 
the release of inflammatory mediators that can increase vascular permeability 
and smooth muscle contractions [282]. In H. polygyrus infection, mast cell 
activation (mastocytosis) is also evident and can be induced by the Th2 
cytokine, IL-9 [272]. The induction of mastocytosis during H. polygyrus 
infection has been associated with the suppression of worm fecundity [283, 
284]. Although mastocytosis has been related to epithelial barrier dysfunction, 
this may also help eliminate parasites such as H. polygyrus from the host. The 
increased secretion of intestinal fluids due to increased gut permeability is 
considered to increased worm expulsion [285-287]. 
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1.11.8 Effect of H. polygyrus infection on B cells 
During H. polygyrus infection, the activities of B cells in the MLN are also 
altered by the Th2 response to the infection [288, 289]. This results in the 
production of parasite-specific antibodies of the IgG and IgE isotypes [290]. 
However, IgE does not have a protective role in H. polygyrus infection [291], 
but IgG produced by pregnant mothers can protect their neonatal offspring 
from infection [292].   
All the above immune mechanisms triggered by H. polygyrus infection are 
aimed at clearing the parasite from the host. However, effects on the host such 
as the epithelial barrier dysfunction, the formation of granulomas, the B cell 
activation in the mesenteric lymph nodes, the goblet cell hyperplasia and even 
the hyper-stimulation of the smooth muscle may influence the establishment 
of a secondary infection.  For example, epithelial damage may increase the 
ability of another pathogen to infect host tissues, whereas increased gut 
motility may enhance the expulsion of the pathogen from the host.  
 
1.11.9 Excretory-secretory products of H. polygyrus 
Excretory-secretory products are parasite secretions which include digestive, 
urinary contents and many other substances, some which may have 
immunomodulatory effects on the host. Although the immune response to 
primary H. polygyrus infection is predominantly Th2 polarized and 
accompanied by regulatory T cell activation, it fails to achieve a fast expulsion 
of the parasite in almost all mouse strains [250, 254, 293]. Many of the 
immunomodulatory effects of H. polygyrus are likely to be the result of the 
action of its excretory-secretory products on the host, which can modulate or 
impede DC function, induce Tregs and suppress Th2 response [294-298]. Over 
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200 proteins have been identified in excretory-secretory extracts from H. 
polygyrus including macrophage migration inhibition factor and 
acetylcholinesterase [299, 300].  
Given the potent immunoregulatory properties of H. polygyrus excretory-
secretory products, it is plausible that they may also influence host 
susceptibility to a secondly pathogen infection, by modulating the immune 
response to the pathogen.  
 
1.11.10 H. polygyrus infection induces the formation of granulomas 
Granulomas are formed in host tissues as part of the host’s immune response 
to persistent antigen stimuli. These can be induced by bacteria, parasites or 
external bodies which stimulate chronic inflammation [301-305]. In the 
intestine, chronic inflammatory autoimmune disease can also cause 
granulomas [306, 307]. There are different classifications of granulomas 
according their origin or morphology [305, 308]. According to their 
morphology, granulomas can be divided into epithelioid, foreign body, 
suppurative and necrotizing [309]. Generally, granulomas contain CD4+ T 
cells, CD11c+ dendritic cells and macrophages [253, 310]. Specifically, in H. 
polygyrus infection the granulomas form as a consequence of the Th2-polarized 
immune response [253, 281, 310]. Their development begins when H. polygyrus 
larva reach the submucosa.  Here, CD11b+ macrophages cells then attach to the 
larvae and attempt to trap it [311]. The granulomas also contain Th2 cells and 
a large number of alternatively activated macrophages [253, 310]. However, 
the function of these structures in H. polygyrus infection is not known. 
Studies have shown granulomas can harbor infectious prions even in the 
absence of FDC [234]. These data suggest that during a chronic infection with 
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H. polygyrus, the induction and formation of granulomas may provide 
additional sites for prion accumulation within the gut. 
 
1.12 Project aims 
The aim of this thesis is to determine the effects of co-infection with H. 
polygyrus on oral prion disease susceptibility and duration.  Previous studies 
have shown that the uptake and replication of prions within the small 
intestinal GALT, especially the PP, is essential for their efficient transmission 
to the CNS where they ultimately cause neurodegeneration [124, 139].  After 
prions are orally acquired they first cross the gut epithelium by M cells in the 
small intestine GALT [124, 125, 135]. Then, in the sub-epithelial dome region 
of the GALT, the prions are then phagocytosed and destroyed by macrophages 
or transported by DC to the FDC in the B cell follicles [129, 139, 191, 312]. The 
FDC in the GALT are the first sites of prion replication in the intestine [191, 
194-197]. Prions may also replicate in chronic inflamed tissues in presence or 
absence, such as in granulomas, of FDC [110, 234, 313]. After the prions 
replicate upon the FDC in PP, they also disseminate inside the host, to other 
secondary lymphoid organs before they spread to the CNS (neuroinvasion) 
[125, 193, 314, 315].  Helminth infections are common in humans and animals. 
A widely used laboratory model to study small intestinal parasitic infections 
is H. polygyrus. Its infection in mice has been well characterized and numerous 
studies have described its pathological effects on the intestinal epithelium, 
goblet cell hyperplasia, mastocytosis, hypercontractibility of the smooth 
muscle, activation of macrophages and granuloma formation. Furthermore, H. 
polygyrus in mice is restricted to the duodenum in the small intestine.  H. 
polygyrus can also modulate host immunity through the activation of its 
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excretory-secretory products. This raises the hypothesis that the effects of H. 
polygyrus on the gut and GALT specifically in the small intestine may 
significantly influence oral prion disease pathogenesis and susceptibility. 
However, the effects of H. polygyrus on the microarchitecture of the GALT 
have not been studied in significant detail. Therefore, given the importance of 
the small intestinal GALT in prion pathogenesis, Chapter 3 will assess the 
effect of H. polygyrus infection on the microarchitecture of the GALT. Data 
from this chapter will be used to identify the key times after H. polygyrus 
infection with distinct pathological characteristics in the gut and GALT. These 
data will be used in Chapter 4 to identify the times after H. polygyrus infection 
in which mice will be co-infected with prions. Chapter 4 will therefore test the 
hypothesis that congruent infection with a small intestine-dwelling 
gastrointestinal pathogen may significantly influence disease pathogenesis 
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2.1 Mice strains and housing 
Female six to twelve weeks old C57BL/6J mice (Charles River Laboratories 
International, Inc. Margate, UK.) were maintained in the small animal facility 
unit under SPF conditions at The Roslin Institute. Mice were provided with 
food and water ad libitum unless otherwise stated. 
All the studies were approved by the Institute’s Ethical Review Committee 
and performed under project licence and regulations of UK Animals Scientific 
Procedures Act. 1986. 
 
2.2 Parasitic infection with H. polygyrus. 
H. polygyrus (L3, infective stage) were kindly provided by Professor Rick 
Maizels (Institute of Infection, Immunity and Inflammation; College of 
Medical, Veterinary and Life Sciences; University of Glasgow) and stored in 
sterile water at 4°C until use. 
H. polygyrus (L3) were administered to mice by oral gavage in water (~200 L3 
/ 0.2 ml). The parasitic infection was confirmed by the presence of worm eggs 
in the faeces. To count the number of eggs, two or three faecal pellets per 
mouse were collected and weighed. Faecal pellets were mixed with 1 ml sterile 
water until dissolved and left to rest for 5 min, mixed again and passed 
through a tea strainer. The faecal suspension was centrifuged for 5 min at 100g 
at room temperature and the supernatant discarded. The pellet was re-
suspended in 1 ml of flotation fluid (saturated sodium chloride (Thermo Fisher 
Scientific; Waltham, MA USA) / 50% w/v glucose (Scientific Laboratory 
Supplies Limited; Nottingham, UK.) in water), rested for 3 min and the eggs 
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were counted using a McMaster chamber and viewed using a Leica Mz-8 
stereoscopic microscope (Leica Microsystems (UK) Ltd., Milton Keynes, UK). 
 
2.3 ME7 prion infection 
Brain homogenates in sterile saline solution were prepared from mice with 
clinical signs of ME7 scrapie infection.   
For oral exposure, mice were fed individual food pellets doused with 50 μl of 
a 1% dilution of scrapie brain homogenate prepared from mice terminally-
affected with ME7 scrapie prions containing approximately 3.3 log10 i.c. ID50 
units. For infection, mice were temporarily caged individually in bedding and 
food free cages with water ad libitum. One single pellet with the prion dose was 
placed in the cage. The mice were returned to their original cages once the 
pellet was observed to be completely ingested. 
All mice infected with prions were closely monitored and scored weekly from 
day 210 after oral exposure until the clinical signs of disease appeared or the 
animal’s wellbeing was considered to be compromised. Clinical condition was 
assessed by the development of clinical signs of prion disease which include: 
loss of weight, staring coat, blinking eyes, hunched position, straight tail, wet 
genitals, gait problems, ataxia and a general decrease of awareness. 
 
2.4 Periodic acid Schiff (PAS) staining 
Snap frozen samples of intestine, Peyer’s patches (PP) and mesenteric lymph 
nodes (MLN) were stored at -20°C until mounted in OCT for sectioning at 6 
µm on a Leica CM1900 cryostat, sections mounted in Menzel-Gläser 
Superfrost Plus slides, and after drying overnight at room temperature they 
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were stored at -20°C until future use. For staining, slides were warmed up for 
30 min at room temperature before fixing them in acetone (Sigma-Aldrich 
Company Ltd.; Dorset, UK) for 10 min after which they were air dried for 15 
min. Staining was achieved using the PAS stain kit (mucin stain) from Abcam 
(Cambridge, UK) according to manufacturer instructions. Briefly, slides were 
immersed in periodic acid solution (5 min), Schiff’s solution (15 min), 
haematoxylin (modified Mayer’s) (3 min), bluing reagent (30 sec), and light 
green solution (2 min) with rinses of distilled water between each step. Slides 
were then dehydrated in a Leica Auto Stainer XL. They were washed in water 
twice (3 min each), Scott’s tap water (2 min), wash in water (2 min), ethanol 
70% (30 sec), ethanol 95% (30 sec), ethanol 95% (30 sec), ethanol 99% (1 min), 
ethanol 99% (1 min), ethanol/xylene (1 min), xylene (1 min), xylene (1 min), 
xylene (1 min).  Finally, slides were mounted with ClearVue Mountant XYL 
(Thermo Fisher Scientific). Sections were viewed using a Nikon brightfield 
compound upright microscope (Nikon; Surrey, UK.). For the analysis, the 
number of goblet cells in 4 villi per mouse were counted. Data are presented 
as the number of cells adjusted to epithelial surface length.  
 
2.5 Immunohistochemistry (IHC) 
2.5.1 Whole mount immunostaining of isolated lymphoid follicles (ILF) 
Three different areas of the gut were sampled (duodenum, ileum, and colon). 
Fresh samples of intestine (~2 cm) were used for whole mount 
immunohistochemistry. For this purpose, sections of intestine were collected 
and maintained in PBS at 4°C. Gut contents were gently squeezed out, and the 
tissues opened up and pinned down with lumen side up in a 35 mm petri dish 
filled with paraffin wax (Thermo fisher Scientific)/10% Mineral oil (Thermo 
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fisher scientific). Individual petri dishes were used per mouse; each contained 
the 3 sampled sections. The intestinal epithelium was gently washed with PBS 
to remove any remaining contents and mucus. Prior to use, the intestinal 
pieces were washed again 3 times (3 min each) with PBS on a shaker at 90 rpm.  
The intestinal epithelium was then removed by incubation in HBSS (Thermo 
fisher scientific)/5 mM EDTA (Thermo Fisher Scientific) for 15 min at 37°C. 
Tissues were then fixed in 10% formal saline (CellPath Ltd.; Wales, UK) for 1 
hr at 4°C. After fixation, the intestinal pieces were washed on the shaker as 
before using TBS-Triton (TBS (0.05M Tris pH7.6 (Sigma-Aldrich Company 
Ltd.) / 0.15 M NaCl (Thermo Fisher Scientific)) /0.5% Triton x100 (Sigma-
Aldrich Company Ltd.) and then blocked with 2.5% normal goat serum 
(Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA) for 30 min 
at room temperature. To detect follicular dendritic cells (FDC), tissues were 
then stained overnight at 4°C with 2 ml of 0.5 µg/ml anti-mouse CD35 
monoclonal antibody (clone 8C12, BD Biosciences; Ca, USA) in TBS-Triton. 
The samples were then washed as before with TBS-Triton, and subsequently 
stained with 2 ml of 4 µg/ml of Alexa Fluor 594 goat anti-rat IgG (Thermo 
Fisher Scientific) in TBS-Triton for 2 hr on a shaker at 40 rpm in the dark. To 
detect B cells, the samples were washed in TBS-Triton and consequently 
stained with 2 ml of 2 µg/ml Alexa Fluor 488 conjugated rat anti-mouse CD45R 
(B220) monoclonal antibody (Thermo Fisher Scientific) for 3 hr on a shaker at 
40 rpm. The intestinal pieces were washed again (three times) with TBS-Triton, 
and then mounted on a Menzel-Gläser Superfrost Plus slide with Dako 
fluorescence mounting medium.  
Images were taken using a Zeiss inverted confocal microscope LSM 710 
(Zeiss). The total number and area of each ILF per sample was calculated 
manually using Zen Blue software (Zeiss). One piece of intestine per small 
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intestine area (duodenum, ileum and colon) per mouse was examined. 
Calculations were adjusted to the area size. 
 
2.5.2 Whole mount immunostaining for M cells 
Fresh PP samples (approximately 1 cm long) were treated as mentioned in 
section 2.5.1 to remove the intestinal contents and mucus. Proximal and distal 
PP were placed in a petri dish. These were fixed with BD Cytofix/CytopermTM 
(BD Bioscience) for 1hr at 4°C followed by 3 washes of 3 min in PBS in a shaker 
at 90 rpm. Then, PBS-BSA-SAP (PBS / 0.5% BSA (Sigma-Aldrich Company 
Ltd.) / 0.1% Saponin (Sigma-Aldrich Company Ltd.)) was added for 30 min to 
block the fixation. The PBS-BSA-SAP was removed, and to detect M cells, the 
tissues were stained with 2 ml of 2.5 µg/ml anti-Gp2 monoclonal antibody 
(MBL International; Woburn, MA, USA.) in PBS-BSA-SAP and incubated 
overnight at 4°C. 
The PP were then washed with PBS, and 2 ml of 2.5 µg/ml of Alexa Flour 488 
conjugated goat anti-rat IgG (Thermo Fisher Scientific) in PBS-BSA-SAP was 
added and incubated for 2 hr at 40 rpm on a shaker. The PP were then washed 
with PBS and 2 ml of 5 µg/ml rhodamine conjugated Ulex Europaeus 
Agglutinin I (UEA-1, Vector laboratories Inc. Burlingame, CA, USA) in PBS-
BSA-SAP was added to detect goblet cells (UEA-1+ GP2-) and incubated for 30 
min. Tissues were washed again, and actin was detected using 2 ml of 10 µg/ml 
Alexa Fluor® 647 conjugated phalloidin (Thermo Fisher Scientific) for 2 hr 
before a brief wash in PBS prior mounting with Dako fluorescent mounting 
media on cavity slides (15 mm diameter x 0.6 mm depth; Thermo fisher 
scientific) 
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Sections were imaged using a Zeiss LSM5 Pascal (Zeiss) upright microscope 
and the analysis was performed using Zen Black software (Zeiss). Z-Stack 
images (20 Slices) of 2 PP follicles per mouse were collected to determine the 
area of the PP and the number of M cells and goblet cells. The thickness of 
imaged area ranged from 25.14 to 65.35 µm for duodenum and from 50.29 to 
90.52 µm for ileum.   
 
2.5.3 Detection of cellular markers by IHC on frozen tissues 
Immunofluorescence was used to detect a number of different cell markers on 
PP and intestine samples. The antibodies used are presented in Tables 2.5.1 
and 2.5.2.  Sections were prepared as previously described in section 2.4. Prior 
to use, slides were washed 3 times for 5 min with TBS-BSA (0.05 M Tris pH7.6 
/ .15 M NaCl / 0.2% (w/v) BSA) before adding 150 µl of 5% blocking serum 
(normal goat serum). After 20 min incubation, the first primary antibody 
(Table 2.5.1) at the appropriate concentration was added and incubated 
overnight at 4⁰C. 
Slides were then washed 3 times in TBS-BSA as mentioned above. Afterwards, 
150 µl of secondary antibody (Table 2.5.2) at the appropriate concentration in 
TBS-BSA was added and incubated for 1 hr before another series of washes in 
TBS-BSA. Consequently, when required, 150 µl of conjugated primary 
antibody (Table 2.5.1) in TBS-BSA at the appropriate concentration was added 
and incubated for 2 hrs at room temperature followed by washes in TBS-BSA.  
Washes were followed by another with PBS before counterstaining with 300 
µl of 2.9 µM DAPI (Thermo Fisher Scientific) in PBS for 3 min. After a brief 
wash in PBS the sections were mounted in Dako fluorescent mounting media. 
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Slides were visualized in a Zeiss LSM 710 Confocal Microscope. Images were 
captured using Zen Black software.   
 
Table 2.5.1 Primary antibodies used for IHC 
Target/Antigen Clone Specie/isotype Cell 
target 
Source 
GP2 2F11-C3 mouse/IgG2a M cells MBL International 
CD45 (B220) RA3-6B2 rat/IgM B cells 
 
Thermo Fisher 
Scientific / BD 
Biosciences 
CD11b M1/70 rat/ IgG2b DC, MΦ BioLegend (London, 
UK) 
CD11c N418 hamster/IgG DC BD Biosciences/ 
BioLegend 





CD21/35 7G6 rat/ IgG2b FDC BD Bioscience 
Synaptophysin 
1 





PrP 1B3 rabbit Prion 
protein 
[316] 
Iba-1 polyclonal rabbit Microglia Wako Chemicals 
GmbH (Neuss, 
Germany) 
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Table 2.5.2 Secondary antibodies used for IHC 
Antibody Source 
Alexa Fluor 488 goat anti rat IgG (H+L) Thermo Fisher Scientific  
Alexa Fluor 594 goat anti rat IgG (H+L) Thermo Fisher Scientific 
Alexa Fluor 647 Goat Anti rabbit IgG (H+L) Thermo Fisher Scientific 
Goat anti rat biotin 
Jackson ImmunoResearch 
Laboratories Inc. 





2.5.4 IHC of paraffin embedded tissues 
Paraffin embedded tissues (spleen, MLN, and PP) were used to detect CD21/35 
and PrPd. Tissues for paraffin embedding were fixed overnight in 2% 
periodate-lysine-paraformaldehyde (PLP) in phosphate buffer or for at least 
24 hrs in 10% formal saline. PLP fixed tissue samples were processed in a tissue 
processor (Leica ASP 300s; Leica microsystems) using the following program: 
70% ethanol (30 min, 37° C), 90% ethanol (30 min, 37° C), 90% ethanol (30 min, 
37° C), absolute ethanol (35 min, 37° C), absolute ethanol (35 min, 37° C), 
absolute ethanol (30 min, 37° C), xylene (30 min, 37° C), xylene (20 min, 37° C), 
xylene (20 min, 37° C), paraffin wax (10 min, 62° C), paraffin wax (15 min, 62° 
C) and paraffin wax (15 min, 62° C); all this under 35 kPa (g) pressure/vacuum 
cycle.  
Tissues fixed in formal saline were prepared using the following program: 
70% ethanol (40 min, 37° C), 90% ethanol (40 min, 37° C), 90% ethanol (40 min, 
37° C), absolute ethanol (40 min, 37° C), absolute ethanol (40 min, 37° C), 
absolute ethanol (30 min, 37° C), xylene (30 min, 37° C), xylene (30 min, 37° C), 
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xylene (30 min, 37° C), paraffin wax (25 min, 62° C), paraffin wax (25 min, 62° 
C) and paraffin wax (25 min, 62° C); under 35 kPa (g) pressure/vacuum cycle.  
After paraffin embedding, 6 µm sections were cut using a microtome, 
mounted on glass slides (Menzel-Gläser Superfrost Plus) and dried overnight 
at 50°C and stored until use. For IHC, slides were dewaxed in Leica Auto 
Stainer XL (Leica microsystems) using the following program: xylene (5 min), 
xylene (5 min), xylene (5 min), ethanol 99% (3 min), ethanol 99% (3 min), 
ethanol 95% (2 min) and washed in water (5 min). Then, the slides were 
autoclaved at 121° C for 15 min either in Target Retrieval Solution (Dako) for 
CD21/35 or in distilled water for PrPd immunostaining.  Afterwards, the slides 
were cooled for 10 min in cold running water. For detection of PrPd, the 
sections were subsequently immersed in 98% formic acid for 10 min and then 
washed for 5 min in running tap water. Slides were then immersed for 10 min 
in a 0.6% solution of hydrogen peroxide in methanol.  Then, they were washed 
5 min in PBS-BSA buffer (0.1% BSA / PBS). Sections were then blocked for 20 
min in 5% normal goat serum before overnight incubation at 4°C with 
appropriate primary antibodies (Table 2.5.1). Then slides were washed in PBS-
BSA 3 times (5 min each), and the secondary antibodies (Table 2.5.2) were 
added and incubated for 1 hr at room temperature. Slides were washed in PBS-
BSA, and ABC kit vectastain PK-6100 standard solution (Vector Laboratories 
Inc.) was added according to manufacturer instructions. After slides washed 
in PBS-BSA, immunostaining was revealed by either 3, 3’-diaminobenzidine 
(DAB; Sigma-Aldrich Company Ltd.) or Vector nova red peroxidase substrate 
kit (Vector Laboratories Inc.). Then slides were washed in running water and 
counterstained with haematoxylin and dehydrated in a Leica Auto Stainer XL 
using the following program: wash in water (5 min), haematoxylin (30 sec), 
wash in water (3 min), wash in water (3 min), Scott’s tap water (2 min), wash 
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in water (2 min), ethanol 70% (30 sec), ethanol 95% (30 sec), ethanol 95% (30 
sec), ethanol 99% (1 min), ethanol 99% (1 min), ethanol/xylene (1 min), xylene 
(1 min), xylene (1 min), xylene (1 min). Finally, slides were mounted with 
ClearVue Mountant XYL.  
Slides were visualized in a Nikon brightfield compound upright microscope 
using Zen Blue software for imaging. 
 
2.5.5 IHC analysis of brain tissues 
Brains were fixed in 10% formal saline. Paraffin-tissue embedding and cutting 
was undertaken by the Easter Bush Pathology Department (The Royal (Dick) 
School of Veterinary Studies, the University of Edinburgh).  
Slides were dewaxed as mentioned in section 2.5.4. Slides were 
immunostained to detect PrPd and glial fibrillary acidic protein (GFAP) by the 
protocol mentioned in section 2.5.4. For ionized calcium binding adaptor 
molecule 1 (Iba1) immunostaining, slides were first microwaved in citrate 
buffer solution (pH 6 of 0.29% tri-sodium citrate (BDH Laboratory Supplies; 
Dorset, UK)/0.05% Tween 20 (Amresco; Solon, Ohio, USA) in distilled water) 
for 10 min. Additional buffer was added throughout the process to ensure the 
tissue was completely immersed. Slides were then cooled in running tap water 
for 10 min. 
All the slides were then pre-treated for 10 min in a 0.6% solution of hydrogen 
peroxide in methanol before being immunostained as described in the 
protocol in section 2.5.4.   
Slides were visualized with a Nikon optic microscope using Zen Blue 
software. 
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2.5.6 Paraffin embedded tissue (PET) blot IHC detection of PrPSc. 
PLP-fixed, paraffin embedded tissue sections prepared and cut as mentioned 
in Section 2.5.4 were mounted on 0.45 µm nitrocellulose membrane (Bio-Rad 
Laboratories, Inc. Germany) [317] and dried overnight at 50°C, and stored 
until use. The sections were dewaxed (Xylene (5 min), Xylene (5 min), 
Xylene/Isopropan-2 ol (5 min), 100% Isopropan-2 ol (5 min), 95% Isopropan-2 
ol (5 min), 70% Isopropan-2 ol (5 min), 50% Isopropan-2 ol (5 min), distilled 
water (5 min) and TBST ( 0.01 M Tris pH 7.8 (Sigma-Aldrich Company Ltd.) / 
0.1 M NaCl / 0.05% Tween-20) (5 min), TBST (5 min)). Sections were then cut 
out to fit in a 24 well plate with TBST and then, the TBST was replaced with a 
solution of 0.4% proteinase K (PK; Sigma-Aldrich Company Ltd.) in 0.01 M 
Tris pH 7.8 / 0.1 M NaCl / 1% Brij (Sigma-Aldrich Company Ltd.) in water for 
overnight incubation at 55°C. 
After, the PK was removed, the membranes were washed 3 times in TBST (5 
min each). Afterwards, the sections were incubated in guanidine 
isothiocyanate solution (0.01 M Tris- pH 7.8 / 35.46% guanidine isothiocyanate 
(BD Biosciences)) for 10 min, followed by another 3 washes with TBST. Next, 
a 2% casein (disodium maleate / Western blocking reagent, Roche Diagnostics 
GmbH; Mannheim, Germany) in TBST solution was added and incubated for 
30 min. Sections were then immunostained with 1B3 anti PrP antiserum (Table 
2.5.1) for 2 hr at room temperature. The membranes were then washed and 
subsequently incubated for 1 hr with goat anti-rabbit alkaline phosphate 
(Jackson ImmunoResearch Laboratories Inc.) in 2% casein/TBST solution. 
Then, the membranes were washed 3 times, and subsequently incubated in 
sodium-tris-magnesium (NTM) solution (0.8 M Tris pH9 (Sigma-Aldrich 
Company Ltd.) / 0.99 M NaCl / 0.48% MgCl2 (Thermo Fisher Scientific)) for 10 
min. The NTM was removed and immunostaining revealed on the membranes 
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by alkaline phosphatase substrate (Sigma FastTM BCIP®/NBT, Sigma-Aldrich 
Company Ltd.). The reaction was stopped using 0.02 M EDTA solution (5 
min). Finally, the membranes were washed with distilled water and dried 
overnight before analysis and storage.  
Membranes were visualized using a Zeiss StereoLumar V12 Fluorescent 
Stereomicroscope with Zen Blue software.  
 
2.6 Image analysis of fluorescently stained sections 
The magnitude of immunostaining in specific tissue regions was determined 
using ImageJ software. Sets of images were taken under the same microscope 
settings. PP were mostly imaged under 10x objective in order to have the full 
view of the follicle and for the intestinal epithelium.  
Thresholds were established for each set of images before the color analysis. 
The thresholds were established using the Image J macro for multiple colour 
backgrounds (Appendix 7.1). To do so, a straight line was draw. This line 
should cross all the intensities of each colour in each channel. With the line 
placed in the image, the macro was run. This displayed one graph per channel 
in which the intensity of the pixels that the line cross were shown. Using these 
graphs, the minimal threshold was determined and the background colour 
avoided for further analysis.   
Image analysis for colour quantification was determined using the Image J 
macro for multiple colour analysis (Appendix 7.2). First, the macro was 
modified using the previous established thresholds. Then, the image was open 
in Image J and color/channel order was corrected (if needed) to match the 
macro (Ch1=red, Ch2=green, Ch3=blue). After selecting the area of interest 
using freehand or polygon selection, the macro was run. The result was a list 
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of numbers from 1 to 7 and their values. Each number represent a color; 
0=black, 1=red, 2=green, 3=yellow, 4=blue, 5=magenta, 6=cyan, 7=white. The 
value corresponds to the number of pixels. Considering that 0 is the lack of 
colour, primary colours (red, green and blue) are absolute, and secondary 
colours are co-localized staining (yellow=red + green; magenta=red + blue; 
cyan=blue + green; and white=red + green + blue), it was possible to determine 
the number of pixels of determined intensity in certain area.  
 
2.7 Brain pathology assessment  
Formalin-fixed brains were coronal cut in five different anatomical sections 
(cranial to caudal: septum, hippocampus, superior colliculus, cerebellum and 
medulla) and embedded in paraffin for sectioning at 6 µm. The assessment of 
the brain histopathology was blinded.  
 
2.7.1 Assessment of prion- specific spongiform encephalopathy in 
brain tissue. 
The magnitude of the spongiform pathology (vacuolation) was assessed, in 9 
different grey matter regions and 3 distinct white matter regions of the brain 
as described [94]. Sections were stained with H&E and the magnitude of 
vacuolation was determined using a scale of 0-5 index (0 represents no 
vacuolation and 5 represents dense vacuolation) in the nine grey matter areas 
(G1=medulla, G2=cerebellum, G3=superior colliculus, G4=hypothalamus, 
G5=thalamus, G6=hippocampus, G7=septum, G8=retro-splenial cortex, 
G9=cingulate and motor cortex) and a scale of 0-3 index for the 3 white matter 
areas (W1=cerebellum, W2=tegmentum, W3=basal cerebral peduncle or 
pyramidal tract).   
 




Figure 2.1. Brain pathology scoring system for PrPd, GFAP and Iba1.  
The magnitude of PrPd deposition, astrocyte and microglia reactivity was 
determined using a scale of 0-3.  Sections of brain from C57BL/6 mice infected 
with scrapie (ME7) were stained with 1B3, anti-GFAP or anti-iba1 to detect 
PrPd, astrocytes and microglia respectively. The scoring system assigns a 
value of 0 where no staining is detected and 3 where dense staining is 
detected. A score of 0 was not assigned to anti-GFAP and anti-iba1 stained 
sections as astrocytes and microglia are normally found in the areas scored. 
Representative images are shown. 
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Figure 2.2. Types of PrPSc deposition in C57BL/6 mice infected with 
scrapie (ME7). 
Each raw show a representative image at different magnification (column) of 
different types of PrPSc deposition in brain sections of C57BL/6 mice infected 
with scrapie (ME7). Deposition types were classified as fine punctate deposits, 
coarse, pericellular, perivacuolar, plaque, and perivascular deposition.  
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2.7.2 Assessment of PrPd deposition in brain tissue. 
The magnitude of the presence and the magnitude of PrPd deposition was 
assessed in 7 different grey matter regions of the brain. Sections were stained 
as described in section 2.5.5 and the magnitude of PrP was determined using 
a scale of 0-3 index (0 represents no PrPd detected and 3 represents dense 
deposition detected) (Figure2.1). The grey matter areas analysed were 
G2=cerebellum, G4=hypothalamus, G5=thalamus, G6=hippocampus, 
G7=septum, G8=retro-splenial cortex, G9=cingulate and motor cortex). Within 
each area, the type of PrPSc deposition was determined and classified as: no 
PrPd detected; fine punctate deposits; coarse deposition; and other forms of 
deposits (plaque, perivascular, perivacuolar and pericellular) (Figure 2.2).  
 
2.7.3 Assessment of astrocyte reactivity in brain tissue. 
The magnitude of astrocyte reactivity was assessed in 6 different grey matter 
regions by GFAP expression. Sections were stained as described in section 
2.5.5 and the magnitude of GFAP was determined using a scale of 1-3 index (1 
represents normal expression of GFAP detected and 3 represents dense GFAP 
expression detected) (Figure 2.1). The grey matter areas analysed were 
G4=hypothalamus, G5=thalamus, G6=hippocampus, G7=septum, G8=retro-
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2.7.4 Assessment of microglia reactivity in brain tissue. 
The magnitude of microglia reactivity was assessed in 7 different grey matter 
regions by Iba1 expression. Sections were stained as described in section 2.5.5 
and the magnitude of Iba1 expression was determined using a scale of 1-3 
index (1 represents normal expression of Iba1 detected, and 3 represents dense 
Iba1 expression detected) (Figure 2.1). The grey matter areas analysed were 
G2=cerebellum, G4=hypothalamus, G5=thalamus, G6=hippocampus, 
G7=septum, G8=retro-splenial cortex, G9=cingulate and motor cortex.  
 
2.8 Statistical analysis 
Statistical analysis was performed using GraphPad Prism 7 () and Microsoft 
Excel. Data are presented as median of individuals. Differences between 
groups were determined by one way analysis of variance (ANOVA), followed 
by Dunnett post-hoc test to compare each group with the control group. P 
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3.1 Abstract 
H. polygyrus is a natural murine helminth that specifically infects the small 
intestine and is a useful comparative model for helminth infections in humans 
and livestock. Although the host immune response to H. polygyrus infection 
has been well characterized, the influence of the parasite on the 
microarchitecture of the intestine and the gut associated lymphoid tissues 
(GALT) has not been described. GALT consist of Peyer’s patches (PP) and 
isolated lymphoid follicles (ILF). These tissues help to protect from infections 
and maintain the homeostasis of the intestine. These functions may be 
enhanced or compromised by H. polygyrus infection or the actions of its 
excretory products. This chapter shows that H. polygyrus infection increases 
the size of follicular dendritic cells (FDC) in PP follicles. H. polygyrus infection 
also altered the positioning of mononuclear phagocytes within PP and 
reduced the number of ILF in both the small and large intestines. These data 
demonstrate that H. polygyrus infection significantly alters the 
microarchitecture of the GALT. H. polygyrus infection also induces the 
formation of granulomas (lymphoid cell aggregates surrounded by fibroblasts 
formed as an inflammatory response) in the gut wall. These granulomas could 
be characterized into different developmental stages and were first detected 
from day 8 post infection.  
Data presented in this chapter confirmed that H. polygyrus infection was 
specific to the small intestine and identified significant effects on FDC, 
mononuclear phagocytes, and M cells which are also known to have an active 
role in prion disease pathogenesis. Since granulomas are also important sites 
of prion accumulation, their induction during H. polygyrus infection may also 
serve as a prion accumulation site. These data will be used to inform the design 
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of the studies of the subsequent chapter which will determine the effects of 
congruent infection with H. polygyrus and prion diseases. 
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3.2 Introduction 
H. polygyrus is a natural mouse small intestine restricted helminth parasite and 
has been widely used as a comparative model to study human (Ancylostoma 
duodenale, Necator americanus) and livestock (Haemonchus contortus, Teladorsagia 
circumcincta) helminths, due its similar phylogenetic origin [247]. Although H. 
polygyrus has been well characterized, little is known of the possible 
implications of parasitic co-infections on the pathogenesis of infectious prion 
diseases.  
Within the intestine, luminal antigens are taken up into the gut associated 
lymphoid tissues (GALT) via the specialised follicle associated epithelium 
(FAE) [318, 319]. In the FAE of GALT (Peyer’s patches (PP) and isolated 
lymphoid follicles (ILF)) reside M cells which sample intestinal contents [129, 
320]. Dendritic cells may also be able to perform this function by extending 
their dendrites into the gut lumen and directly sampling the contents [173, 321, 
322]. Smaller antigens can also cross the gut epithelium via goblet cells and 
enterocytes [139, 175, 323]. Once the antigens are taken up from the intestinal 
lumen by any of these cells, they are subsequently acquired by macrophages 
or dendritic cells [208, 323, 324]. 
During nematode infections (including H. polygyrus), the host develops 
enteritis (small intestine inflammation) [254], goblet cells hyperplasia [260], 
mastocytosis [283], and epithelial damage. These inflammatory processes can 
affect the permeability of the intestine by weakening the tight junctions 
between the epithelial cells [254, 325, 326]. These alterations to the gut could 
potentially enhance the uptake of other pathogens during the parasitic 
infection. Increased antigen uptake had been reported in Crohn’s disease 
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affected ileum with low grade inflammation [327, 328]. However, the effect of 
H. polygyrus on antigen uptake has not been studied. 
The aim of this chapter, therefore, is to characterize the effects of H. polygyrus 
infection on GALT and gut microarchitecture. These data will then be used in 
the subsequent chapter to study their potential effects on oral prion disease 
pathogenesis and susceptibility. 
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3.3 Results 
3.3.1 Confirmation of H. polygyrus infection 
C57BL/6J female mice (90 days old) were orally infected with 200 L3 by 
gavage. To confirm the infection, individual faecal samples were analysed to 
determine the number of eggs/g of faeces using the McMaster technique. 
Figure 3.1 shows fecal egg burden on days 11, 18, 25 and 32 post infection. The 
maximum egg production was reached on day 18 with a mean of 1522 eggs/g 
of faeces. These data confirmed that H. polygyrus had established a chronic 
infection which lasted at least 32 days.  
 
 
Figure. 3.1 Mean faecal egg burden following infection of C57Bl/6 mice 
with H. polygyrus. Groups of 4 female C57Bl/6J mice were orally infected 
with 200 L3 larvae, and the number of eggs in faeces was determined at 
intervals afterwards. Each bar represents mean ± SD number of egg/g of 
faeces from 4 individual samples. 
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3.3.2 Effect of H. polygyrus on villi microarchitecture 
The intestinal epithelium consists of a permeable mono-cellular layer that act 
as a barrier in contact with the exterior, and it has been suggested that a 
dysfunction of this can predispose to other disease [329, 330].  To determine 
the effect of H. polygyrus infection on villus microarchitecture, groups of mice 
infected with H. polygyrus were culled at different times (days 1, 3, 8, 14, 21, 
and 35) post infection and tissues were collected for analysis. Snap frozen 
sections of duodenum, ileum and colon were H&E stained. Figure 3.2 shows 
that damage to the epithelium and the presence of worms were evident in the 
duodenum from day 8 onwards; in the ileum there were no evident changes 
until day 14 when there was an apparent increase of goblet cells. In the colon, 
no changes were observed.  
Next, the effect of H. polygyrus on villus length, width, and perimeter were 
determined. Usually, 8 to 12 duodenal villi and 8 to 14 ileal villi were analysed 
per mouse for each characteristic. To determine villus width, each villus width 
was measured at the base (from crypt to crypt), at the middle of the villus 
length and at the top; and the mean of these measurements determined. Figure 
3.3A, shows the effects of H. polygyrus infection on duodenal villi. This analysis 
showed that although H. polygyrus infection did not alter villus length or 
perimeter, there was a significant increase in villus width (p≤0.011) on days 8 
and 14 post infection. In contrary, assessment of the villi in the ileum did not 
reveal any significant difference in villus width (Figure 3.3B). However, there 
were significant differences in villus length (p=0.035) and perimeter (p=0.019) 
at day 1 post infection. No effect of H. polygyrus infection on the histopathology 
of the colon was observed (Figure 3.3C).  
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These data confirm that changes to the villi caused by H. polygyrus infection 
are restricted to the small intestine. The changes predominantly consist of 
damage to the epithelium, an increase in villus width in the duodenum; and 















Chapter 3. Effect of H. polygyrus infection on the gut microarchitecture and the gut associated lymphoid tissues (GALT)  64 
 
Figure 3.2 Effect of oral H. polygyrus infection on the gut epithelium.  Groups of 4 female C57Bl/6J mice were orally infected 
with 200 L3 larvae, and the duodenum, ileum and colon collected at intervals afterwards and H&E stained tissue sections 
analysed by microscopy. In the duodenum, damage of the epithelium (red arrows), and the presence of worms (black arrows) 
were visible on days 8 and 14 post infection. In ileum, on day 14, unstained spaces apparently correspond to goblet cells (green 
arrows).  
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Figure 3.3 Effect of oral H. polygyrus infection on the morphology of the 
gut epithelium. Groups of female C57Bl/6 mice were orally infected with 200 
L3 larvae, and the duodenum, ileum and colon collected at intervals afterwards 
and H&E stained tissue sections analysed by microscopy. Villus length, width 
and perimeter were determined in (A) the duodenum, and (B) the ileum. Data 
show mean ± SD for 4 mice/group. 8-12 villi/mouse were measured in the 
duodenum, and 8-14 villi/mouse were measured in the ileum. (C) Crypt depth 
was compared in the colon in 3 distinct regions in 3-4 mice/group. Significant 
differences to the naïve group were compared by ANOVA, followed by 
Dunnett’s multiple comparison test. 
 
 
3.3.3 Effect of H. polygyrus on goblet cells 
To determine the effect of H. polygyrus infection on goblet cells, sections of 
duodenum were stained with Periodic acid–Schiff (PAS). Figure 3.4A shows 
the abundance of goblet cells (magenta) at different days post H. polygyrus 
infection. Goblet cell hyperplasia was clearly evident on day 14 post infection. 
Quantitative analysis of goblet cells density in the gut epithelium revealed a 
statistically significant increase in the number of goblet cells (p≤0.023) in 
duodenum on days 14 and 21 post H. polygyrus infection (Figure 3.4B). 
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Figure 3.4 Effect of oral H. polygyrus infection on goblet cell density in 
the duodenum. Groups of female C57Bl/6 mice were orally infected with 200 
L3 larvae, and the duodenum collected at intervals afterwards and PAS 
stained to detect goblet cells. (A) Images show the abundance of PAS+ goblet 
cells (magenta) in representative samples from the duodenum at each time 
point. Sections were counterstained with haematoxylin (blue) to detect cell 
nuclei. (B) Morphometric analysis of goblet cell density in the villous epithelium 
in the duodenum. Data were obtained from four villi/mouse and show mean ± 
SD for 4 mice/group. Significant differences to the naïve group were compared 
by ANOVA, followed by Dunnett’s multiple comparison test. 
 
3.3.4 Effect of H. polygyrus on mononuclear phagocytes in the lamina 
propria of the small intestine. 
Mononuclear phagocytes in the lamina propria of the small intestine 
(duodenum and ileum) were also analysed by immunohistochemistry (IHC) 
at different time-points post H. polygyrus infection. The markers used to detect 
the mononuclear phagocytes were CD11c, CD68, and CD11b (Figures 3.5A 
and 3.6A). A statistically significant increase in the level of CD11b+ staining 
(p=0.0068) in the lamina propria of the duodenum was observed at day 21 post 
infection (Figure 3.5B). Levels of CD68+ and CD11c+ staining (Figure 3.5B) were 
unchanged. A similar trend was also observed in the ileum (Figure 3.6B). 
CD11b+ staining was significantly increased on day 21 (p=0.0469), whereas 
CD11c+ and CD68+ staining appeared unchanged. Nonetheless, it is important 
to notice that the significant increase of CD11b+ staining in the ileum is caused 
by the high staining levels in only one of the four mice studied. However, these 
data show that H. polygyrus significantly influenced CD11b+ expression in the 
lamina propria of the small intestine.  
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Figure 3.5 Effect of oral H. polygyrus infection on the distribution of mononuclear phagocytes in the lamina propria of 
the duodenum. Groups of female C57Bl/6 mice were orally infected with 200 L3 larvae, and the duodenum collected at intervals 
afterwards. (A) Sections were immunostained to detect CD11c+ (green), CD68+ (blue), CD11b+ (red) mononuclear phagocytes, 
and counterstained with DAPI (white) to detect cell nuclei. (B) Morphometric analysis of the % area CD11c+, CD68+ or CD11b+ 
immunostaining in the lamina propria. Each point represents the data from individual mice (3-4 mice/group). Horizontal bar 
represents the median of the group. Significant differences to the naïve group were compared by ANOVA, followed by Dunnett’s 
multiple comparison test. 
 
 




Chapter 3. Effect of H. polygyrus infection on the gut microarchitecture and the gut associated lymphoid tissues (GALT)  72 
 
Figure 3.6 Effect of oral H. polygyrus infection on the distribution of mononuclear phagocytes in the lamina propria of 
the ileum. Groups of female C57Bl/6 mice were orally infected with 200 L3 larvae, and the ileum collected at intervals afterwards.  
(A) Sections were immunostained to detect CD11c+ (green), CD68+ (blue), CD11b+ (red) mononuclear phagocytes, and 
counterstained with DAPI (white) to detect cell nuclei. (B) Morphometric analysis of the % area CD11c+, CD68+ or CD11b+ 
immunostaining in the lamina propria. Each point represents the data from individual mice (3-4 mice/group). Horizontal bar 
represents the median of the group.  Significant differences to the naïve group were compared by ANOVA, followed by Dunnett’s 
multiple comparison test. 
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3.3.5 Effect of H. polygyrus infection on enteric nerves  
Studies suggest that the spread of oral prion infection to the central nervous 
system is through enteric nerves [206, 331, 332] and thus the effect of H. 
polygyrus infection on enteric nerves was determined.  To identify the presence 
of nerves, sections of small intestine were stained with anti-synaptophysin-1 
to detect synaptic vesicles (Figure 3.7A). Levels of synaptophysin-1 staining 
were unchanged at any of the time-points after H. polygyrus infection (when 
compared to the naive group (Figure 3.7B). As PrPSc needs PrPC as substrate, 
the level of PrPC on enteric nerves was determined in a parallel set of duodenal 
sections. Representative images from each time-point post infection are 
presented in Figure 3.8A. PrPC staining levels were also unchanged when 
compared to the naive group (Figure 3.8B). Together, these data suggest there 
was no significant effect of H. polygyrus infection on enteric nerve status in the 
lamina propria.  
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Figure 3.7 Effect of oral H. polygyrus infection on the distribution of 
synaptophysin-1 expressing enteric nerves in the lamina propria of the 
duodenum. Groups of female C57Bl/6 mice were orally infected with 200 L3 
larvae, and the duodenum collected at intervals afterwards. (A) Sections were 
immunostained to detect synaptophysin-1 (green), CD11b (red) and 
counterstained with DAPI (orange) to detect cell nuclei. Non-specific staining 
localized out of the lamina propria (e.g. Day 8) was not considered for analysis. 
(B) Morphometric analysis of the % area synaptophysin-1+ immunostaining in 
the lamina propria. Each point represents the data from individual mice (3-4 
mice/group). Horizontal bar represents the median of the group. Significant 
differences to the naïve group were compared by ANOVA, followed by 
Dunnett’s multiple comparison test. 
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Figure 3.8 Effect of oral H. polygyrus infection on the distribution of PrPC 
expressing enteric nerves in the lamina propria of the duodenum.  Groups 
of female C57Bl/6 mice were orally infected with 200 L3 larvae, and the 
duodenum collected at intervals afterwards.  (A) Sections were immunostained 
to detect PrPC (green), CD11b (red) and counterstained with DAPI (orange) to 
detect cell nuclei. (B) Morphometric analysis of the % area PrPC+ 
immunostaining in the lamina propria. Each point represents the data from 
individual mice (3-4 mice/group). Horizontal bar represents the median of the 
group. Significant differences to the naïve group were compared by ANOVA, 
followed by Dunnett’s multiple comparison test. 
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3.3.6 Effect of H. polygyrus infection on the number and size of ILF 
ILF are dynamic lymphoid structures similar to the Peyer patches that may 
uptake and replicate prions [333-335]. In order to determine if ILF density or 
size was altered during H. polygyrus infection, pieces of duodenum, ileum and 
colon were whole-mounted immunostained with B220 antibody to detect the 
B cell clusters (ILF) at different times post H. polygyrus infection (Figure 3.9A 
to 3.11A). The density and the area of ILF were calculated in each sample. In 
the duodenum (Figure 3.9A), there was a statistically significant reduction in 
the number of ILF (p=0.038) on day 14 post H. polygyrus infection (Figure 3.9B). 
In the ileum (Figure 3.10A) no statistically significant effects of H. polygyrus 
infection on either the number (Figure 3.10B) or size (Figure 3.10C) of the ILF 
were detected. Meanwhile, in the colon (Figure 3.11A), there was a statistically 
significant reduction in the number of ILF (p=0.018) on day 14 post H. 
polygyrus infection (Figure 3.11B), but the size of the ILF was not altered 
(Figure 3.11C). Therefore, these data show that H. polygyrus infection 
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Figure 3.9 Effect of oral H. polygyrus infection on the density of isolated 
lymphoid follicles (ILF) in the duodenum. Groups of female C57Bl/6 mice 
were orally infected with 200 L3 larvae, and the duodenum collected at 
intervals afterwards. (A) 2 cm portions of duodenum were whole-mount 
immunostained using B220 to detect B cell clusters (ILF) (white arrows, green). 
Orange arrows show sites of H. polygyrus damage to epithelium.  
Morphometric analysis of the (B) number of ILF and (C) the mean ILF area in 
each sample. Each point represents data from individual mice (4 mice/group).  
Horizontal bar represents the median of the group. Significant differences to 
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Figure 3.10 Effect of oral H. polygyrus infection on the density of isolated 
lymphoid follicles (ILF) in the ileum. Groups of female C57Bl/6 mice were 
orally infected with 200 L3 larvae, and the ileum collected at intervals 
afterwards. (A) 2 cm portions of ileum were whole-mount immunostained using 
B220 to detect B cell clusters (ILF) (white arrows, green). Morphometric 
analysis of the (B) number of ILF and (C) the mean ILF area in each sample.  
Each point represents data from individual mice (4 mice/group). Horizontal bar 
represents the median of the group. Significant differences to the naïve group 
were compared by ANOVA, followed by Dunnett’s multiple comparison test. 
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Figure 3.11 Effect of oral H. polygyrus infection on the density of isolated 
lymphoid follicles (ILF) in the colon. Groups of female C57Bl/6 mice were 
orally infected with 200 L3 larvae, and the colon collected at intervals 
afterwards. (A) 2 cm portions of colon were whole-mount immunostained using 
B220 to detect B cell clusters (ILF) (white arrows, green). Morphometric 
analysis of the (B) number of ILF and (C) the mean ILF area in each sample.  
Each point represents data from individual mice (4 mice/group). Horizontal bar 
represents the median of the group. Significant differences to the naïve group 
were compared by ANOVA, followed by Dunnett’s multiple comparison test. 
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3.3.7 Influence of H. polygyrus infection on the FAE overlying the 
Peyer’s patches. 
M cells which sample luminal antigens such as prions or bacteria are present 
in the FAE of the Peyer’s patches [336-338]. Goblet cells are also present, and 
it has been suggested that these can also act as antigen entrance sites [175, 323]. 
To assess the effect of H. polygyrus infection on the PP microarchitecture, at 
each time-point, one duodenal and one ileal PP were whole mounted 
immunostained to detect M cells (GP2+cells; green) and goblet cells (GP2-UEA-
1+ cells; red) (Figures 3.12A & 3.13A). From each image, the area of each FAE 
was measured as well as the number of M cells and goblet cells within them. 
No statistically significant effect of H. polygyrus infection on the area of the 
FAE in duodenum (Figure 3.12B) or ileum (Figure 3.13B) was detected. 
However, in the duodenum, M cell density was statistically significantly 
increased (p=0.0003) on day 35 post H. polygyrus infection (Figure 3.12C). In 
the ileum, H. polygyrus infection had no statistically significant effect on M cell 
density (Figure 3.13C). The density of goblet cells was also statistically 
significantly increased on days 14, 21 and 35 in the duodenum (Figure 3.12D; 
p≤0.0026), and on days 21 and 35 (Figure 3.13D; p≤0.039) in ileum. These data 
demonstarte that H. polygyrus infection significantly increased the density of 
M cells and goblet cells in the FAE of PP.  
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Figure 3.12 Effect of oral H. polygyrus infection on the density of M cells 
and goblet cells in the follicle-associated epithelia (FAE) overlying the 
Peyer’s patches (PP) in the duodenum. Groups of female C57Bl/6 mice 
were orally infected with 200 L3 larvae, and the duodenum collected at 
intervals afterwards. (A) PP were whole-mount immunostained to detect M 
cells (Gp2+ cells, green) and goblet cell (UEA-1+ cells, red). Tissues were 
counterstained to detect F-actin (blue).  Morphometric analysis of the (B) mean 
FAE size in each PP, (C) M cell (Gp2+UEA-1- cells) density, and (D) goblet 
cell density (Gp2-UEA-1+ cells). Each point represents mean data from two 
FAE from 2-4 mice/group. Horizontal bar represents the median of the group.  
Significant differences to the naïve group were compared by ANOVA, followed 
by Dunnett’s multiple comparison test. 
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Figure 3.13 Effect of oral H. polygyrus infection on the density of M cells 
and goblet cells in the follicle-associated epithelia (FAE) overlying the 
Peyer’s patches (PP) in the ileum. Groups of female C57Bl/6 mice were 
orally infected with 200 L3 larvae, and the ileum collected at intervals 
afterwards. (A) PP were whole-mount immunostained to detect M cells (Gp2+ 
cells, green) and goblet cell (UEA-1-binding cells, red). Tissues were 
counterstained to detect F-actin (blue).  Morphometric analysis of the (B) mean 
FAE size in each PP, (C) M cell (Gp2+UEA-1- cells) density, and (D) goblet 
cell density (Gp2-UEA-1+ cells). Each point represents mean data from two 
FAE from 2-4 mice/group. Horizontal bar represents the median of the group. 
Significant differences to the naïve group were compared by ANOVA, followed 
by Dunnett’s multiple comparison test. 
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3.3.8 Effect of H. polygyrus infection on mononuclear phagocytes in the 
Peyer’s patches. 
Mononuclear phagocytes (macrophages and dendritic cells) have the ability to 
sample the lumininal content [321, 339], and in the absence of CD11c+ cells oral 
prion infection is impaired [180], suggesting a necessary role in oral prion 
infection. To determine if this cells are affected by H. polygyrus infection, PP 
sections were immunostained to detect CD11c+ and CD68+ mononuclear 
phagocytes (Figure 3.14). An increased abundance of CD11c+ and CD68+ 
mononuclear phagocytes was observed on day 8 post infection in the PP of 
duodenum and ileum (Figure 3.14).  
PP areas were next divided into three distinct regions: dome (from crypt to 
crypt), middle and base (Figure 3.15A). In the duodenum no statistically 
significant differences in the overall abundance of these cells was observed 
(Figure 3.15 All). However, detailed analysis of the different regions of the 
duodenal PP, showed that after H. polygyrus infection, the expression of CD68 
was statistically significantly increased in the base of the PP folicles (Figure 
3.15B) on day 1 and 14 post infection (p≤0.046) when compared to naive mice. 
The distribution of CD11c expression in duodenal PP was unchanged. In the 
ileum, no statistically significant changes in the expression of CD11c+ or CD68+ 
cells were detected (Figure 3.16). These data show that although H. polygyrus 
infection do not significantly affect the abundance of CD11c+ and CD68+ 
mononuclear phagocytes in the PP follicle, CD68+ cells concentrated in the base 
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Figure 3.14 Effect of oral H. polygyrus infection on mononuclear phagocytes in the Peyer’s patches of the duodenum 
and ileum. Groups of female C57Bl/6 mice were orally infected with 200 L3 larvae, and Peyer’s patches collected at intervals 
afterwards. Sections were immunostained to detect CD11c+ (green), CD68+ (red), and counterstained with DAPI (blue) to detect 
cell nuclei. Upper panels, duodenal PP; lower panels, ileal PP. Images are representative of one mice/group 
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Figure 3.15 Effect of oral H. polygyrus infection on the distribution of 
mononuclear phagocytes in the Peyer’s patches (PP) of the duodenum. 
Groups of female C57Bl/6 mice were orally infected with 200 L3 larvae, and 
the duodenal PP collected at intervals afterwards. (A) Representative PP 
immunostained to detect CD11c+ (green), CD68+ (red), and counterstained 
with DAPI (blue) to detect cell nuclei. D, dome region; M, middle region; B, 
base region. (B) Morphometric analysis of the % area CD68+ immunostaining 
in each PP region. (C) Morphometric analysis of the % area CD11c+ 
immunostaining in each PP region. Each point represents the data from one 
PP follicle from each mouse/group. Horizontal bar represents the median of 
the group. Significant differences to the naïve group were compared by 
ANOVA, followed by Dunnett’s multiple comparison test. 
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Figure 3.16 Effect of oral H. polygyrus infection on the distribution of 
mononuclear phagocytes in the Peyer’s patches (PP) of the ileum. 
Groups of female C57Bl/6 mice were orally infected with 200 L3 larvae, and 
the ileal PP collected at intervals afterwards. (Left-hand panels) Morphometric 
analysis of the % area CD68+ immunostaining in each PP region (see Figure. 
3.15). (Right-hand panels) Morphometric analysis of the % area CD11c+ 
immunostaining in each PP region. Each point represents the data from one 
PP follicle from each mouse/group. Horizontal bar represents the median of 
the group. Significant differences to the naïve group were compared by 
ANOVA, followed by Dunnett’s multiple comparison test. 
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3.3.9 Effect of H. polygyrus infection on FDC within the Peyer’s patches. 
Follicular dendritic cells are prion replication sites [197, 204, 340, 341]. Within 
the GALT, these cells are located in the germinal centre of the PP. To determine 
the effect of H. polygyrus infection on FDC, duodenal and ileal PP were also 
immunostained to detect FDC (CD35+ cells), PrPC and B cells (B220+ cells) at 
different times post H. polygyrus infection (Figures 3.17A & 3.18A). Analysis of 
the duodenal PP follicles showed that  H. polygyrus infection increased the area 
of CD35+ staining with statistical significance (p≤0.0198) on days 8 and 14 
(Figure 3.17B). However, within the the FDC area the levels of CD35+ or PrPc+ 
staining were unchanged (Figure 3.17C). Parallel analysis of ileal PP sections 
(Figure 3.18A), showed no statistically significant effect on the area of CD35+ 
staining (Figure 3.18B) or in CD35+ stained area (Figure 3.18C). These 
demonstrate that H. polygyrus infection significantly increases the size of the 
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Figure. 3.17 Effect of oral H. polygyrus infection on follicular dendritic cell (FDC) status in the Peyer’s patches (PP) of 
the duodenum. Groups of female C57Bl/6 mice were orally infected with 200 L3 larvae, and the duodenal PP collected at 
intervals afterwards. (A) Sections were immunostained to detect PrPC-expressing (blue) FDC (CD35+ cells; red) in the B cell 
follicles (B220+ cells, green). Representative images are shown on the top row. Below, same sample/images show immunostaing 
to detect FDC and DAPI (white). B) Morphometric analysis of the % area CD35+ immunostaining (FDC size) within the B cell 
follicles of each PP. (C) Morphometric analysis of the % area CD35+ immunostaining (upper panel), % area PrPC+ 
immunostaining (middle panel), and % area B220+ immunostaining (lower panel) in each PP. Each point represents mean data 
from one PP follicle from each mouse/group. Horizontal bar represents the median of the group. Significant differences to the 
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Figure. 3.18 Effect of oral H. polygyrus infection on follicular dendritic cell (FDC) status in the Peyer’s patches (PP) of 
the ileum. Groups of female C57Bl/6 mice were orally infected with 200 L3 larvae, and the ileal PP collected at intervals 
afterwards. (A) Sections were immunostained to detect PrPC-expressing (blue) FDC (CD35+ cells; red) in the B cell follicles 
(B220+ cells, green). Representative images are shown on the top row. Below, same sample/images show immunostaing to 
detect FDC and DAPI (white). B) Morphometric analysis of the % area CD35+ immunostaining (FDC size) within the B cell 
follicles of each PP. (C) Morphometric analysis of the % area CD35+ immunostaining (upper panel), % area PrPC+ 
immunostaining (middle panel), and % area B220+ immunostaining (lower panel) in each PP. Each point represents mean data 
from one PP follicle from each mouse/group. Horizontal bar represents the median of the group. Significant differences to the 
naïve group were compared by ANOVA, followed by Dunnett’s multiple comparison test. 
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3.3.10 Assesment of the granulomas caused by H. polygyrus infection. 
Granulomas are host inflammatory derived structures which can form around 
non degradable persistent antigen [308]. It has been implied that granulomas 
can act as prion replication sites, even in the absence of FDC [234]. In this 
study, the granulomas that formed during H. polygyrus infection were found 
at different developmental stages even in the same animal. Using H&E 
staining, it was evident that H. polygyrus cysts were visible from day 3 post 
infection. Next, the granulomas formed during H. polygyrus infection were 
clasified into 5 types (G1-G5) according to their developmental stage (Figure 
3.19A). These structures begin as a cyst, which contains the worm in what 
could correspond to a moult stage (G1). The G2 stage was characterized by 
disperse eosinophilic agregation. Then, the agregation consolididates into a 
more compact rounded structure which begins to develop the characteristic 
features of a granuloma, such as a fibrous capsule (G3). This develops into G4 
stage, a carefully organized structure with a compact nucleus predominantly 
compromising macrophages surounded by a mixed collagen-fibroblast 
capsule. At this stage, a granuloma can either rupture, expelling all its content 
or remain. After the granuloma ruptures, the tissue repairs and remodels itself 
(G5). Using this classification, it was possible to characterize the presence of 
these different developmental stages of the granulomas at different times post 
H. polygyrus infection. During the early H. polygyrus infection, there was a 
predominant presence of the G1 and G2 stages, whereas at the later times, the 
G5 stage prevailed (Figure 3.19B). 
Complementary IHC analysis of the granulomas, demonstrated an abundance 
of CD11b+ macrophages within them, surrounded by a dense network of 
nerves positive for PrPC and synaptophysin-1 (Figure 3.20). The presence of 
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PrPC+ expressing nerves in these granulomas, suggests that they may be 
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Figure 3.19 Oral H. polygyrus infection induces the formation of 
granulomas in the wall of the duodenum. Groups of female C57Bl/6 mice 
were orally infected with 200 L3 larvae, and the duodenum collected at 
intervals afterwards. (A) Representative H&E stained sections of intestines 
from infected mice. Granulomas were classified into five distinct stages: G1 - 
formation of the cyst or larvae moult stage; G2 - dispersed eosinophilic 
agregation around the cyst site; G3 - consolidation of the agregate into a more 
compact and rounded structure which begins to develop the typical 
characteristics of a granuloma such as the presence of a fibrous capsule; G4 
- fully organized granuloma structure with a compact nucleus predominantly 
containig macrophages, by a mixed collagen-fibroblast capsule and G5 - tissue 
repair and remodelling after rupture of the granuloma. (B) 8 cm of duodenum 
was analysed and the number of each type of granuloma at intervals after H. 
polygyrus infection was determined. Each bar represents mean ± SD number 
of granulomas of each type in two tissue samples from 4 mice/group.   
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Figure 3.20 The granulomas induced in the wall of the duodenum after 
oral H. polygyrus infection contain mononuclear phagocytes and are 
surrounded by synaptophysin-1 and PrPC expressing enteric nerves.  
Groups of female C57Bl/6 mice were orally infected with 200 L3 larvae, and 
the duodenum collected at intervals afterwards. (Upper row) Representative 
H&E stained sections of G2, G3 and G4 granulomas in the intestines from 
infected mice. (Middle row) Sections were immunostained to detect 
synaptophysin-1-expressing enteric nerves (green), CD11b+ mononuclear 
phagocytes (pink) and cell nuclei (grey/white). (Lower row) Sections were 
immunostained to detect PrPC-expressing enteric nerves (green), CD11b+ 
mononuclear phagocytes (pink) and cell nuclei (grey/white).   
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3.4 Discussion  
In this chapter, the effect of H. polygyrus infection on the gut and GALT 
microarchitecture was determined. This analysis showed that the worm 
infection was restricted to the small intestine. H. polygyrus infection adversely 
affected the intestinal villi (epithelial disruption, goblet cells hyperplasia and 
increased CD11b+ staining in the lamina propria), and reduced the number of 
ILF in duodenum and colon. In PP, H. polygyrus infection increased the 
number of M cells, altered the positioning of CD68+ mononuclear phagocytes, 
and increased the area of CD35+ expressing FDC. H. polygyrus infection also 
caused the formation of granulomas surrounded by a dense membrane 
containing synaptophysin-1 and PrPC expressing nerves. Previous studies 
suggest that the small intestine is the main site of prion acquisition [198]. It has 
also been shown that M cells and enterocytes in the FAE of PP transport prions 
[135, 139, 198]. Goblet cells can also transport molecules smaller than 70 kD 
[342] and the minimal prion infection unit is thought to be between 50-150 kD 
[343-345], suggesting that goblet cells may be able to transport prions. 
Therefore, since these cells can play an important role in prion neuroinvasion, 
it is plausible that the effects of H. polygyrus on the gut and GALT 
microarchitecture may significantly affect the uptake of orally acquired prions.  
H. polygyrus infection increased M cell and goblet cell density in the FAE of 
PP. Although increased number of M cells has also been reported as a 
consequence of bacterial infection such as Salmonella or Streptococcus [346], the 
effects on M cells occurred as an acute response within the first few days post 
bacterial infection. This contrasts with the findings in this study where M cell 
density was increased at later times. M cell density has been correlated with 
prion disease susceptibility [347]; and prion disease is ablated in the absence 
of M cells [135]. FDC are esential sites for prion replication and play a key role 
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in prion disease pathogenesis [204, 348]. In the germinal centres of the PP 
follicles, the size of FDC (CD35+) was also significantly increased on day 8 and 
14 post H. polygyrus infection, suggesting increased activation of these cells. 
However, from data presented it was uncertain whether this was due to an 
increased number of FDC, increased FDC size, or whether FDC 
activity/function was altered.  
H. polygyrus infection altered the positioning of CD68+ mononuclear phagocyte 
in PP. Given that there has been a dabate regarding the type and origin of the 
mononuclear phagocytes, and regarding the wide expresion of CD11c, in this 
study CD68 was used as a marker for monocytes/macrophages and CD11c as 
a DC marker. The importance of these cells rely on their capacity to sample 
antigens from the intestinal lumen (when located in the dome), present 
antigens to FDC in germinal centre and degrade antigens. As expected both 
markers were expresed. In naïve mice CD11c+ staining was mainly located in 
the PP dome; contary although CD68+ staining was located in the oposite side, 
in the base of PP, there was also some colocalized staining. The increased CD68 
staining (indicative of macrophages) with statistical significance in the base of 
duodenal PP during H. polygyrus infection and the particular effect observed 
on day 8 post H. polygyrus infection on mononuclear phagocytes, suggests 
changes in the positioning of the mononuclear phagocytes in the PP. However, 
these may also be result of an increased influx of the number of these cells, an 
alteration to their activation status, or an increase expresion of  CD68. Further 
experiments are clearly necessary to resolve this issue. An increased 
abundance of macrophages at the time of oral prion infection, potentially lead 
to increased phagocytosis and destruction of the prions, reducing disease 
susceptibility. Also, changes in the abundance of mononuclear phagocytes in 
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the dome could influence the amount of antigen sampling and therefore, the 
suceptibility to an infection. 
As expected, the hyperplasia of goblet cells in PP and villi ratify findings of 
other studies which found a goblet cell hyperplasia between days 6-14 post 
infection [254, 265]. Although an increased number of goblet cells is an innate 
response against enteric and worm infections as a defence mechanism [265, 
349], it had been suggested that the goblet cell hyperplasia cause during H. 
polygyrus infection is also a T cell dependent event [260]. However, 
independently of the goblet cell hyperplasia origin, goblet cell function is 
associated with an increase of mucus which had been associated with parasitic 
infection clearance [264] as well as the increase contractility of the smooth 
muscle present during the infection [269, 350]. Therefore, these factors can 
either reduce the possibilities of antigen uptake during H. polygyrus infection 
due the faster intestinal transit or increase those probabilities. The latter may 
be possible, because in the PP, the intestinal mucus is not attached to the FAE  
[351]. Therefore, the mucus can be cleared constantly from PP with the 
increased intestinal peristalsis during infection [351]. This may leave the FAE 
exposed to other antigens such as prions; in which case, the time that prions 
take to cross the FAE would be an important factor to consider. Also, as the 
goblet cells may be antigen entrance sites, their increase population may 
increase the probabilities that prions get through the FAE from the gut lumen. 
The reduction of ILF (B cell follicles) in the duodenum and colon coincides 
with the reported increased number of B cells in the mesenteric lymph nodes 
(MLN) after H. polygyrus infection [352]. It is possible that migration of B cells 
from the intestine to the MLN in response to H. polygyrus infection is 
responsible for the effect on ILF. Similar to the proposed redistribution of the 
systemic T and B lymphocytes to the MLN during H. polygyrus infection [353]. 
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In the small intestinal villi, mononuclear phagocytes expression was 
determined using CD11c, CD68 and CD11b markers. All are normally 
detected in the lamina propria as showed in naïve mice. In this study, although 
statistical analysis did not show significant differences in CD11c and CD68 
expression in the lamina propria, the increased abundance of CD11b+ 
expression was statistically significant in duodenum and ileum. Although in 
the ileum only one out of four mice had this reaction, in the duodenum half of 
them did. A similar increase in CD11b+F4/80+ cells has been observed in the 
peritoneal cavity following H. polygyrus infection [256]. However, the 
CD11b+F4/80+ cell accumulation is suggested to occur within 7 days post H. 
polygyrus infection [256]. This contrasts with the findings in this study where 
lamina propria CD11b+ cells were not significantly increased until day 21 post 
infection. As there were no significant changes in CD11c or CD68, specific 
changes in CD11b expression may be related with the mechanism to trap the 
parasite and the granuloma formation. CD11b complement receptor is 
expressed by H. polygyrus larvae, and this may mediate macrophages (CD11b+) 
adherence to H. polygyrus larvae as a trapping mechanism [311].  Also, in other 
infections (Brucella melitensis and Mycobacterium bovis) CD11b+ cells are main 
components of granulomas [354, 355]. Therefore, the increased expression of 
this marker in the lamina propria on day 21 post H. polygyrus may suggest a 
relation with the granulomas formed during H. polygyrus infection. The major 
number of granulomas (G2-G4) were detected on days 14 and 21 post 
infection. Given that by day 21 the number of granulomas seems to be 
reduced, it is possible that the increase of CD11b+ mononuclear phagocytes 
may be related with tissue repairing and clearance of granuloma debris.  
Atrophy of the intestinal villi and hypertrophy of the crypts have also been 
observed during H. polygyrus infection [251, 260].  These changes were evident 
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in the duodenum on days 8 and 14 post infection and are most likely associated 
with an inflammatory process caused by the adult parasite as it bursts out of 
the submucosa and begins feeding on the gut epithelium. Enteritis is observed 
between days 6 and 15 post H. polygyrus infection when calculated using a 
score system which considers the extension of the epithelial damage, edema, 
villus length, crypt depth and inflammatory cell infiltrates [254, 356]. As 
mentioned before, the inflammatory process can affect the permeability of the 
intestine by weakening the tight junctions between the epithelial cells [254, 
325, 326] and therefore, be a potential site of prion entry. 
Data in this chapter show that H. polygyrus infection has a significant effect on 
the gut microarchitecture of the gut and GALT. These changes may influence 
the efficiency of the uptake of antigens sampled from the gut lumen. Taking 
all these data into consideration, days 1, 8 and 14 of H. polygyrus infection may 
represent interesting time-points that may influence the uptake of second 
pathogens such as orally acquired prions. On day 1 post H. polygyrus infection 
the infecting larvae invade the epithelium and reach the serosa layer for its 
implantation. On day 8 post infection, the adult worms emerge from the 
intestinal wall and establish infection in the lumen where they cause epithelial 
disruption and changes to the villus morphology. At this time, CD68+ 
mononuclear phagocyte positioning within the PP was altered, FDC size was 
increased, and granulomas were evident in the gut wall. On day 14 post 
infection, the integrity of the duodenal epithelium was disrupted, there was 
an increased number of goblet cells, a reduction in the number of ILF in 
duodenum, and the increased FDC size remained, as well as granulomas.  
Since the integrity of the intestinal epithelium and mononuclear phagocytes 
are important for the efficient uptake of prions from the gut lumen, and FDC 
and granulomas can be sites of prion replication, these suggest that H. 
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polygyrus infection may have a significant influence in prion disease. 
Therefore, on the next chapter, the effects of co-infection with H. polygyrus on 
prion disease pathogenesis and susceptibility will be determined. 
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4.1 Abstract 
Data in the previous chapter showed that H. polygyrus caused significant 
pathology only in the small intestine and the gut associated lymphoid tissues 
(GALT) within it.  Since early prion accumulation within Peyer’s patches (PP) 
in the small intestine is essential for the efficient transmission of disease to the 
brain, in this chapter the effects of H. polygyrus infection on oral prion disease 
pathogenesis were determined. Groups of mice were first orally infected with 
H. polygyrus and either on the same day (day 0) or on days 1, 8 or 14 post 
infection, the mice were subsequently orally co-infected with ME7 scrapie 
prions. The effect of H. polygyrus co-infection on the early accumulation of 
prions upon follicular dendritic cells (FDC) in the PP, mesenteric lymph nodes 
(MLN), and spleen was then determined, as well the subsequent effects on 
prion disease susceptibility and duration. The results showed that co-infection 
with H. polygyrus had a significant influence on the early accumulation of 
prions upon FDC in the MLN. However, co-infection with H. polygyrus had 
only modest effects  on oral prion disease susceptibility and disease duration. 
Although the histopathological signs of prion disease in the brain were similar 
in all groups whether they were co-infected with H. polygyrus or not; in certain 
brain regions the magnitude of the spongiform pathology and PrPSc 
accumulation was modestly but significantly reduced in the mice co-infected 
with prions and H. polygyrus on the same day. Therefore, although data in 
Chapter 3 showed that oral infection with H. polygyrus causes significant 
pathological disturbances in the small intestine, data presented in this chapter 
showed that co-infection with H. polygyrus had only a modest influence on oral 
prion disease pathogenesis and susceptibility.   
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4.2 Introduction 
Chapter 3 determined the effects of oral H. polygyrus infection on the 
microarchitecture of the gut associated lymphoid tissues (GALT) and the small 
and large intestines. Data from those studies confirmed that H. polygyrus 
infection and the effects that it caused on the gut and GALT microarchitecture 
were restricted to the small intestine. As described in the previous chapter, the 
main effects caused by H. polygyrus infection that were observed on the 
intestine included enteritis, disturbances to villous morphology, epithelial 
damage, increased abundance of CD11b+ mononuclear phagocytes in the 
lamina propria, and increased goblet cell density in the gut epithelium. H. 
polygyrus infection also caused a reduction in the number of isolated lymphoid 
follicles (ILF) in duodenum and colon, and in the Peyer’s patches (PP) 
modified the abundance of CD68 expression by mononuclear phagocytes, 
increased the size of the FDC in the B cell follicles and increased the density of 
M cells in the follicle-associated epithelium (FAE).  H. polygyrus infection also 
induced the formation of granulomas in the gut wall, which were surrounded 
by a dense network of PrPC-expressing enteric nerves.  
After oral exposure many prion isolates initially accumulate and replicate 
upon PrPC-expressing follicular dendritic cells (FDC) within the GALT in the 
small intestine, such as the PP [357, 358]. This initial replication of prions upon 
FDC in the PP is essential for the efficient spread of disease to the central 
nervous system (CNS) [340, 359, 360]. The prions are first considered to be 
transported across the gut epithelium by M cells, enterocytes or dendritic cells 
[321, 361, 362] in the FAE which covers the PP [361, 363, 364, 365]. Data show 
that the prions are subsequently acquired by CD11c+ mononuclear phagocytes 
(conventional dendritic cells (DC)) which deliver them to the FDC within the 
B-cell follicles of the PP [179, 211, 312, 366].   
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Inflammation and pathogen infection can significantly affect prion disease 
pathogenesis, for example by enhancing the uptake of prions from the site of 
infection, or by providing additional sites of prion accumulation within host 
tissues [234, 238, 313, 367]. Data also show that M cell density in the gut 
epithelium can significantly influence oral prion disease susceptibility [333].  
Increased M cell-density at the time of oral exposure significantly increased 
the uptake of prions from intestine into PP, shortening survival times and 
increasing disease susceptibility [137]. Since M cells, CD11c+ mononuclear 
phagocytes and FDC each play important role in the uptake of prions from the 
gut lumen, and their subsequent propagation to and replication within PP, the 
effects of H. polygyrus infection on these cells in the small intestine may also 
have a significant effect on oral prion disease pathogenesis and susceptibility.  
Therefore, the aim of the experiments described in this chapter was to test the 
hypothesis that co-infection with a small intestine-restricted pathogen such as 








4.3.1 Co-infection with H. polygyrus and ME7 scrapie prions 
Since oral exposure to a limiting dose of ME7 scrapie prions typically yields a 
disease incidence of 100% in wild-type (control) mice, its use here would 
enable the effects of H. polygyrus co-infection on survival time and prion 
disease susceptibility to be determined. C57BL/6J female mice (90 days old) 
were orally infected with 200 L3 infective larvae by gavage. Then, on different 
days post H. polygyrus infection (days 0, 1, 8 and 14) groups of mice were 
subsequently orally infected with a limiting dose consistent of 50 µl of 1% 
dilution of scrapie brain homogenate prepared from mice terminally-affected 
with ME7 scrapie prions containing approximately 3.3 log10 i.c. ID50 units. A 
parallel group of mice were orally infected with prions alone as a control.   
H. polygyrus infection was confirmed in 5 mice/group by calculating the 
number of eggs/g of faeces using the McMaster technique as described in 
Section 2.2.  This analysis was performed at weeks 2, 3, and 4 post H. polygyrus 
infection, and then at monthly intervals for the remainder of the experiment 
(either until the mice developed terminal clinical prion disease, or when the 
study was terminated at 504 days post prion infection). This analysis 
confirmed that H. polygyrus infection for each group was successful. 
The mean faecal egg burdens for each mouse group co-infected with prions at 
different weeks (Figure 4.1) had some differences in comparison with the egg 
burden presented in chapter 3 (Figure 3.1). Mice infected with H. polygyrus 
alone had a maximum mean egg production of 1522 eggs/g of faeces at day 18 
post infection. Similarly, mice co-infected with prions and H. polygyrus on the 
same day (day 0) had a similar trend. However, mice infected with prions at 
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day one after H. polygyrus infection had a reduced egg burden; and mice 
infected with prions at day 8 post H. polygyrus infection had their maximum 
egg burden at later time (day 21). Responsiveness to H. polygyrus infection is 
dependent on the mouse strain. C57BL/6 mice are considered to be 
intermediate responders to H. polygyrus; it takes them from 8 to 20 weeks to 
clear worm burden [245]. Similarly, when mice were co-infected with prions 
on day 8 and 14 post H. polygyrus infection, the worm eggs were detected in 
the faeces until 16-20 weeks (23±25 eggs/g of faeces) after parasite exposure. 
In contrast, in mice that were co-infected with prions on the same day (day 0) 
or on day 1 after H. polygyrus infection, eggs were detectable in the faeces for 
up to 4 weeks (17±19 eggs/g of faeces) after oral exposure. Subsequent 
monthly analyses showed that after these times the eggs were undetectable in 
the faeces of mice from all groups, suggesting that the parasite infections had 
been cleared by the host.   
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Figure 4.1 Mean faecal egg burden following infection with H. polygyrus. 
Female C57Bl/6 mice were orally infected with 200 L3 larvae, and then on days 
0, 1, 8 or 14, the mice were subsequently orally infected with ME7 scrapie 
prions. The number of eggs in faeces was determined at intervals afterwards. 
Each point represents mean ± SD number of egg/g of faeces from 5 individual 
mice/group. 
 
4.3.2 Effect of H. polygyrus infection on the early accumulation of 
prions in the PP. 
Within weeks after oral exposure, high levels of ME7 scrapie prions first 
accumulate upon FDC before they establish infection in the nervous system 
[204, 340, 348, 360]. The effects of H. polygyrus on the early accumulation of 
prions within the PP was therefore determined. Mice orally infected with H. 
polygyrus and prions as described above were culled at 5, 10 and 15 weeks after 
prion infection (4 mice/group) and the influence of H. polygyrus infection on 
prion accumulation within the PP was determined (Figure 4.2). 
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Figure 4.2 Experimental design for early prion detection at 5, 10 and 15 weeks in H. polygyrus co-infected mice. Groups 
of 4 female C57BL/6 mice were orally infected with 200 H. polygyrus L3, and on days 0, 1, 8 or 14 the mice were subsequently 
orally infected with a limiting dose of ME7 scrapie prions. Also, a control group was infected with prions alone. Tissues (PP, 
spleen and MLN) were harvested at 5, 10 and 15 weeks post prion infection to detect early prion accumulation. 
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First, serial sections of PP were cut and immunostained to detect CD21/35-
expressing FDC and the prion disease-specific (PrPd) abnormal PrP 
accumulations [368]. PrPd refers to prion disease-associated abnormal PrP 
detected by IHC in affected tissues. Paraffin-embedded tissue (PET) blot 
analysis (Section 2.5.6) was used to confirm that any PrPd accumulations were 
prion disease-specific, proteinase K-resistant PrPSc (Figure 4.3A). 
The incidence of PrPSc+ FDC networks in tissues from each mouse/group was 
then determined. First, the number of FDC networks (CD21/35+) was 
determined in each mouse sample; then, each FDC network was compared in 
the serial sections stained to detect PrPd and PrPSc. If the FDC network was 
positive for the three stainings, it was considered a PrPSc+. The percentage of 
PrPSc+ FDC networks in one sample per mice was considered as the incidence. 
This method had been used to determine the incidence of PrPSc+ PP follicles in 
mice at 5, 10 and 15 weeks post orally infection (50 µl of a 1% of scrapie brain 
homogenate containing approximately 3.3 log10 i.c. ID50 units) [135, 205]. Data 
presented in Figure 4.3B, shows the median incidence of PrPSc+ FDC networks 
in all groups at 5, 10 and 15 weeks post prion infection in the PP. Here, in the 
mice infected with prions alone, PrPSc+ FDC networks were first detected from 
5 weeks post-prion infection, increasing slightly in their abundance by 15 
weeks (Figure 4.3A; Appendix 7.3.1). This analysis showed that co-infection 
with H. polygyrus appeared to have little influence on the early accumulation 
of prions in the PP. However, the incidence of PrPSc+ FDC networks in the PP 
of mice co-infected with prions and H. polygyrus on the same day (day 0) was 
statistically significantly reduced at 15 weeks post prion infection (p<0.034). 
Therefore, co-infection with H. polygyrus had a limited influence on the early 
accumulation of prions upon FDC in the PP. 
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Figure 4.3 Effect of H. polygyrus co-infection on the early accumulation 
of PrPSc upon follicular dendritic cells (FDC) in Peyer’s patches (PP). 
Female C57Bl/6 mice were orally infected with 200 L3 larvae, and then on days 
0, 1, 8 or 14, the mice were subsequently orally infected with ME7 scrapie 
prions. PP were collected at 5, 10 and 15 weeks after prion infection and 
analysed by IHC and PET immunoblot. (A) Representative images of PP 
without (upper panels) and with (lower panels) high levels of disease-specific 
PrP (PrPd, brown) in association with FDC (CD21/35+ cells, brown). Analysis 
of adjacent sections by PET immunoblot analysis confirmed the absence (red 
arrow) or presence (black arrow) of prion specific PK-resistant PrPSc (blue). 
(B) Assessment of the incidence of FDC networks containing PrPSc in each 
group of mice at 5, 10 and 15 weeks after prion exposure. Each point 
represents mean data from individual mice (1-12 PP/mouse; 4 mice/group). 
Horizontal bar represents the median value of the group. Significant 
differences to the group infected with prions alone were compared by ANOVA, 
followed by Dunnett’s multiple comparison test. 
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4.3.3 Effect of H. polygyrus infection on the early accumulation of 
prions in the mesenteric lymph nodes (MLN) and spleen. 
After their initial accumulation in the PP, the prions subsequently spread to 
the MLN and spleen [206, 208]. Next, the influence of H. polygyrus infection on 
prion accumulation within the MLN and spleen was determined. Previous 
studies had shown that in the spleens and MLN, PrPSc accumulations in FDC 
networks had been detected at 70 days (10 weeks) post infection when using 
the same prion infective dose [205]. However, when prion (ME7) infection was 
by skin scarification, PrPSc accumulation in spleen was not detected until 80 
days postinfection [315].  
In control mice of this study, some evidence of PrPSc+ FDC networks was 
detectable in the MLN at 5 weeks post-prion infection, but a greater incidence 
was observed by 15 weeks (Figure 4.4; Appendix 7.3.2).  The incidence of PrPSc+ 
FDC networks in the MLNs of mice given prions alone at this time point was 
statistically significantly greater than that observed in any of the mice that 
were co-infected with H. polygyrus (Figure 4.4; Appendix 7.3.2).  
In contrast, in the spleens of mice infected with prions alone no PrPSc+ FDC 
networks were detected. Contrary, in co-infected groups only limited numbers 
of PrPSc+ FDC networks were observed suggesting that only limiting levels of 
prions had been disseminated to their spleens during this time. Furthermore, 
H. polygyrus infection had no statistically significant effect on the incidence of 
PrPSc+ FDC networks in these spleens (Figure 4.5; Appendix 7.3.3).   
Taken together, although co-infection with H. polygyrus had a limited 
influence on the early accumulation of prions upon FDC in the PP, it did 
significantly affect the dissemination of prions to the MLN.  
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Figure 4.4 Effect of H. polygyrus co-infection on the early accumulation 
of PrPSc upon follicular dendritic cells (FDC) in mesenteric lymph nodes 
(MLN). Female C57Bl/6 mice were orally infected with 200 L3 larvae, and then 
on days 0, 1, 8 or 14, the mice were subsequently orally infected with ME7 
scrapie prions. MLN were collected at 5, 10 and 15 weeks after prion infection 
and analysed by IHC and PET immunoblot. (A) Representative image of MLN 
follicles without and with high levels of disease-specific PrP (PrPd, brown) in 
association with FDC (CD21/35+ cells, brown).  Analysis of an adjacent section 
by PET immunoblot analysis confirmed the absence (red arrows) or presence 
(black arrows) of prion specific PK-resistant PrPSc (blue). (B) Assessment of 
the incidence of FDC networks containing PrPSc in each group of mice at 5, 10 
and 15 weeks after prion exposure. Each point represents mean data from 
individual mice (2-3 MLN/mouse; 4 mice/group). Horizontal bar represents the 
median value of the group. Significant differences to the group infected with 
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Figure 4.5 Effect of H. polygyrus co-infection on the early accumulation 
of PrPSc upon follicular dendritic cells (FDC) in the spleen. Female 
C57Bl/6 mice were orally infected with 200 L3 larvae, and then on days 0, 1, 8 
or 14, the mice were subsequently orally infected with ME7 scrapie prions. 
Spleens were collected at 5, 10 and 15 weeks after prion infection and 
analysed by IHC and PET immunoblot. (A) Representative images of spleen 
without (upper panels) and with (lower panels) high levels of disease-specific 
PrP (PrPd, brown) in association with FDC (CD21/35+ cells, brown). Analysis 
of adjacent sections by PET immunoblot analysis confirmed the absence (red 
arrows) or presence (black arrows) of prion specific PK-resistant PrPSc (blue) 
(B)  Assessment of the incidence of FDC networks containing PrPSc in each 
group of mice at 5, 10 and 15 weeks after prion exposure. Each point 
represents mean data from individual mice (4 mice/group). Horizontal bar 
represents median value of the group. Significant differences to the group 
infected with prions alone were compared by ANOVA, followed by Dunnett’s 
multiple comparison test.  
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4.3.4 The granulomas induced in the gut wall by H. polygyrus infection 
do not accumulate PrPSc in prion-infected mice. 
As Chapter 3 shows (Section 3.3.10), infection with the larval stages of H. 
polygyrus induces the development of granulomas in the wall of duodenum. 
Some experimentally-induced soft tissue granulomas have been shown to be 
capable of accumulating prions in prion-infected mice [234]. Data in this thesis 
show no evidence of FDC networks in granulomas induced by H. polygyrus as 
no CD 21/35 staining was detected (Figure 4.6A). However, Chapter 3 showed 
PrPC+ immunostaining on the periphery of the granulomas (Figure 3.20). This 
immunostaining corresponded to a dense network of PrPC-expressing enteric 
nerves. Therefore, it raised the possibility that the granulomas induced by H. 
polygyrus might also be capable of accumulating prions in the intestines of 
prion-infected mice. To test this hypothesis, duodenal samples from the same 
mice used in Sections 4.3.2 & 4.3.3 were immunostained to detect PrPd. PET 
immunoblot analysis of adjacent section was used to confirm the presence of 
PrPSc. Representative images of typical H. polygyrus-induced granulomas in 
the intestines of prion infected mice are presented in Figure 4.6. In this study, 
no PrPd or PrPSc was detected in any of the granulomas at any time point 
throughout the prion infection (Figure 4.6B). This analysis clearly shows that 
the granulomas induced in the gut wall by H. polygyrus infection do not 
accumulate PrPSc in prion-infected mice.   
  
 




Figure 4.6 The granulomas induced in the gut after oral H. polygyrus are 
not sites of early PrPSc accumulation in mice co-infected with prions. 
Groups of 4 female C57Bl/6 mice were orally infected with 200 L3 larvae, and 
then on days 0, 1, 8 or 14, the mice were subsequently orally infected with 
ME7 scrapie prions. Small intestines were collected 5, 10 and 15 weeks after 
prion infection and analysed by IHC and PET immunoblot. (A) IHC analysis 
showed that no CD21/35 (brown), PrPd (brown, left) or PrPSc (blue/black, right) 
accumulations were detected with the H. polygyrus induced granulomas in the 
gut wall. (B) Table shows the incidence of PrPSc+ granulomas in the intestine 
at 5, 10 and 15 weeks after prion exposure.   
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4.3.5 Effect of H. polygyrus co-infection or prion disease susceptibility 
and disease duration.  
As above C57BL/6J female mice (90 days old) were orally infected with 200 
infective L3 by gavage. Then, on different days post H. polygyrus infection 
(days 0, 1, 8 and 14) groups of 8 mice were subsequently orally infected with 
a limiting dose of scrapie prions: 50 μl of a 1% dilution of scrapie brain 
homogenate prepared from mice terminally-affected with ME7 scrapie prions 
containing approximately 3.3 log10 i.c. ID50 units. A parallel group of 8 mice 
were orally infected with prions alone as a control. Each group of mice were 
clinically assessed weekly, from day 210 post prion infection, for the 
development of clinical signs of prion disease (Section 2.3) to terminal stage of 
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Figure 4.7 Experimental design of H. polygyrus co-infection on prion disease susceptibility and disease duration. 
Groups of 8 female C57BL/6 mice were orally infected with 200 H. polygyrus L3, and on days 0, 1, 8 or 14 the mice were 
subsequently orally infected with ME7 scrapie prions. Also, a control group was infected with prions alone. Mice were monitored 
for clinical signs of prion disease; this was done weekly from day 210 post prion infection until the development of terminal stage 
of clinical prion disease or when the study was terminated at 504 days post prion infection. 
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First, for each mouse the time from prion infection to the time of cull due to 
development of terminal prion disease (survival) was determined. Survival 
curves for each group of co-infected mice compared to the prions alone group 
are presented in Figure 4.8. Half of the mice orally exposed to prions alone 
succumbed to terminal prion disease (Table 4.1 & Figure 4.8). It was 
considered that the mice developed clinical prion disease (Section 2.3) up to 
terminal stage when the animal wellbeing was compromised (e.g. poor body 
condition and inability to fed or have water). Further statistical analysis (Log-
rank (Mantel-Cox) test) showed that co-infection with H. polygyrus did not 
have a significant effect on the survival time. Similarly, Fisher’s exact test (each 
group was compared with the control) and chi-square test (all groups 
compared together) showed that the coinfection did not have a significant 
effect on the incidence (number animals which developed prion disease up to 
terminal stage from the all the survivals-infected in each group) of terminal 
prion disease irrespective of the time at which the mice were co-infected with 














Table 4.1 Clinical and histopathological incidence of prion disease, PrPSc+ 




Chapter 4. Effect of H. polygyrus infection on orally acquired prion disease
  134 
 
For each group of mice, the time from prion exposure to the first detectable 
onset of clinical signs, the incubation period (considered as positive score 
compatible with TSE), was determined (Appendix 7.3.4 & Figure 4.9A). The 
clinically positive control mice infected with prions alone presented clinical 
prion disease with a mean incubation period of 384 ± 10 days (Figure 4.9A). 
Further statistical analysis showed that H. polygyrus co-infection did not 
significantly influence the time taken to develop the first clinical signs of 
disease as the incubation periods for each group were similar to the control 
mice infected with prions alone.  
Next, for each group of mice the duration of the clinical phase of the prion 
disease was determined: duration from the onset of clinical signs (incubation 
period) to the development of terminal prion disease. The mean duration of 
the clinical phase in control mice infected with prions alone was 25 ±7 days 
(Appendix 7.3.4 & Figure 4.9B). Although H. polygyrus co-infection did not 
significantly influence the duration of the clinical phase when mice were co-
infected with prions on days 0, 1 and 14 post-H. polygyrus, the duration of 
clinical phase was statistically significantly longer when mice were co-infected 
with prions on day 8 post H. polygyrus infection 98 ±126 days (Figure 4.9B; 
p<0.047). However, this statistical difference appears to be influenced by only 
one mouse with a greatly extended survival time. Therefore, data show that 
H. polygyrus infection may under some circumstances prolong the clinical 
phase of prion disease in co-infected animals.   
Finally, the effects of H. polygyrus infection on prion disease survival time was 
also considered: the time from prion infection to the time of cull due to 
development of terminal clinical signs of prion disease. The clinically positive 
control mice infected with prions alone succumbed to clinical prion disease 
with a mean time of 394 ± 14 days (Appendix 7.3.4 & Figure 4.9C). Although 
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H. polygyrus infection had no statistically significant influence on the survival 
times of any of the groups of mice which were co-infected with prions, the 
survival time of mice infected with prions on day 8 post H. polygyrus infection 
was ~47 days longer (441 ±21 days).   
Together, these data show that despite the significant pathological 
disturbances in the small intestine caused by H. polygyrus, co-infection with 
prions only have modest effects; oral prion disease susceptibility (considered 
as disease incidence) and duration were increased in comparison with the 
scrapie alone control group.   
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Figure 4.8 Effect of H. polygyrus co-infection on the susceptibility to oral 
prion infection. Female C57Bl/6 mice were orally infected with 200 L3 larvae, 
and then on days 0, 1, 8 or 14, the mice were subsequently orally infected with 
ME7 scrapie prions. Survival curves compare prion disease susceptibility for 
each group of mice. Each point represents the prion disease survival times for 
individual mice (6-8 mice/group). Significant differences were compared by 
Log-rank (Mantel-Cox) test. 
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Figure 4.9 Effect of H. polygyrus co-infection on the development of 
clinical prion disease. Female C57Bl/6 mice were orally infected with 200 L3 
larvae, and then on days 0, 1, 8 or 14, the mice were subsequently orally 
infected with ME7 scrapie prions. The effects of H. polygyrus co-infection on 
(A) prion disease incubation period (time from prion exposure to onset of 
clinical signs), (B) duration of clinical disease, and (C) survival time (from prion 
infection to terminal disease) were determined for each mouse. Each point 
represents data from individual mice (4-6 mice/group). Horizontal bar 
represents the median time of each group. Significant differences to the group 
infected with prions alone were compared by ANOVA, followed by Dunnett’s 




Chapter 4. Effect of H. polygyrus infection on orally acquired prion disease
  140 
 
4.3.6 Effect of H. polygyrus co-infection on the development of prion 
disease-specific neuropathology in the brain.  
Next the effects of H. polygyrus co-infection on the development of the 
characteristic spongiform pathology (vacuolation), astrogliosis, microgliosis 
and PrPSc accumulation which are associated with terminal infection with ME7 
scrapie prions were determined. Brains from each mouse from each group 
were stained using H&E (for assessment of spongiform pathology) or 
immunostained to detect PrPd, GFAP+ astrocytes and Iba1+ microglia. All 
samples were blinded before assessment. 
All the brains from the clinically-affected mice showed the characteristic 
histopathological signs of prion disease (Figure 4.10). In these brains, the most 
affected regions were the thalamus and the hippocampus with presence of 
vacuolation, PrPd deposits, astrocytosis (GFAP), and reactive microglia (Iba1). 
None of these signs were detected in any of the clinically-negative mice 
(Figure 4.10).   
The incidence of animals in each group that displayed prion disease-specific 
spongiform pathology is presented in Table 4.1. Then, the mean vacuolation 
score for each brain area in each group was compared (Figure 4.11). This 
analysis showed that the magnitude of the spongiform pathology in these 
regions was similar in the brains of clinically-affected mice from each group.  
However, in the hypothalamus of mice co-infected with H. polygyrus and 
prions on the same day (day 0), the magnitude of the vacuolation score was 
significantly reduced when compared with clinical positive control mice 
infected with prions alone (Figure 4.11B; p<0.038).   
Brain sections from the same mice from each group were also immunostained 
to detect PrPd, and the magnitude of its abundance was scored as described in 
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Sections 2.7.1 and 2.7.2. The incidence of PrPd deposition observed in the brain 
was consistent with the incidence of vacuolation and presence of clinical signs 
of prion disease (Table 4.1). The mean score of the PrPd deposition in brain 
area in each group was then compared (Figure 4.12). As above the magnitude 
of the PrPd deposition was similar in the brains of clinically-affected mice from 
each group (Appendix 7.3.6). However, in the hippocampus of mice co-
infected with H. polygyrus and prions on the same day (day 0), the magnitude 
of the PrPd deposition was also significantly reduced when compared with 
clinical positive mice which were infected with prions alone (Figure 4.12; 
p<0.014). Although these significant differences may imply a biological effect, 
it is also important to consider that PrPd deposition is accumulative. Mice co-
infected on the same day (day 0) had a shorter survival time (382±26) than 
those from the prions alone group (394±14) (individual data of each mouse is 
available in the Appendix 7.3.6). Therefore, the shorted survival time may 
affect the accumulation of PrPd deposition in affected areas. Figure 4.10 show 
the histopathological differences between clinical positive and clinical 
negative animals; differences in brain histopathological scoring are shown in 
Figure 2.1.    
The type of the PrPd deposition was also assessed using the criteria described 
in Section 2.7.1. This analysis showed that in the clinically-affected brains the 
PrPd deposition was predominantly fine punctate and coarse in all groups 
(Appendix 7.3.6). H. polygyrus co-infection had no significant effect on the type 
of deposition presented in the brain when compared to mice infected with 
prions alone.  
Next, brain sections from all mice from each group were immunostained to 
detect GFAP+ astrocytes and the magnitude of the immunostaining was scored 
as described in Section 2.7.3 (Appendix 7.3.7). The mean GFAP 
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immunolabelling scores in each of the different brain areas were then 
compared (Figure 4.13). This analysis showed that H. polygyrus co-infection 
did not significantly influence the magnitude of the GFAP immunostaining 
detected in the brain, when compared to the brains from the mice infected with 
prions alone. 
Finally, brain sections were immunostained to detect Iba1+ microglia and the 
magnitude of the immunostaining scored as mentioned in Section 2.7.4. The 
mean Iba1 immunolabelling scores/group for each brain area are presented in 
Figure 4.14 (Appendix 7.3.7). This analysis also showed that H. polygyrus co-
infection did not significantly influence the magnitude of the Iba1+ 
immunostaining detected in the brain, when compared to the brains from the 
mice infected with prions alone. 
Taken together, these data confirmed that all the mice which presented with 
positive clinical signs of prion disease also displayed the characteristic 
pathology of prions disease in their brains. None of the clinically negative 
animals showed any histopathological signs of prion disease in their brains 
suggesting they were free of prion disease and would have been unlikely to 
have developed prion disease had they survived longer. However, the 
possibility that these mice remained as subclinical carriers cannot be excluded. 
In the clinically-affected mice, the most affected regions of the brain with 
pathological changes were the thalamus and the hippocampus. Although the 
histopathological signs of prion disease were similar in all groups whether 
they were co-infected with H. polygyrus or not, significant effects were 
observed in the mice infected with prions and H. polygyrus on the same day, 
with significantly reduced vacuolation in the hypothalamus and PrPd 
deposition in the hippocampus. However, the difference was only one point 
on the scale used, thus the biological significance remains to be determined in 
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Figure 4.10 Effect of H. polygyrus co-infection on the development of characteristic hallmarks of prion disease 
neuropathology. Female C57Bl/6 mice were orally infected with 200 L3 larvae, and then on days 0, 1, 8 or 14, the mice were 
subsequently orally infected with ME7 scrapie prions. Brains were collected from all mice with clinical signs of prion disease and 
clinically-negative survivors for IHC analysis. High levels of spongiform pathology (H&E, upper row) are evident as small holes 
in the tissue, heavy accumulations of PrPd (brown staining deposition, second row), reactive astrocytes expressing GFAP 
(brown, third row) and active microglia expressing Iba1 (brown, bottom row) were detected in the brains of all the mice with 
clinical prion disease. Astrocytes and microglia are normally found in the brain, but in contrast with the pathological tissues they 
have thin dendrites and are less abundant. None of these histopathological signs of prion disease were detected in the brains 
of any of the clinically-negative mice up to at least 504 days after oral exposure. Images are only representative of a positive 
and a negative mice/group. 
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Figure 4.11 Effect of H. polygyrus co-infection on the development of 
spongiform pathology in prion infected mice. Female C57Bl/6 mice were 
orally infected with 200 L3 larvae, and then on days 0, 1, 8 or 14, the mice 
were subsequently orally infected with ME7 scrapie prions. Brains were 
collected from all mice with clinical signs of prion disease and clinically-
negative survivors, and the H&E sections analysed. The severity and 
distribution of the vacuolation within each brain was scored on a scale of 1-5 
in nine grey matter areas: G1, dorsal medulla; G2, cerebellar cortex; G3, 
superior colliculus; G4, hypothalamus; G5, thalamus; G6, hippocampus; G7, 
septum; G8, retrosplenial and adjacent motor cortex; G9, cingulate and 
adjacent motor cortex. (A) Mean vacuolation scores for all mouse groups. (B) 
Comparison of prions alone with the day 0 co-infection group. (C) Comparison 
of prions alone with the day 1 co-infection group. (D) Comparison of prions 
alone with the day 8 co-infection group. (E) Comparison of prions alone with 
the day 14 co-infection group. Each point represents the mean vacuolation 
score ± SD (3-6 clinical positive and 4 clinical negative mice/group). Significant 
differences to the group infected with prions alone were compared by ANOVA, 
followed by Dunnett’s multiple comparison test. 
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Figure 4.12 Effect of H. polygyrus co-infection on the magnitude of the 
prion disease specific PrPd accumulation in the brains of prion infected 
mice. Female C57Bl/6 mice were orally infected with 200 L3 larvae, and then 
on days 0, 1, 8 or 14, the mice were subsequently orally infected with ME7 
scrapie prions.  Brains were collected from all mice with clinical signs of prion 
disease and clinically-negative survivors, and immunostained to detect PrPd. 
The severity and distribution of the PrPd accumulation within each brain was 
scored on a scale of 1-3 in seven grey matter areas: G2, cerebellar cortex; G4, 
hypothalamus; G5, thalamus; G6, hippocampus; G7, septum; G8, retrosplenial 
and adjacent motor cortex; G9, cingulate and adjacent motor cortex. (A) Mean 
PrPd accumulation scores for all mouse groups. (B) Comparison of prions 
alone with the day 0 co-infection group. (C) Comparison of prions alone with 
the day 1 co-infection group.  (D) Comparison of prions alone with the day 8 
co-infection group.  (E) Comparison of prions alone with the day 14 co-infection 
group. Each point represents the mean PrPd accumulation score ± SD (3-6 
clinical positive and 4 clinical negative mice/group). Significant differences to 
the group infected with prions alone were compared by ANOVA, followed by 
Dunnett’s multiple comparison test. 
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Figure 4.13 Effect of H. polygyrus co-infection on the magnitude of 
astrocyte activation in the brains of prion infected mice. Groups of 8 
female C57Bl/6 mice were orally infected with 200 L3 larvae, and then on days 
0, 1, 8 or 14, the mice were subsequently orally infected with ME7 scrapie 
prions. Brains were collected from all mice with clinical signs of prion disease, 
or clinically-negative survivors, and immunostained to detect GFAP+ reactive 
astrocytes. The severity and distribution of the GFAP+ immunostaining within 
each brain was scored on a scale of 1-3 in six grey matter areas: G4, 
hypothalamus; G5, thalamus; G6, hippocampus; G7, septum; G8, retrosplenial 
and adjacent motor cortex; G9, cingulate and adjacent motor cortex. (A) Mean 
GFAP+ accumulation scores for all mouse groups. (B) Comparison of prions 
alone with the day 0 co-infection group. (C) Comparison of prions alone with 
the day 1 co-infection group. (D) Comparison of prions alone with the day 8 
co-infection group. (E) Comparison of prions alone with the day 14 co-infection 
group. Each point represents the mean GFAP+ immunostaining score ± SD 
(3-6 clinical positive and 4 clinical negative mice/group). Significant differences 
to the group infected with prions alone were compared by ANOVA, followed 
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Figure 4.14 Effect of H. polygyrus co-infection on the magnitude of 
microglial activation in the brains of prion infected mice. Female C57Bl/6 
mice were orally infected with 200 L3 larvae, and then on days 0, 1, 8 or 14, 
the mice were subsequently orally infected with ME7 scrapie prions. Brains 
were collected from all mice with clinical signs of prion disease and clinically-
negative survivors, and immunostained to detect Iba1+ microglia. The severity 
and distribution of the Iba1+ immunostaining within each brain was scored on 
a scale of 1-3 in six grey matter areas: G4, hypothalamus; G5, thalamus; G6, 
hippocampus; G7, septum; G8, retrosplenial and adjacent motor cortex; G9, 
cingulate and adjacent motor cortex. (A) Mean PrPd accumulation scores for 
all mouse groups. (B) Comparison of prions alone with the day 0 co-infection 
group. (C) Comparison of prions alone with the day 1 co-infection group. (D) 
Comparison of prions alone with the day 8 co-infection group. (E) Comparison 
of prions alone with the day 14 co-infection group. Each point represents the 
mean Iba1+ immunostaining score ± SD (3-6 clinical positive and 4 clinical 
negative mice/group). Significant differences to the group infected with prions 
alone were compared by ANOVA, followed by Dennett’s multiple comparison 
test. 
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4.3.7 PrPSc deposition in PP and spleens at the terminal stage of prion 
disease  
In mice orally infected with ME7 scrapie prions, PrPSc accumulation is 
maintained upon FDC in the PP and spleen until the clinical phase [125, 194, 
195, 341]. The PP and spleens from each animal collected either at the end of 
the clinical stage or the end of the experiment (for clinically negative 
survivors) were analysed by IHC and PET immunoblotting to detect FDC 
(CD21/35+ cells), PrPd and PrPSc (Figure 4.15 & Appendix 7.3.5). The incidence 
of PrPSc+ FDC in each tissue is shown in Table 4.1. This analysis confirmed that 
FDC-associated PrPSc accumulations were detected in all the PP and spleens 
collected from the mice with clinical prion disease. Co-infection with H. 
polygyrus did not influence the incidence of the PrPSc+ FDC in PP and spleen at 
the terminal stage of the disease when compared to those from mice infected 
with prions alone. Furthermore, no signs of PrPSc accumulation were detected 
in any of the tissues from the clinically negative mice suggesting these mice 
were free of prion infection.   
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Figure 4.15 Effect of H. polygyrus co-infection on the accumulation of 
PrPSc upon follicular dendritic cells (FDC) in Peyer’s patches (PP) and the 
spleen. Female C57Bl/6 mice were orally infected with 200 L3 larvae, and then 
on days 0, 1, 8 or 14, the mice were subsequently orally infected with ME7 
scrapie prions. PP and spleens were collected from all mice with clinical signs 
of prion disease and clinically-negative survivors, and analysed by IHC and 
PET blot. Representative images of PP and spleen from clinically positive and 
negative animals are shown. In all PP and spleens from mice with positive 
clinical signs of prion disease, high levels of disease-specific PrPd (PrPd, 
brown) were detected in association with FDC (CD21/35+ cells, brown). 
Analysis of adjacent sections by PET immunoblot analysis confirmed the 
presence of prion specific PK-resistant PrPSc (blue/black, black arrow, right 
panels). No PrPd or PrPSc accumulations were detected in association with 
FDC in any of the tissues from the clinically-negative survivors.   
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4.4 Discussion 
In this chapter the effect of H. polygyrus infection in the small intestine on oral 
prion disease susceptibility and duration was assessed. Groups of mice were 
first orally infected with H. polygyrus and either on the same day (day 0) or on 
days 1, 8 or 14 post infection, the mice were subsequently orally co-infected 
with ME7 scrapie prions. The effect of H. polygyrus co-infection on the early 
accumulation of prions upon FDC in the PP, MLN, and spleen were then 
determined, as well the subsequent effects on prion disease susceptibility and 
duration. The results showed that co-infection with H. polygyrus had only a 
limited influence on the early accumulation of prions upon FDC in the PP, 
however it did appear to restrict its dissemination to the MLN. Despite of this, 
co-infection with H. polygyrus did not affect oral prion disease susceptibility 
(incidence of disease). Although the histopathological signs of prion disease 
were similar in all groups whether they were co-infected with H. polygyrus or 
not, a significant reduction in the magnitude of the spongiform pathology and 
PrPd accumulation was detected in certain brain regions when the mice co-
infected with prions and H. polygyrus on the same day.  Therefore, although 
data in Chapter 3 showed that oral infection with H. polygyrus causes 
significant pathological disturbances in the small intestine, data in this chapter 
showed that co-infection with H. polygyrus had only a modest influence on oral 
prion disease pathogenesis and susceptibility.   
In the previous chapter it was shown that H. polygyrus infection specifically 
affected the microarchitecture of the small intestine and the GALT within it. 
Given that small intestine GALT are important sites of prion uptake, 
accumulation and replication after oral exposure [124, 125, 194, 195, 369], the 
effects of a small intestine-restricted parasitic infection (H. polygyrus) on prion 
disease pathogenesis and susceptibility were studied. After oral exposure the 
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prions cross through the specialised enterocytes or M cells in the epithelium 
covering the PP [139, 369, 370]. Afterwards the prions are then acquired by 
mononuclear phagocytes in the subepithelial dome region [139] of the PP from 
where they are subsequently propagated to the FDC in the B cell follicles of 
the PP and on towards other tissues via the lymph and blood to the MLN and 
spleen [333, 371-373]. Early detection of PrPSc by cryoelectron microscopy has 
shown PrPSc accumulation upon FDC in PP as early as 7-21 days post infection, 
which subsequently spreads to the myenteric plexus neurons by day 21 [139]. 
In this chapter PET immunoblot analysis confirmed the presence of PrPSc upon 
FDC in PP from 5 weeks post prion infection. H. polygyrus co-infection had 
little influence on the accumulation of PrPSc within PP except when the mice 
were co-infected with H. polygyrus and prions on the same day, where a 
significant reduction in the incidence of PrPSc-positive FDC networks at 15 
weeks post prion infection was observed. However, this result may be due to 
the number of PP follicles sampled. For this analysis, all the visible PP of each 
mouse were collected and processed. However, the final number of PP follicles 
suitable for analysis (FDC+) in sections ranged from 1-12 per mouse (Appendix 
7.3.1). Therefore, the probability of detecting PrPSc+ FDC was greater when 
larger numbers of follicles were available. Further analyses with more tissue 
sections from these mice may be needed to corroborate this result.  However, 
given that mice with negative PP were also negative in the other tissue 
samples, the possibility that these animals were negative due the prion 
limiting dose remains.  
Following their replication upon FDC in the PP, the prions are subsequently 
disseminated to the MLN and spleen. In mice co-infected with H. polygyrus the 
abundance of PrPSc+ FDC in the MLN after prion exposure was significantly 
reduced in comparison with control mice group infected with prions alone at 
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15 weeks post prion infection. The absent or low detection of PrPSc in the MLN 
of these co-infected mice (Appendix 7.3.2) may be a consequence of the effects 
of H. polygyrus infection on the MLN. For example the migration of CD11c 
CD8α DC from the lamina propria to the MLN is reported to be reduced in H. 
polygyrus infected mice [374]. Within the MLN changes to the positioning of  
CD11c+ DC from the T cell areas to below the sub capsular sinus in the inter-
follicular areas and to the T cell-B borders have been described [374, 375]. As 
CD11c+ DC have been proposed to play an important role in the initial delivery 
of prions to the FDC within the draining lymphoid tissues [180, 205, 376], the 
reduced detection of PrPSc deposition in MLN 15 weeks after scrapie infection 
may be a consequence of H. polygyrus infection on CD11c+ cells. It is also 
possible that this effect could be related to the increased abundance of CD68+ 
cells (macrophages) in the PP after H. polygyrus infection described in the 
previous chapter (Figure 3.15). In the lymph nodes, macrophages have been 
suggested to phagocytose PrPSc form FDC [186, 377, 378]. Since macrophages 
and DC can phagocytose PrPSc and degrade prions [178, 379], the increased 
number or activation of macrophages in the PP and MLN during H. polygyrus 
infection may reduce the amount of PrPSc transported to the MLN or 
replication within it. During chronic H. polygyrus infection, there are high 
levels of Foxp3 regulatory T cells (Treg) in the MLN and spleen [294]. 
Therefore, H. polygyrus induced Treg may down regulate host immune 
responses in MLN and spleen, resulting in the low levels of PrPSc detected in 
these organs in some of the co-infected mice. 
It had been suggested that after prions are orally acquired, they need to 
replicate in PP before dissemination to MLN and spleen before prions are 
found in the CNS [125]. In this context, the spleen had special consideration in 
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prion pathogenesis due the amount of FDC. However, splenectomised mice 
had been shown to develop the disease [205]. 
In the PP, the lack of CD11c+ cells impedes prion accumulation within them 
[211]. However, this only reduces the susceptibility to develop prion disease 
[211]. Therefore, although prion replication in the PP may be needed to 
increase pathogenicity of the prions to infect a host, this may not be necessary 
to develop the disease. In this study, prion accumulation in the MLN was 
restricted at early time; however, the susceptibility to prion disease was not 
altered. This is compatible with the concept that prion replication over MLN 
may not be essential [125].     
Studies suggest that there is a close relation and communication between the 
gut and the nervous system. Interactions between enteric microbiota and 
nervous system had been related with autism or anxiety-depressive disorders 
[380]. Furthermore, intestinal macrophages may have direct communication 
with the nervous system [381, 382]. Specifically, during H. polygyrus infection, 
it has been shown that mucosal neurons express neuromedin U (NMU) [383]. 
This neuropeptide is express by cholinergic neurons in the gastrointestinal 
tract and is closely related with worm expulsion by regulating the activities of 
innate lymphoid cells, regulating inflammation, repairing tissue, and 
therefore, facilitating the worm expulsion [383, 384]. Considering that 
acetylcholinesterase is among the excretory secretory products of H. polygyrus 
[250], it may be possible to speculate that this enzyme may block the activation 
of the cholinergic neurons that express NMU and therefore influence the 
severity of prion disease. Another possibility is that H. polygyrus infection, 
which drives a predominantly Th2 response [256], is mainly activating NMU-
expressing neurons, and given their overexcitability they may not increase 
prions disease characteristics. Whether prion disease itself also affects the 
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activities of the NMU-expressing neurones is not known, but potential effects 
on this pathway may explain the effects of co-infection with prions on worm 
burden. 
Although the number of eggs is not necessarily related to the number of 
worms [385], this parameter is used as an indicator of the worm infection. 
Here, the egg burden was altered in its number and duration by prion co-
infection (Figure 4.1). This alteration were apparently related with the stage of 
H. polygyrus infection at which prions were administrated. This has not been 
reported before, but some speculations are presented ahead. Mice infected 
with prions at day 1 after H. polygyrus infection had a reduced egg burden. 
Also, in the same group and in mice infected with prions and H. polygyrus on 
the same day, eggs were detected in the faeces for up to 4 weeks (17±19 eggs/g 
of faeces) after H. polygyrus oral exposure. This means that they have a shorter 
egg output. C57BL/6 mice are considered to be intermediate responders to H. 
polygyrus which takes from 8 to 20 weeks to clear worm burden infection [245, 
386]. Similar to the groups which were infected with prions at days 8 and 14 
post H. polygyrus infection; in which the presence of eggs in faeces were 
detected until 16-20 weeks (23±25 eggs/g of faeces) after parasite exposure. In 
Chapter 3 no effects were detected in duodenum epithelium at day 1 post H. 
polygyrus. Therefore, the reduced egg burden may suggest that either there 
was a prion-parasite interaction or both infections may have an immune 
synergic effect which reduces worm fertility or influences early worm 
expulsion. Prion-worm interaction has been suggested before. Even more, in a 
study in which different developmental stages of a fly larvae (Sacrophaga 
canaria) were fed with brains of hamsters infected with prions, the 
consumption of infected larvae proved to transmit prion disease to other 
hamsters [387]. 
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A third effect was noticed when the maximum egg burden was reach later in 
time (day 21) on mice infected with prions at day 8 post H. polygyrus infection. 
It is important to notice that at the time of prion infection, worms were on their 
second moult stage and ready to break out into the intestinal lumen. So, if 
prion co-infection delay adult worms to emerge or delay worm mating, both 
are just speculative explanations.  
Regarding the apparent increase egg output in mice co-infected with prions at 
day 14 post H. polygyrus (Figure 4.1), it is worth to clarify that this result is 
caused by an individual effect. Although the mean number of eggs in faeces is 
26932, the standard deviation was very wide (±1534 eggs/g. of faeces); and 
these mice had not been infected with prions at the time of the first 
measurement (day 14). Therefore, these data need to be interpreted with 
caution.  
As mentioned previously, it has been suggested that chronic inflammation 
may favour prion replication in inflamed organs such as mammary gland, 
kidney, lung and liver. However, in these circumstances PrPSc accumulation 
was dependent upon the presence of newly formed lymphoid structures [110, 
313, 388]. Chronic inflammation can lead to development of granulomas. 
These lympho-follicular inflammatory sites are developed during H. polygyrus 
infection. It has been suggested that prion can accumulate in soft tissue 
granulomas even in the absence of FDC [234]. However, in this study no PrPSc 
was detected in the worm-induced granulomas. Although this may be 
contradictory, it is consistent with a study in sheep where no PrPSc was 
detected in granulomas [389]. Differences in these findings may be related to 
the type of granuloma. These structures are a common pathological finding in 
chronic inflammatory process and can have different origins (bacterial, 
parasites foreign bodies) which seem to be reflected in some histopathological 
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differences [305, 390, 391]. Therefore, these contradictory findings may be 
associated with differences between an induced and a natural granuloma 
[302], and possibly to the area of the body where the granulomas are formed. 
Although in this chapter, the pathology of H. polygyrus in the small intestine 
epithelium seems to have a limited effect with statistical significance on prion 
disease, results suggest that there may be a significant biological effect of this 
coinfection. Table 4.1 show that prion infection may enhance prion disease 
susceptibility. Furthermore, the stage of H. polygyrus infection at which mice 
were co-infected with prions seems to influence the incidence of clinical 
disease. Evidence show that mice co-infected on day 0 and 8 post H. polygyrus 
had an incidence of 57% and 60% of clinical positive prion disease, while mice 
co-infected on day 1 and 14 post H. polygyrus had an incidence of 83% and 85%. 
Despite causing significant histopathological disturbances to the duodenum 
and within PP, coinfection with H. polygyrus did not significantly influence 
prion disease susceptibility, survival times or the development of 
neuropathology in the brain. Data from this study suggest that gastrointestinal 
helminth infections specifically in the small intestine may have little influence 
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 Introduction 
Prion diseases are progressive neurodegenerative diseases which can affect 
human and animals with fatal consequences. Although their origin can be 
sporadic or genetic, some are caused by the infectious prion particle (PrPSc) 
[392-395]. This is the pathological infectious form of the cellular prion protein 
(PrPC) which can be normally found in different tissues such as synaptic 
membranes of neurons and astrocytes, muscle, kidney, heart, secondary 
lymphoid organs and gastrointestinal tract [64, 396-399]. Although the exact 
route of exposure of infectious prions is unclear, many may be orally acquired, 
such as following consumption of contaminated food or pasture. While some 
gaps still exist in the understanding of pathogenesis following infection of the 
host, the requirement for certain key cell types to facilitate the spread of prions 
from the intestine to the central nervous system has been demonstrated.  
Studies of experimental mice orally infected with prions show that the prions 
are first transported across the gut epithelium in the small intestine and into 
the Peyer’s patches (PP) by M cells [135, 198, 369]. Once the prions are shed 
into the underlying subepithelial dome region of the PP they are then taken 
up by mononuclear phagocytes or dendritic cells (DC) [211, 400, 401]. If the 
prions are phagocytosed by dendritic cells, data imply that they are most-
likely destroyed [178, 378, 379]. If the prions are acquired by DC, they can be 
carried to the follicular dendritic cells (FDC) in the B cell follicles where they 
replicate [186, 340]. Prions replicate upon FDC at early stage of the infection 
before infecting the peripheral nervous system, through which they spread to 
the central nervous system (CNS).  Since the early replication of prions in the 
small intestinal gut associated lymphoid tissues (GALT) is essential for the 
prions to establish host infection [124], factors such as inflammation may 
significantly influence prion disease pathogenesis. However, the effects that 
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co-infection or inflammation specifically in the small intestine may have on 
oral prion disease pathogenesis are not known. Therefore, the aim of this thesis 
was to test the hypothesis that a congruent infection with a gastro-intestinal 
pathogen specifically in the small intestine may significantly influence 
susceptibility to an orally-acquired prion infection.  
In order to test this hypothesis, the natural mouse intestinal helminth 
pathogen H. polygyrus was used. This helminth was considered ideal for co-
infection with prions as it establishes infection specifically in the small 
intestine (duodenum) where it induces a chronic infection which is cleared 
from the host (C57BL/6) within 8-20 weeks [386]. The strain of the mouse 
determines resistance or susceptibility to the H. polygyrus infection. While CBA 
or A/J mice are slow responders which can host H. polygyrus infection for more 
than 20 weeks [402-406], other strains such as SJL and SWR can clear the 
infection within 4-6 weeks and are considered fast responsive [286, 402, 405, 
407, 408]. However, there is a range of intermediate responders including 
C57BL/6 (used in this study), BALB and NIH [386, 409]. Oral infection with H. 
polygyrus also leads to the development of significant pathology in the gut 
epithelium and induces the formation of granulomas in the gut wall.  
Furthermore, it has been shown that H. polygyrus infection can modulate other 
immune responses, including allergy and autoimmune inflammation [289, 
410]. 
H. polygyrus induces a polarized Th2 response that includes goblet cell 
hyperplasia, mastocytosis, enteritis and increased smooth muscle contractions 
and granulomas are normally developed during the infection [260, 269, 407, 
411]. However, little was known of the effects of H. polygyrus on the 
microarchitecture of the GALT and the status of key cell types which are 
known to play an important role in oral prion disease pathogenesis, such as M 
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cells, FDC and enteric nerves. Therefore, the aim of the studies described in 
Chapter 3 was to provide a detailed characterization of the effects of oral H. 
polygyrus infection on the microarchitecture of the gut and the GALT. As 
mentioned above, specific attention was given to the effects of infection on the 
cells which prions exploit in the intestine to establish host infection, including: 
M cells, macrophages, DC, FDC and enteric nerves. Data from those studies 
were then used to inform the design of the experiments described in Chapter 
4, which aimed to test the hypothesis that a small intestine-restricted pathogen 
such as H. polygyrus might significantly influence oral prion disease 
pathogenesis and susceptibility. Data from these studies revealed that 
although oral H. polygyrus infection caused significant disturbances to the 
microarchitecture of the small intestine and the GALT within it, these changes 
had limited effects on oral prion disease pathogenesis and susceptibility. 
When mice were coinfected with H. polygyrus and prions, the presence of H. 
polygyrus eggs in faeces suggest that parasite infection was cleared faster.  Data 
also suggested that the early PrPSc detection within MLN follicular dendritic 
cell network was reduced in some mice. In some animals the duration of 
clinical prion disease was longer, and in the brain, the accumulation of PrPd 
and the spongiform pathology were reduced. However, despite these effects 
co-infection did not affect oral prion disease susceptibility.   
A number of experimental co-infections with different pathogens and prions 
have previously been performed. In experimental viral co-infections in mice, 
such as intranasal co-infection with Piry-arbovirus virus at 15 weeks post 
intracranial ME7 scrapie prion infection, the microglial inflammatory response 
is increased, but no behavioral changes related to these were detected [412]. In 
the co-infection of mice with murine Friend leukemia virus (retrovirus) and 
22L scrapie prions (inoculated intraperitoneal) on the same day, no effects on 
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prion disease pathology were detected; even though scrapie infectivity was 
increased in an in vitro model [240]. However, when mice were co-infected 
with MAdV (mice adenovirus) and scrapie at a later time point (after 128 
days), susceptibility to prion disease increased [239]. Similarly, oral co-
infection with the bacterial pathogen S. typhimurium and RML6 scrapie prions 
showed an increased prion disease susceptibility associated with the acute 
inflammation in the cecum and colon caused by Salmonella [413]. Despite that 
this subspecie of Salmonella induced a moderate, acute suppurative 
inflammation restricted to the caecum and colon [414]; studies with S. 
typhimurium administered in gut loops, induced M cells differentiation in 
murine PP [415]. M cells are an entry site of prions [416], and its differentiation 
during S. typhimurium infection is dependent on the phosphatase activity of 
SopB, which is an essential protein that mediates the RANKL; this mediate the 
transformation of epithelial cells into M cells [415]. Contrary, previous studies 
with the large intestinal parasite Trichuris muris did not have a significant 
impact on orally acquired ME7 prion disease in C57BL/6J mice [124]. These 
results suggest that the pathogen, prion strain, timing of infection as well as 
the inoculation route may play an important role in the ability of a co-infection 
to alter prion disease development.  
Certain factors have been shown to modify prion disease pathogenesis, or the 
distribution of prions in the host. For example, prions have been shown to be 
able to accumulate in certain chronically inflamed tissues within prion-
infected hosts. These include ectopic/tertiary lymphoid tissues induced in the 
liver, kidney, pancreas, lung and mammary gland, as well as soft-tissue 
granulomas [235, 389, 417]. However, the increased number of colonic isolated 
lymphoid follicles (ILF) caused by T. muris did not influence prion disease 
susceptibility or disease onset even though there was increased accumulation 
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of PrPSc in the large intestine GALT at an earlier time post prion infection (15 
weeks). Other indirect effects of the inflammatory response may be critical 
such as the increased differentiation of M cells found in the presence of 
Salmonella infection [415] or cholera toxin [418]. Therefore, that fact that these 
aspects were not altered at the time of infection may underlie the reason why 
H. polygyrus did not alter significantly oral prion disease susceptibility.  
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5.2 Results 
5.2.1 Effect of H. polygyrus infection on ILF 
ILF are dynamic structures that similar to PP are in direct contact with the 
intestinal lumen. These structures have a FAE with M cells and a B cell-
containing germinal centre [335, 419]. They are also capable of inducing 
specific immune responses to antigens within the gut lumen [334, 419]. Data 
in this thesis showed that H. polygyrus infection reduced the number of ILF in 
the duodenum and colon on day 14 after infection (Figures 3.9 and 3.11). This 
is the first study to show this effect of H. polygyrus infection. This contrasts 
with the effects of inflammation [420], commensal bacteria [421] and the large 
intestine restricted helminth T. muris [422] that have been shown to stimulate 
ILF maturation. Neo-formation of ILF is dependent on RANKL to transform 
the gut villus epithelium into FAE in the small intestine [127, 130, 335], and the 
migration of B cells to the neo-lymphoid sites [423]. During H. polygyrus 
infection the Th2 response in the MLN is accompanied by an increased 
accumulation of B cells [403, 424], where these cells are retained and as a 
consequence depleted from other peripheral lymph nodes [353]; therefore, the 
effect on ILF may due to a downregulation or blocking of neo-formation of ILF 
by B cell sequestration. In the absence of PP, ILF were able to substitute PP 
function and accumulate ME7 prions when administered orally [125]. 
Furthermore, mice which only had ILF developed prion disease similar 
disease incidences and survival times as intact control mice [125]. Therefore, 
the reduction of ILF in the presence of H. polygyrus infection could have had 
the potential to reduce the uptake of orally-acquired prions from the intestinal 
lumen.    
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5.2.2 Effect of H. polygyrus infection on M cells 
M cells are antigen sampling epithelial cells in the epithelium that overlies 
GALT. These cells also play an essential role in the initial uptake of prions from 
the gut lumen [135, 369, 416]. B cells may play an important role in M cell 
differentiation as in their absence, specifically a CD11c+ population, there is a 
reduction of M cells [425][426]. Subepithelial dome stromal cells express 
RANKL which is essential for M cell differentiation [130, 427, 428]. Also, the 
transcription factor Spi-B is expressed on M cell differentiation [429]; although 
other pathways may also be involved in M cell differentiation as Spi-B may 
not be sufficient to induce differentiation [430, 431]. Bacteria like Streptococcus 
pneumoniae in rabbits or S. typhimurium in mice can activate M cell 
differentiation [346, 432, 433]. In the case of Salmonella, the increased density 
of M cells in the FAE is associated with SopB protein which induces the FAE 
enterocyte transition by activating tWnt/B-catenin signal that leads to the 
activation of the RANKL and its receptor [434]. 
In this thesis, contrary to what would be expected in bacterial infections, the 
density of M cells was increased at a late time post infection with H. polygyrus 
on day 35. This late response may be attributed to H. polygyrus 
immunomodulatory effects through their excretory-secretory products. 
Although the effect of these on M cells have not been studied, it is known that 
other helminths such as Schistosoma mansoni can reduce the severity of 
collagen-induced arthritis by downregulation of IFNγ, and the upregulation 
of the Th2 response  (IL4), as well as the anti-inflammatory cytokine (IL10) 
[435].  In this model, where S. mansoni was administered before the induction 
of arthritis, the gene expression of cytokines (IL-1, IL-6, IL-10, TNFα, and 
TGFβ), Foxp3 and RANKL were measured. The results showed a significant 
reduction of RANKL expression in S. mansoni/collagen-induced arthritis mice 
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[435]. Considering the role of RANKL in M cell differentiation it may be 
possible that H. polygyrus may also have a similarly immunomodulatory effect, 
which suppress M cell hyperplasia. Furthermore, it had also been shown that 
H. polygyrus also had immunomodulatory effects in arthritis models, although 
RANKL levels were not measured [436].  
In contrast, the increased density of M cells may be attributed to the 
inflammation induced by H. polygyrus infection. It is known that inflammation 
is another factor known to increase M cell density [337, 437]. H. polygyrus 
infection causes goblet cells hyperplasia and crypt hypertrophy. These 
changes may affect cell differentiation. Studies suggest that all the intestinal 
epithelial cells have the same origin in the intestinal epithelial stem cells, 
located in the intestinal crypts [428]. Therefore, it is possible that when mice 
clear H. polygyrus infection and goblet cell density is reduced there is a 
reciprocal compensatory increase in M cell differentiation.  
 
5.2.3 Effect of H. polygyrus infection on FDC 
FDC are stromal cells derived from vascular mural cells [438], and located in 
the B cell follicles within secondary lymphoid organs (PP, MLN, spleen etc.) 
[438, 439] and tertiary lymphoid organs [440]. These can develop in non-
lymphoid tissues under chronic inflammation in autoimmune diseases such 
as rheumatoid arthritis or chronic infections as hepatitis [420, 440, 441]. FDC 
are mutually dependent on B cells; while FDC provide CXCL13 to aggregate 
B cells expressing CXCR5 [442], B cells provide lymphotoxin and TNFα which 
promotes FDC maturation and maintenance [199, 200, 202, 443-445]. 
FDC capture and retain unprocessed antigens in the form of immune 
complexes [446]. In prion infection FDC act as prion accumulation and 
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replication sites [204, 447]. This is similar to the pathway of HIV dissemination 
[448]. FDC activation had also been shown to be influenced by commensal 
bacterial products in synergy with retinoic acid [449]. During H. polygyrus 
infection, data in this thesis suggested that FDC size was increased. It would 
be interesting to explore the possibility that these cells are proliferating or just 
expanding. The importance of this finding is that as FDC are sites of prion 
accumulation and replication, and their increased size or number during prion 
disease may provide additional sites of prion replication in lymphoid tissues. 
During H. polygyrus infection, there are changes in the villi and disruption of 
the epithelium. Thus, antigens could enter through the damaged epithelium. 
However, there was no increase in prion replication in the PP. This suggests 
that if the prions enter through the disrupted epithelium, prions were not  
taken to the FDC in the GALT. Likewise, mice that lack GALT but have M cells 
only in the villous epithelium do not accumulate prions in the MLN, 
suggesting this uptake through the villous epithelium does not deliver prions 
to FDC in the MLN [137]. It is also possible that prions do not enter through 
the damaged epithelium due to reduced exposure by the increased peristalsis 
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5.2.4 Effect of H. polygyrus on mononuclear phagocytes 
In the intestine mononuclear phagocytes (DC and macrophages) are typically 
found in the lamina propria and in the PP [450]. They also maintain a close 
interaction with the MLN to maintain the homeostasis of the gut by regulating 
inflammation and controlling infections [450, 451]. Their positioning in the 
lamina propria enables them to sample antigens from the intestinal lumen 
which they subsequently carry to lymphocytes to induce an immune response 
[173, 179, 312, 366]. In prion pathogenesis, DC can also acquire prions [210, 
452]. CD11c+ cells transport prions to the FDC and in the absence of DC 
expressing CXCR5, which attract DC to the B cell follicles, prion disease 
susceptibility is reduced [205]. Furthermore, in the absence of CD11c+ cells the 
early accumulation of prions in the GALT is blocked [180]. Macrophages have 
also been shown to have prion clearance properties [453, 454]. In this study, 
during H. polygyrus infection the distribution of these cells was significantly 
altered. While in the lamina propria CD11c+ cells were reduced on day 8, there 
was an increased density of CD11b+ cells on day 21 and in the PP, and CD68+ 
cells were increased on day 14.  Studies have reported that during H. polygyrus 
infection, CD11c+ cells migrate from the intestine to the mesenteric lymph 
nodes [375, 455, 456]. Therefore, it could be possible that mice co-infected with 
prions on that day could have an increased uptake due the damage of the 
epithelium; however, their transport to lymphoid organs may be limited by 
the reduced CD11c+ cells available. The increased detection of CD11b+ and 
CD68+ cells was later, on days 14 and 21. It has been described that H. polygyrus 
can activate macrophages by alternative and classical pathways from day 7 in 
colon; and their antimicrobial activity against Citrobacter rodentium was 
reduced in a co-infected model [401]. Also, the increased number of 
macrophages had been associated with the presence of granulomas [401]. 
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Therefore, although it is known that H. polygyrus can activate macrophages in 
its host, their function may also be limited. This effect may be reflected in 
increased prion pathology as macrophages may not be able to degrade prions 
at early times. However, most of the studies on H. polygyrus do not study the 
chronic infection and there is limited information regarding later time points. 
Also, it is possible that the increased number of macrophages in the lamina 
propria may have limited prion uptake from the disrupted epithelium when 
prion co-infection occurred on day 14 post H. polygyrus, and that could explain 
why no significant effects were detected. Within the PP, the increase detection 
of CD68+ cells may correspond to tingible body macrophages. They clear the 
apoptotic B cells in the germinal centres, but prions have been identified 
within them [139]. As they can degrade prions [400], they may have stopped 
prion dissemination to other lymphoid organs. 
 
5.2.5 Does prion infection alter H. polygyrus pathogenesis? 
Interestingly, prion infection appeared to influence H. polygyrus egg burden. 
Although the main objective of this study was to determine the effect of H. 
polygyrus on prion disease, different trends in the egg burden of each group 
were noted. These results suggest that there may be an influence of the prion 
infection over H. polygyrus infection which may need further studies as these 
have not been reported before.   
Although the cause of this effect is unknown, it may be possible that prions 
may affect H. polygyrus viability on their larval stage, the host immune 
response to H. polygyrus or the worm fecundity. It is important to consider that 
egg burden may be influenced by the worm burden,  the worm fertility (e.g. 
sex-ratio of adult parasites or mating success), and the relation of food intake-
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faecal egestion (food deprivation increases eggs/g of faeces output) [385]. In 
the groups of mice that were co-infected with prions on the same day or one 
day after H. polygyrus, there was a shorter time of egg production (4weeks); 
while in the mice co-infected with prions on day 1 after H. polygyrus, a marked 
reduction in the egg production was detected. At this time, it is possible that 
the worms and the prions get in contact with each other. It is known that 
worms also have a nervous system; and possibly this interaction may have 
affected the larva in some way that is reflected on the adult stage of the worms. 
Although evidence show the opposite as no PrPSc was detected by ELISA in 
adult worms (H. contortus, T. circumcincta, Chabertia ovina, Cooperia curticei, 
and Oesophagostomum venulosum) collected from necropsied ewes with 
clinical scrapie; neither H. polygyrus larvae hatched from eggs from prion 
infected mice transmit prion disease [457]; evidence suggest that some insect 
larvae (Sacrophaga canaria; fly larvae) can accumulate PrPSc and transmit 
prion disease. Whether prions can affect H. polygyrus larval viability or egg 
production remains to be determined. Despite that all the groups in this study 
underwent the same procedure, they were under different stage of H. 
polygyrus when caged individually in a bedding-less environment for prion 
infection. This stress may have also impacted the result by modifying the host 
immune response, causing a faster clearance, affect worm viability and egg 
production. It may also be possible that the adult worm burden is modified in 
some other pathway by the effect of prions in the nervous system. Thus, 
considering that H. polygyrus acts on the enteric neurons to activate NMU 
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5.2.6 Limited detection of PrPSc in MLN in H. polygyrus-prion co-
infection   
At 15 weeks after prion infection the incidence of PrPSc+ FDC in the MLN of 
mice co-infected with H. polygyrus and prions was lower when compared with 
those infected with prions alone. During H. polygyrus infection, the migration 
of CD11c+ cells to the MLN is reduced [458]. While most of this is likely from 
the lamina propria, it is known that DC are able to carry live enteric bacteria 
like Enterobacter cloacae within them from the PP to the MLN [324]. CD11c+ cells 
had also been shown to be essential for an appropriate infection and prion 
pathogenesis from the intestine lumen to the lymphoid organs [180, 376]; 
therefore, if their migration is impaired so may be prion translocation. As 
accumulation of prions in the secondary lymphoid organs is necessary for 
efficient prion disease development [125, 193, 348], if this is impeded, normal 
prion disease pathogeny will likely do too. However, as presented in this 
thesis, the lack of dissemination to the MLN did not affect the onset of prion 
disease or any other parameter of pathogenesis. Consistent with previous data 
[125], this suggests that the MLN are not essential sites of prion replication or 
accumulation and its necessity for prion disease pathogenesis may be limited 
after oral exposure. A similar conclusion was derived in a separate study using 
mice with a CXCR5 deficiency restricted to CD11c+ cells in which the 
susceptibility to prion disease was reduced, but the early accumulation of 
prions in MLN was not impaired [205]. 
Similarly, B cells had been implicated in the transport of prions from the FDC 
in the germinal centres of draining lymph nodes to non-draining lymphoid 
organs. This was demonstrated in mice treated with modulator or B cell 
restricted sphingosine 1-phosphate receptor (S1PR), which result in blocked 
prion dissemination [315]. S1PR control the egress of B and T cells from the 
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secondary lymphoid organs, and when blocked retain the lymphocytes within 
the lymphoid organ [459]. In chapter 3 of this thesis it was shown that during 
H. polygyrus infection, the number of ILF (B cell follicles) was almost ablated 
in the duodenum and colon. This suggests that B cell migration to the gut may 
be reduced during H. polygyrus infection leading to reduced dissemination to 
the MLN by B cells. 
 
5.2.7 Effect of H. polygyrus-prion co-infection on the terminal stage of 
prion disease 
As expected, only mice with clinical signs of prion disease at the time of cull 
had any pathological signs of prion disease in their tissues. The clinical 
positive mice from the co-infected groups did not show significant statistical 
differences in the incubation period or the survival time when compared to 
the group given prions alone. However, when mice were co-infected with 
prions on day 8 after H. polygyrus infection the duration of the clinical disease 
was longer. This could be due to the increased number of mononuclear 
phagocytes and the reduction of CD11c+ cells on this day. This may have 
limited the amount of prion particles that are taken to the FDC [211] and by 
limiting the number of infective particles, then less prions may get to the 
nerves. Although they developed the disease, this reduction may explain why 
it took longer to reach the terminal stage. Another potential factor to consider 
is intestinal peristalsis. This is considered to be increased during H. polygyrus 
infection [269], therefore, the intestinal contents are cleared in shorter time. If 
the intestinal contents including the prions flow faster, then the exposure time 
for prions to be uptaken may be reduced and they will be evacuated. Other 
considerations may be that the nerve-gut communication control prion 
neuroinvasion route. The expression of NMU which is a regulatory 
 
Chapter 5. General discussion  179 
 
neuropeptide of inflammation, tissue repair and worm expulsion [383], is 
expressed by the mucosal neurons during H. polygyrus infection [382]. 
Therefore, when mice are co-infected with H. polygyrus and prions on the same 
day, the transport of prions to the brain or through it may have been be altered. 
There are also numerous connections between the gut and brain. An example 
of this are the changes in cognition and behaviour attributed to the changes in 
microbiota induced by helminth infection [460]. However, even though H. 
polygyrus can modify gut microbiota composition [461], the microbiota on 
prion disease may have a little or no impact on prion pathogenesis [462, 463]. 
The survival times in this study can be compared with a similar study 
designed to determine whether a nematode infection could modify the 
scrapie incubation time. This was a similar study that used C57BL mice and 
co-infected them with H. polygyrus. It differentiates from this thesis because 
in most groups, mice were first infected with scrapie (orally with 100 µl of a 
2% or intraperitoneally with 100 µl of a 1% suspension of scrapie (C506-M3)-
infected mouse brain (corresponding to 105 ID50)) on day 0. Mice that were 
orally infected with prions received 200 L3 larvae of H. polygyrus infection 
either on day -7, +60 or +150 or repeatedly infected at those times [457]. The 
results were that mice inoculated with scrapie by oral route had a 
significantly longer survival times (313 days; except for group +150 (307 
days)) in all parasitized groups compared to the unparasitized control group 
(301 days) [457]. However, parasite infection did not significantly change the 
survival time (244 days) in animals inoculated with scrapie by the 
intraperitoneal route in comparison with its control (339 days) [457]. These is 
similar to the findings in this thesis where the survival time (Figure 4.9) was 
394 ±14 days for the scrapie alone group and 455 ±32 days for mice infected 
with prions at day 8 post H. polygyrus infection. Nevertheless, this parameter 
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was not statistically significant. This may be explained by the wide standard 
deviation which result from a small sample number. While here only 8 mice 
were used, the other study used 14. Also, these studies used a different prion 
strain. Despite that the results in this thesis do not have statistical 
significance, the results suggest a similar trend of longer survival time when 
co-infected with prions on day 8 post H. polygyrus infection.   
 
5.2.8 Prions do not accumulate or replicate in granulomas formed 
during H. polygyrus infection. 
Contrary to expectation, no PrPSc was detected in the granulomas induced by 
H. polygyrus infection. It has been suggested that prions can accumulate and 
replicate in chronic inflamed tissues in granulomas, even in the absence of 
FDC [234]. This result was not reproducible in this study. However, important 
differences between these studies such as the origin of the granulomas, their 
site of induction and experimental design may help explain the differing 
results observed. In this study, granulomas were formed as a natural host 
response to a parasitic infection. In the other study, the granulomas were 
induced through the administration of complete Freud’s adjuvant (CFA) or 
Zymosan resuspended in paraffin oil (Z/PFO) [234]. The origin of the 
granulomas is reflected in their structure [305]. Granulomas formed by CFA 
inoculation alone have minimal interstitial changes in comparison with the 
ones generated using CFA and bacillus Calmette-Guérin [464]. Although all 
granulomas independently of their origin share similar characteristic features, 
such as mononuclear macrophage compact collection, epithelioid cells, and 
with ageing fibroblast capsule [465], data in this thesis imply that the location 
of the granulomas may also have a particular influence in their 
histopathological composition. In this study the formation of granulomas took 
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place in a soft tissue. Other studies in different soft tissue (mammary gland) 
also did not report any prion replication in granulomas [389]. These contrast 
with the apparent ability of granulomas in the skin to accumulate prions [234]. 
However, the skin may itself be a site of prion accumulation [466]. Finally, the 
experimental design may also be a key difference. While in this thesis the prion 
infection was established before, after and during the formation of 
granulomas, in the Heikenwalder [417] study the prions were administered in 
granulomas induced 50 days before and boosted at 25 days.  
 
5.2.9 Helminth effects on other prion diseases and hosts 
Findings in this thesis show that helminth infection has a limited statistical 
effect on prion disease susceptibility. Like H. polygyrus, there are many other 
helminths that may have a similar effect in hosts like human, sheep or deer. 
For example, it may be possible to think that helminths that affect deer, cattle 
and sheep such as H. contortus, Teladorsagia circumcincta which affects the 
abomasum; Nematodirus spp. that affect the small intestine; Trichuris spp. 
which affect the caecum and large intestine; Capillaria spp. which is a 
migratory parasite that affect the lung and the intestine; or Chabertia spp. 
which affect all the intestinal tract [467], may behave similarly to H. polygyrus 
in a prion co-infection. However, helminths have evolved with their host and 
adaptation strategies vary between host and helminth species. For example, 
parasites such as Ancylostoma duodenale (human parasite) and Haemonchus 
contortus (ruminant parasite) differ from H. polygyrus in the way they attach 
and feed. Others may induce chronic inflammation and the formation of 
tertiary lymphoid organs which may influence prion accumulation. These 
specific characteristics may explain why parasites such as H. contortus from 
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scrapie infected sheep can transmit scrapie into mouse [468]; or why sheep 
infected with T. circumcincta (abomasum parasite) developed scrapie 
symptoms at a younger age [469], but prion disease susceptibility was not 
affected in naturally infected scrapie sheep which received either monthly 
doses (20,000 infective larvae (L3)) or  repeatedly doses (10,000 L3 at 6, 8 and 
14 months old) of T. circumcincta [457]. Therefore, these differences between 
the pathogenesis of different helminths may limit the applicability of 
comparing the results in the thesis with natural infections. 
 
5.3 Concluding remarks 
Together, the data presented in this thesis shows that co-infection with H. 
polygyrus has only limited effect on oral prion disease susceptibility and 
disease duration. However, this complex model (H. polygyrus-prion co-
infection) did reveal some interesting insights of the interactions between 
these pathogens in the intestine such as limited prion accumulation on MLN 
or the longer duration of the clinical phase of prion disease. Prion disease may 
also affect H. polygyrus egg burdens. Thus, although the early accumulation of 
prions in the GALT in the small intestine is essential for efficient 
neuroinavsion after oral exposure, data in this thesis show that the pathology 
caused in the small intestine by infection with a helminth such H. polygyrus 
does not affect prion disease susceptibility.  
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Appendix  
7.1 Multiple colour backgrounds (Image J macro) 
// Generic multiple colour macro for assisting setting of thresholds 
// Analyses pixel intensities along a line selection 
// for a series of greyscale slices in a stack, each corresponding to a colour 
channel 
// Expandable to any number of colour channels (slices) 
 
// Check for RGB image and convert to greyscale stack 
// Breaks if image name includes "(RGB)" 
image = getImageID(); selectImage(image); info = getInfo();  
if (indexOf(info, "(RGB)") >1) { 
 getLine(x1,y1,x2,y2,width); 
 run("RGB Split"); 
 run("Convert Images to Stack"); 
 makeLine(x1,y1,x2,y2);} 
 
Greyscales = 255; if (indexOf(info, "pixel: 16")>1) {Greyscales = 65535;} 
 
setLineWidth(1); 
getLine(startx, starty, endx, endy, temp); 
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stack = getImageID(); 
 
selectImage(stack); slices = nSlices(); 
 
for (i =0; i<slices; i++) { 
 selectImage(stack); 
 slice = "slice="+(i+1); 
 run("Set Slice...", slice); 
 ydata = getProfile(); 
         Plot.create(slice, "pixels", "intensity"); 
         Plot.setLimits(0, ydata.length, 0, Greyscales); 
         Plot.setLineWidth(1); 
 Plot.setColor("red"); 
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7.2 Multiple colour analysis (Image J macro) 
// Generic multiple colour co-localisation analysis macro 
// Analyses a series of greyscale slices in a stack, each corresponding to a colour 
channel 
// Expandable to any number of colour channels (slices) 
// Provides number of pixels above threshold for each combination of colour 
channels 
// Data provided is in bins corresponding to (for three channels): 
//  
// Bin Ch 1 Ch 2 Ch 3 
// 0 - - - 
// 1 + - -  
// 2 - + - 
// 3 + + - 
// 4 - - + 
// 5 + - + 
// 6 - + + 
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// Set threshold values for each colour channel (each slice) 
// Add extra thresholds for more than 5 channels 
Threshold = newArray(6); 
 
Threshold[1] = 80; 
Threshold[2] = 60; 
Threshold[3] = 50; 
Threshold[4] = 50; 
Threshold[5] = 50; 
 
// Check for RGB image and convert to greyscale stack 
// Where Ch 1 = red, Ch 2 = green, Ch 3 = blue 
// Breaks if image name includes "(RGB)" 
image = getImageID(); selectImage(image); info = getInfo();  
if (indexOf(info, "(RGB)") >1) { 
 run("RGB Split"); 
 run("Convert Images to Stack"); 
 exit("Draw your ROI and rerun the macro");} 
 
stack = getImageID(); selectImage(stack); slices = nSlices(); 
results = newArray(pow(2, slices)); 
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7.3 Raw data from mice co-infected with H. polygyrus and prions 
C57BL/6J female mice (90 days old) were orally infected with 200 L3 infective 
larvae by gavage. Then, on different days post H. polygyrus infection (days 0, 
1, 8 and 14) groups of mice (8 mice/group) were subsequently orally infected 
with 50 μl of a 1% dilution of scrapie brain homogenate prepared from mice 
terminally-affected with ME7 scrapie prions containing approximately 3.3 
log10 i.c. ID50 units. A parallel group of mice were orally infected with prions 
alone as a control.  
For early prion detection Peyer’s patches (PP), spleens (SPL) and mesenteric 
lymph nodes (MLN) were analysed at 5, 10 and 15 weeks post prion infection. 
Mice allowed to develop terminal stage of prion disease were clinically 
assessed weekly, from day 210 post prion infection, for the development of 
clinical signs of prion disease (Section 2.3) to terminal stage of the disease 
(Figure 4.7). Data obtained from the analysed tissues are presented. Incubation 
period, clinical sign period, and survival time are presented in days. Blank 
spaces correspond to animals that do no present clinical signs of prion disease; 
grey lines mark mice with different causes of dead (not prion disease related); 
positive (+) and negative (-) scores for each tissue (SPL, PP and brain) and its 
respective analysis. For spleen and PP, CD 21/35, PrPd, PrPSc. For brain PrPd, 
vacuolation, PrPd type (C, coarse; FP, fine punctate; PC, pericellular), GFAP 
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7.3.1 Early prion detection in Peyer’s patches    
      
85039 7 5 71.4286 35.35714
85040 10 2 20
85041 5 0 0
85042 2 1 50
85043 33.33333
85044 5 2 40
85045 5 3 60
85047 1 0 0
85046 7 3 42.8571 56.13095
85048 4 3 75
85049 6 4 66.6667
85050 10 4 40
85059 4 1 25 17.5
85060 4 1 25
85061 2 0 0
85062 5 1 20
85063 5 1 20 24.82143
85064 5 2 40
85065 4 1 25
85066 7 1 14.2857
85067 3 0 0 6.25
85068 1 0 0
85069 12 3 25
85070 3 0 0
85099 11 5 45.4545 19.69697
85100 3 1 33.3333
85101 8 0 0
85102 4 0 0
85103 2 1 50 22.22222
85104
85105 6 1 16.6667
85106 3 0 0
85107 5 2 40 41.78571
85108 10 2 20
85109 7 4 57.1429
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85119 7 2 28.5714 34.64286
85120 4 2 50
85121 5 1 20
85122 5 2 40
85123 6 0 0 15.55556
85124 6 0 0
85125 9 2 22.2222
85126 5 2 40
85127 7 4 57.1429 36.99405
85128 6 2 33.3333
85129 10 2 20
85130 8 3 37.5
85139 3 1 33.3333 22.22222
85140 3 1 33.3333
85141 5 0 0
85142 3 0 0 33.33333
85143 5 2 40
85144 5 3 60
85145 9 3 33.3333
85146 3 1 33.3333 52.08333
85147 2 2 100
85148 4 3 75
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7.3.2 Early prion detection in mesenteric lymph nodes    
 
85039 10 1 10 5.625
85040 8 1 12.5
85041 7 0 0
85042 11 0 0
85043 10 0 0 0
85044
85045 8 0 0
85047 8 0 0
85046 13 6 46.1538 65.3846
85048 6 3 50




85061 16 0 0
85062 3 0 0
85063 9 0 0 6.25
85064 4 0 0
85065 4 1 25
85066 11 0 0
85067 3 0 0 0
85068 7 0 0
85069 10 0 0
85070
85099 8.33333
85100 7 0 0
85101 3 0 0
85102 4 1 25
85103 8 0 0 5.35714
85104 14 3 21.4286
85105 3 0 0
85106 4 0 0
85107 4 0 0 0
85108
85109 5 0 0
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85119 10 0 0 0
85120 7 0 0
85121 13 0 0
85122 10 0 0
85123 9 1 11.1111 15.2778
85124 12 1 8.33333
85125 6 1 16.6667
85126 4 1 25
85127 2 0 0 10
85128 5 2 40
85129 3 0 0
85130 2 0 0
85139 12 1 8.33333 2.77778
85140 20 0 0
85141 8 0 0
85142 26 0 0 0
85143 0
85144 9 0 0
85145 10 0 0
85146 15 3 20 12.2222
85147 30 5 16.6667
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7.3.3 Early prion detection in spleens 
 
85039 53 0 0 0
85040 36 0 0
85041 50 0 0
85042 0 0
85043 53 0 0 0
85044 66 0 0
85045 385 0 0
85047 77 0 0




85059 0 0 0.96154
85060 0 0
85061 0 0
85062 26 1 3.8462
85063 0 0 3.59907
85064 0 0
85065 68 8 11.765
85066 38 1 2.6316












85107 46 4 8.6957 3.58901
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85123 0 0 3.57143
85124 0 0
85125 0 0
85126 35 5 14.286




85139 0 0 0
85140 0 0
85141 0 0
85142 36 3 8.3333 7.08333
85143 0 0
85144 60 12 20
85145 0 0
85146 38 2 5.2632 4.1567
85147 0 0
85148 0 0
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7.3.4 Incubation period, clinical signs period and survival time in days 
 
1 384 17 401
2 504
3 504
4 391 10 401
5 391 10 401
6 504
7 504
8 370 3 373
9 391 24 415




14 342 10 352
15 363 17 380
16 378 2 380
17 384 17 401
18 260
19 504
20 391 10 401
21 378 16 394
22 391 10 401
23 421 15 436
24 363 10 373
25 398 25 423
26 394
27 283
28 391 45 436
29 428 36 464
30 217 287 504
31 217 279 496
32 504
33 351 1 352
34 139
35 351 15 366
36 351 36 387
37 186
38 370 17 387
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7.3.5 Positive and negative scores for CD 21/35, PrPd, PrPSc staining in 
spleen and PP; in brain, vacuolation and PrPd 
CD21/35 PrP
d PrPSc CD21/35 PrP
d PrPSc  Vacuolation PrPd
1 + + + + + + + +
2 + - - + + - - -
3 - - - + - - - -
4 + + + + + + + +
5 + + + + + + + +
6 + - - + - - - -
7 + - - + - - - -
8 + + + + + + + +
9 - - NT + + + + +
10 + - - + - - + -
11 + - - + - - - NT
12 + - - + - - - -
13 + - - + - - - -
14 + + NT + + + + +
15 + + + + + + + +
16 + + + + + - + +
17 + + + + + + + +
18 + - - + - - - -
19 + - - + - - - -
20 + + + + + + + +
21 + + + + + + + +
22 + + + + + + + +
23 + + + NT NT NT + +
24 + + + + + NT + +
25 + + + NT NT NT + +
26 + - - + - - - -
27 NT NT NT NT NT NT - -
28 + + + + + + + +
29 + + NT + + + + +
30 + - - + - - - -
31 + - - + - - - -
32 - - - + - - - -
33 + + + + + + + +
34 - - - + + + - -
35 + - + + + - + +
36 + + + + + + + +
37 NT NT NT NT NT NT - -
38 + + + + + + + +
39 + + + + + + + +









0. Appendix  220 
 























1 1 2 2 1 1 1 1 C/FP C FP FP C FP FP
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4 1 2 1 1 0 2 1 C C C/FP C/FP 0 C/FP C/FP
5 1 2 2 1 1 1 1 C C C FP PC C FP
6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
8 1 2 1 1 0 1 1 C C C FP 0 FP C/FP
9 1 1 1 1 0 1 1 C C FP FP 0 C C
10 0 0 0 0 0 NT NT 0 0 0 0 0 NT NT
11 NT NT NT 0 0 NT NT NT NT NT 0 0 NT NT
12 0 0 0 0 0 0 0 0 0 0 0 0 0 0
13 0 0 0 0 0 0 0 0 0 0 0 0 0 0
14 1 1 1 1 0 1 1 C C FP FP 0 FP C
15 1 1 1 1 0 1 1 C C FP FP 0 C C
16 1 2 2 1 0 1 1 C C C FP 0 C C
17 1 1 2 1 0 1 1 C C C/FP FP 0 C/FP C
18 0 0 0 0 0 0 0 0 0 0 0 0 0 0
19 0 0 0 0 0 NT NT 0 0 0 0 0 NT NT
20 1 2 1 1 0 1 1 C/FP C C/FP FP 0 FP C
21 1 1 2 2 0 1 1 C C C/FP FP 0 FP C/FP
22 1 2 2 1 0 1 1 C/FP C FP FP 0 FP C
23 1 1 2 1 0 1 1 C/FP C FP FP 0 FP C/FP












0. Appendix  221 
 
 
25 1 2 2 1 1 1 0 FP C C FP C C 0
26 0 0 0 0 0 0 0 0 0 0 0 0 0 0
27 0 0 0 0 0 0 0 0 0 0 0 0 0 0
28 1 2 2 1 1 2 2 C C C FP FP C C
29 1 1 1 1 1 1 1 FP C FP FP C C/FP C/FP
30 0 0 0 0 0 0 0 0 0 0 0 0 0 0
31 0 0 0 0 0 0 0 0 0 0 0 0 0 0
32 0 0 0 0 0 0 0 0 0 0 0 0 0 0
33 1 2 1 0 0 1 1 C C C 0 0 C 1
34 0 0 0 0 0 0 0 0 0 0 0 0 0 0
35 1 2 1 1 0 1 1 C C FP FP 0 C 1
36 1 1 1 0 0 1 1 C C FP 0 0 C/FP 1
37 0 0 0 0 0 0 0 0 0 0 0 0 0 0
38 1 2 2 1 0 1 1 C/FP C C FP 0 C/FP 1
39 1 2 1 1 0 1 1 C C C FP 0 C/FP 1
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1 3 3 3 2 3 2 1 1 2 1 1 1 1
2 1 1 1 2 1 1 1 1 1 1 1 1 1
3 1 1 1 1 NT NT NT NT 1 1 1 1 1
4 3 2 3 2 2 1 2 2 3 2 1 1 1
5 3 2 3 2 2 3 3 2 3 2 2 2 2
6 1 1 2 1 1 3 NT NT NT NT 1 NT NT
7 1 1 2 1 NT NT 1 2 1 1 1 1 1
8 3 2 2 1 2 3 2 2 3 1 2 1 1
9 3 3 3 2 3 2 2 3 3 1 1 2 2
10 1 1 2 2 NT NT 1 1 1 NT NT NT NT
11 NT NT NT NT NT NT NT NT NT NT NT NT NT
12 1 1 1 1 1 1 1 1 1 1 1 1 1
13 1 1 2 1 3 1 NT NT NT NT NT NT NT
14 2 2 2 2 3 3 2 3 2 1 1 2 2
15 2 1 2 1 2 2 2 1 2 1 1 1 2
16 3 3 3 2 3 2 2 2 3 1 2 2 2
17 3 2 3 2 3 2 2 2 3 2 2 1 1
18 1 1 1 1 1 1 1 1 1 1 1 1 1
19 1 1 1 1 1 1 1 1 1 1 1 1 1
20 3 2 2 1 3 3 2 3 3 1 1 3 2
21 2 2 3 2 3 3 2 2 3 1 2 2 2
22 3 2 2 1 3 3 1 2 2 1 1 2 1
23 3 1 2 2 2 2 2 1 3 1 1 1 1
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25 3 3 2 1 2 1 2 2 3 1 NT 2 1
26 1 1 1 1 NT NT 1 1 1 1 1 1 1
27 1 1 1 1 2 1 1 1 1 1 1 NT NT
28 3 2 3 3 3 2 2 2 3 2 2 2 2
29 3 2 2 1 2 2 1 1 2 1 1 1 1
30 1 1 1 1 1 1 1 1 1 1 1 NT NT
31 1 1 1 2 1 1 1 1 1 1 1 1 1
32 1 1 2 1 2 1 1 1 1 1 1 1 1
33 3 3 2 3 2 2 NT NT 3 3 2 2 1
34 1 1 1 2 2 1 1 1 1 1 1 1 1
35 2 2 3 1 3 3 2 3 3 1 2 2 2
36 3 3 2 1 2 3 2 2 3 1 1 NT 1
37 1 1 1 1 1 1 1 1 1 1 1 1 1
38 3 3 2 3 3 2 2 2 3 1 2 1 1
39 NT NT NT NT NT NT 2 2 3 NT 2 NT NT
40 1 1 1 1 2 1 1 1 2 1 1 1 1
Day 14
Day 8
